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3.
fille-' Btmàf m m  dèilgn ed  th é  m tm xt
m d  m e # #  o l aciivafclon o f jghe complement #y#t#m In human 
0H# ''In order io  do , renal hl#p#y im aletlal wae- obtained 
from  104 p a ilen ii. Baçh:of Mop#W# M l into one of  
# 0  following. d lJ tln d  p a tW og lm l #t#.gori#» ol'glomorulo^' 
pepbrW# ( # # i  m em branow QM {MOM)#----haembtanoproilloratlvo 
ON (MPdK)# fb W  ON (0)Q$ IiW <A% ~SohW elnnepW tl# (BSN). 
ayeWnW lupu# orythématoeu# ( % #  Wd m inim al ohmg# 
nephtodo syndrome (MONS)# ' ■ f h e  Mopmlee were-examined  
lo r  # o  pre##mee o l  Immunoglobulin#* '#a##leàl and alternative  
pathway component#* " 03- and 0 8  and the,, ieru m  conoentratton# 
o f the complement protein#* <at '"tbe #n#e M the blopey* were.
, also, meaanredv'
There wâe evidence of. w e n # |y #  complement activation  
in  a ll  # # e a # e  grot##" with me, exception o f MCNS and deposition  
of C3 was apparent In a ll M PàN and SLB jblopelee and at lea st  
a9% efM #N .F àN an d H S N b l^ ^ ^
f  he evidence presented In tM-#' study anggeet# #mt* In 
MGN and SLE* # e - complement iyetem  wa# activated prim arily  
by immune- oomplexe# Involving IgG anMbodle.# via-tiie c la ssica l  
pathway elnde m ore blopele# w ere positive for c la ssica l than 
alternative pathway/component# .and there w ere eigniflcant 
Correlation# between the Intensltie# of deposition of 03  and
4.
IgG. Proper## itéqémtlf present in SHE
and-wuf also loundth a  small number of MGN MopeWe 
miggesUng that acllvaiion of the .aliomativo pathway may 
also ha Involved'In.theia-'IWo^#iea#ei*:- - The Intensity of 
AotlVa#m% wa# greater I# than In M W  with Wgh intonsltlos
pi deposition ahd' r e d u c #  serum  m wantm tW w . of complement 
prôteW #
fa  MPON. EGN Wh# BSN both pathwàÿ» of aotlvation were  
Imrolvod m d  aWiOUgh l#:-MPW and 'BSN m ore hiopeiee were 
positive for o iterm tlve rather t e n 'd a ie le a l  pathway component# 
and In FGN the cpw erm 'w a# true# # rr# m tlo n  itudlee* comparing 
the InteneW ee of deposition of icla##|:ml end M tem etlve pathway 
component# w ith # o # e -o f .:G3# weW  nnahle to dletingniah which 
pathway whl;ptimarilyre#poh#lhle' for G3 catmholiem#
"MCNS whe Included In Ihl# etndy' to represent e control 
group end evidence- of ac#v#lon  of ' complement m m  found, 
only weakly*- In twoblopeioe# ' . '
■Activation o f the - compleme#^ eyetem  I# known to he under 
the control of e#vem l-pla#m à protein#- an# "the ro le  of these  
protein# ha#not been prevlohely a#e###ed In GN* It wa#
‘ è o n ilié r e #  pOee&hle t W f W  com#eme%t -activation apparent 
In alm ost a ll type# of ON nn# Wenme Ih: som e m ay have been - 
the resu lt o f a hrcakdov# In the m#chW .#m for controlling 
complement activation* . ïn .o td er  to cw m ln e  this poaalMllty*
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th e  deposition.'M ’theée  control, p ro te in#  of com plem ent ' 
a c tiv a tio n ,, €  Î ♦‘tnhibitor-(C  Î-IM îî), ' C3b -Inactivator (C3MHA)
■and B IH  glQbuiiii'-wae’ Studied ând the  se ru m  concen tra tions 
of th eçe  pro tein# ' m 'eaeured . , . . .
. T h é 'serum , concontrationo of coptroï p ro tein#  w e re  seldom  
^rW nced w ith low eerilm  lèvélp  of;.d3l#H4''ln-the aprum  from  
fou r'pa tien t#  am tlo w  p iH  level#  in  the  se ru m  from  only one 
pa tien t and  ald |ough the 'iunctlosia l acUvlty of tîm. protein© was 
no t m ea su re d  tîiÇre l e , no -evidence to  auggost th a t com plem ent 
B G t W a t W n , g We r a l  clue to  an  acqhirod  or. a  genetic ,deficiency  
"of con tro l protdins*. A lso  tho alghificant c o rré la tio n s  betw een 
concen tra tions of GIs' and Cl-KMH in  FO N  and hetw een hoth'-CShlHA 
and p  lB  and G3.i n  MFCÏN and 8LE suggests  th a t  activa tion  In the 
c ircu la tio n  was un'der the  control of-i'he#e p ro te in s  in  tîiese  d ise a se  . 
groups* \   ^ - TV- / " , ; ;
T here  Is otrông. evidence to  'suggoofc tha t JBlH-v/as p re se n t in  
the tlG G uesin .r.eep.onoe W deposition ' of-C.S and ae-'such w as regu lating  
the ac tiv itie s  of G3b; ^  IH was- p re s e n t in  94% of C3 positive  b iopsies 
and v/ae n e v e r found in  tW  absence of G3# 'tîte  in ten sitie s  of deposition- 
of C3 c o rre lâ te d w ith  those-: o l’B  IH in  MGN, MPC5N and FON and.
- the  distribution# p a tte rn s  of th ese  two %>r#tcins in /the  g lom eru li %vere 
v e r y  ;; '. p l H ■ wau%l^ro.éeht''ëven .jin M dheys o f  th re e  .M.PGN
p a tien ts  w ith c ircu la ting  .nephritic-.factor.
The Otiwr con tro l p ro te in  of 0 3 b / Ç3bINA, w as p re se n t in
6.
m t f  % I b iopsies end therefore this study offers llttie  evidence 
for the ro le  of €3bîHA in'the regulation of C3b In ON# Absence 
of G.IblNA need not mean a breakdown in  regtdation since the 
mode of action of 03M NA.|s to en^ymatlcatly inactivate CSb#
The ro le  of I» h a rd e r  to  a s s e s s  since  the concordance
betw een b iopsies posiWve fo r  $1# and-C W N H  w as genera lly  not 
<â.om and a  a lgnW cant co rre la tio n  betw een th e  intensitôes of 
th ese  two p ro te in s w as only found in-MPGN. The d istribu tion  
p a tte rn s  of C îs  and OÎ^^INIf* however* w here  both w ere  found 
together* w ere  v e ry  s im ila r  and i t  Is  poss ib le  tha t w here 
C Is  and OÎ^ïNH w e re 'p re se n t in  the sam e b iopsies that CI^INH 
was acting  a s  a  reg u la to r of com plem ent ac# v a# o n  and, w here 
GI*INH w as found alone* i t  m ay be acting a s  a  reg u la to r In one 
of the o th e r hnm êra l m ed ia to r-sy stem s In  which i t  i s  kimvm to 
b e  Involved. O ther p o ss ib ilitie s  have been  suggested*
F ro m  the re su lts  -presented in  th is  study th e re  is  th e re fo re  
l i t t le  evidence to suggest th a t activation  o f the  com plem ent 
sy stem  in  hum an GN in  the  re s u lt  of a  deficiency in  regulation  
of complement*
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G lom erulonéphrltig
Olomérulonephrlbis (0!N) la a diaeaae involving a 
deatructiv# ln#ammatqry lésion  of the glomerulus which 
la often acoompanled by tubular# vascular and interstitial 
abnormaliMea (I), Claaeiflcation was initially  based  
prim arily on clinical findings vdth histopathological 
informa^on being available only following post mortem  
examination (2-5)* After the Introduction of the per­
cutaneous renal biopsy techrdque (6), it  becam e possible to 
employ histological criteria. Now morphological and 
Immunological data are combined to give a m ore useful 
classification.
It is  generally believed that immunological mechaxdsms 
play a major role in the pathogenesis of m ost types of GN.
This belief was based originally on the fact that GN often 
followed an Infection. More recently# the use of various 
Immunological techniques has confirmed the involvement of 
immunological m echanism s in m ost types of GN.
In order to w derstand Immunologically-medlated glomerular 
injury# it is  important to understand how immunological 
p rocesses produce injury. Gell and Coombs (7) have 
divided the specific  immunological m echanism s into four 
categories of hypersensitivity# designated types I to IV 
and these will be considered in turn with particular reference
18.
to the part each plays in  the pathogenesis o f ON.
In type I hypersensitivity* reaglnic antibodies bind by 
their F c  regions to sp ed flc  receptors on the membranes 
of basophils Or m ast cells* In man* these antibodies are  
maltdy of the îgË c lass although Ig(%antibodies may also  
be involved (7* 8). When antigens come into contact with 
their specific  cell^bound antibodies* Immune complexes 
form on the suri&stce of the cell causing membrane changes 
and degranulation* with release  of vasoactive substances* 
particularly M stamine. In addition* platelet activating 
factor (PAF) I» released  which causes platelet dumping 
and subsequent re lease  from  the platelets o f vasoactive  
am ines (9# 10). Vasoactive am ines cause contraction of 
smooth m u id e  and increased capillary permeability*
There are severa l reports of IgE deposition In the 
kidneys of patients with ON. Nagia (11) reported deposidon  
of IgF# IgO and OS in a pa#ent with membranous glom erulo­
nephritis (MON) and asthma and signi#cant amounts o f IgE 
were found in ZZ of 146 renal biopsies from patients with 
various diagnoses (12). The slgnli^cance of IgE* in  the kidney# 
where m ast c<dls are seldom present* is  uncertain but may 
Indicate that an IgE antibody response has taken place.
; . 19.
It has been suggested that IgE antibody may play an 
important role in the deposition of immune complexée in GN 
(12, 13)/ The mechanism proposed is  that anti gene complex 
with IgE antibody on the membranes of circulating basophils 
and vaeoactlve amines are released causing increased  
capillary perm eability and thus aiding deposition of Immune 
complexés within the kidney. It is  therefore possib le that 
a type I hyperseneitivlty résponse may predispose to immune 
complex deposition. The antigèn deposited may be that 
involved la  thé type I reaction or some other unrelated 
antigen. -
An association has been noted between minimal change 
nephrotic syndrome (MCNS) and type I reactions in several 
patients (13 ,14 ,15), and deposition of IgE in MCNS was 
found in one study (13). Other workers failed to substantiate 
these findings (12 ,16 ,17). The frequent absence of 
immunoglobulins in the glom eruli (18) suggests that this , 
disease is  not caused by the deposition of immune 
com plexes. It is  possible however that type I hypersensitivity  
may play som e role in tîie pathogehesis o f MCNS, perhaps 
by increasing capillary pernieability.
Type II H ypersensitivity,
Type II hypersensitiv ity , o r antibody m ediated  hyper-  
sensitiv ity  involves the cOmplexing of antibodies with
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cellular or tie sue-bound antigens. The antibodies are  
usually of the IgG and IgM classee  and damage may result 
in one of three ways; a) from contact between the antibody- 
coated cell and a phagocytic cell via an F c  receptor* 
b) by direct activation of the complement ay a tern by the 
binding of C lq to the immune complex on the cell surface 
with a ll the biological conàequencê» involved in complement 
activation, a» will be diacuaaed later* or c) by antibody- 
dependent Cell-mediated cytotoxicity. The la st mechanism  
involves ti>e K cell which is  a subclass of lymphocyte with 
the capacity to ly se  antibody-coated cells by an, as yet, 
unknown mechanism  (19).
Anti-glom erular basement membrane d isease  (anti- 
GBM disease) is  known to involve a type II hypersensitivity  
reaction. In this* antibodies are formed with specificity  
for the glom erular basement membrane. They may cro ss-  
react witîi lung basem ent membrane (20* 21) and tubular 
basement membrane {21). The association between anti- 
GBM d isease  and the HLA antigen, DRW 2 (22) suggests 
that genetic factors may be involved.
Various initiating mechanism s have been implicated  
in this antibody productions 1) streptococcal antigens 
share certain antigenic determinants with botli lung and 
kidney basem ent membrane (23) * Antibodies formed to
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strep tococcal antigens during an infection could tlte re fo re  
re a c t against basem en t m em brane and re s u lt  in  tlxe 
developm ènt 'Of an  autoim m une d ise a se . E vidence to 
support tills is  that tlxe d isease  m ay occur in  assoc ia tion  
with a  ra ise d  an ti^strep to lysin -O  t i t r é  (24), Z) anti-GBM  
d ise ase  has a lso  been rep o rted  following an influenza A2 
infection (25). In  m o st cases th e re  la no evidence of 
infection, $) an  assoc ia tion  between hydrocarbon exposure 
and anti-GBM  d isease  was noted in six  of eight pa tien ts 
in  one study (26) and ra ts  m ade to inhale benzene developed 
a  d ise ase  s im ila r  clin ically  and m orphologically  to anti-GBM  
d isease  (27). I t  has been suggested that an agent which 
dam ages lung-tissue-m ay cause-the re le a se  of a lte re d  
self-an tigen#  and in itia te  antibody production to lung and 
Iddney basem ent m em brane (26), 4) g lo m eru la r basem ent 
m em brane antigens a re  p re sen t in  norm al se ru m  and urine 
and rabb its  in jected  with GBM preim rations fro m  autologous 
u rin e  develop antl-G BM  d isease  (28). I t  has been proposed 
th a t th ese  basem ent m em brane fragm ents m ay be recognised  
a s  fo reign  perhaps during a  phase of generally  heightened 
im m unological resp o n se  due to  an  infection.
P la sm ap h e re s is  of patiexits with th is  d ise a se  over 
a  pe riod  of tim e, witîi im m unosuppression* re su lts  in the 
rem oval of antibodies (29) and the cessation  of antibody
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pyoduWoAi THiâ suggérés tiiat thé d isease  is  seH  llm l^ n g , 
and ikyonm  $W hypothesis tha t i t  is  caused by dam age 
to tung o r  kidney producing self^an^gens* Once the lung 
o r  kidney ieslon  heàle; the antigenic stim ulus fo r antibody 
producüpn i s  lo s t  and the  kidneys a re  not dam aged fu rth e r. 
F u r th e r  evidence fo r the self*^limiting na tu re  of the d isease  
l ie s  in  the  fac t that* a fte r nephrectom y, the antibody t i tre  
. declines, slowly and^,, if.'transplantation-takps p lace  a fte r 
the elim ination of the anybody, .recu rfence  of'the  d isease  . 
ie rare (21). • ^ .
Once the antibody has bound to the basem ent m ém brane, 
a ll the consequences of a  typé 11 reaction  occur and dam age 
m ay b e  aeon  td in v o ly e  infllt'ration_ of inflam m atory  cells , ' 
proiife^^atlon of g iom eru lar cells , shattering  and corrugation 
o f  the 'basem en t m em b ran e '(1) . . In  rabb its , w here the 
expérim ental d isease  is  called nephrotoseiG n ep h ritis  (NTH)$ 
dam age m ay a lso  be..dem onstrated by-'an in c re a s e ’of basem ent 
m em brane fragm ents in the u rine  (30) /
The im portance' of the com plem ent system  in  th is  d isease  
is  shown when rabb its and ra ts , in.which HTN is  induced, 
a re  depleted of com piém eht (31). The in filtra tio n  of poly^ 
m orphonuciear leucocytes (FMI^ is  reduced  and the patho*
‘ logical les ion  is  tnuch l e s s 'sevéré." ' When PMN a re  depleted, 
the re su lts  a re  the sam e although antibody deposition occurs
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ndrm aU y (3
C erta in  anti-OBM  antibodies, which do no t.ac tiva te  
com plem ent, such as  avian antlboclieo, a re  ctiXl capable 
of producing lim ited  p ro te in u ria  In ra ts  (33). Aloo, in 
tîié hetérologoua phase of guinea-pig HTN, i t  has been 
shown th a t p ro te inu rin  is  Independent of both com plem ent 
activation  and the actions of PMH and very  l it t le  C3 ia 
found deposited in  the glom erulus (34), Some o ther 
m ecim nism  fo r producing dam age m ust th e re fo re  ex ist.
A m ononuclear cell fro m  the bone m arrow  has been 
im plica ted  in the pathogenesis of NTH in  ra ts  (36). if  
ra ts  a r e  depleted of bone m arrow  cells  by irrad ia tio n  
befo re  induction of the d isease , g lom eru lar hyperco llidarity  
Is d ecreased  and p ro te in u ria  is  reduced com pared with 
control an im als witii NTH aimough antibody Is s ti ll  p re sen t 
in  tlie kidney. The effect is  not a lte re d  by dé com plem enting 
th e  an im als. '
In the m ajo rity  of pa tien ts with antl-OBM  d isease  " 
deposition  Of com plem ent components occu rs and the 
com plem ent sy stem  Is  likely  to play a  ro le  In patliogenosle. 
i n  som e patien ts, however,- com plem ent com ponents a re  
not deposited  (Z l, Sh), Some o ther m echanism , perhaps 
involving m ononuclear ce lls  m ust th e re fo re  be responsib le  
fo r tlie  dam age.
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Six days following the Induction of NTH la  rabb its , . 
f lb rla  deposW oa la  fom%d roimd the cap illa ry  loops and 
within Bow m an's apace. C ells ol Bowman!» capsule 
p ro life ra te  and In filtra te  the  fib rin  resu lting-in ' c re scen t 
fo rm a tio n ,. When coagulation was prevented by the  
adm in istra tion  o l à rv in  (37) and w arfarin  (38), no fib rin  
w as'deposited , few er o res cents ■■formed and p ro life ra tio n  
of tlie cells  of Bow m an's cax^side was m uch reduced 
although immimogXo'buHn deposition was unaffected (38).
Thus a t  le a s t  two in te rre la te d  hum oral e ffec to r 
sy stem s, th e .com plém ent and coagulation system s, and- ' 
perlm ps a lso  the partic ipa tion  of a  m ononuclear cell 
h^fluence the pathogenesis of .experim ental anti -OBM d isease . 
Antl-GBM  d isease , a s .rep o rted , com prises only a  sm all 
p roportion  of GN patien ts (20, 21).
T here  I# sOiAe evidence to-suggest th a t a  typo II hy p e r­
sensitiv ity  ■réaction- m ay be  involved in tlie patlxogeneais of 
focal g lom eru lonephritis (FCtN) since IgA eluted fro m  tlie 
kidney of an FGN patiesit was found to .bind weaidy to 
m esang ial ce lls  in  no rm al kidney sections' (39). This is  
discues'ed in 'm o re  deta il in. tlie introduction to -chapter 5.
Some types of- GN, o rig inally  thought to  involve the  
depo-sltlon of im m une com plexes fornaed in # ie  c ir  culation, 
m ay in  fac t be  due to tlie binding of antigens, p a rtic u la rly  a t
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'the aspect of the basement'membrane and
the oubsequént formation of lihmime complexes In situ (40). 
This is based on the fact that thé preformed Immtme 
complexe© cannot W mactO'to-crOss the basem ent.membrane 
in ejsperlmental OH, potentlaEy nephrltOgenlc'antigens have 
been detected In'à èiibepltheliol position in normal rats ■ 
and workers have frequently failed to. detect circulating 
immune complexes in ,d|aea$eo with-glomerular oub- 
. ep ithelial depoéite particularly in  m em branous glome ru le  « 
nephrWe (îàçH ),
DHA,W known to  have a  strong affinity for glomerular 
basement membrane (40a) and it  la  possible that DHA binds 
-to basemeht membrane and immune complexes form In situ. 
The significance of this mechanism in the OH of GLB is not 
known but i t  may be Important In those patients with an 
MON-like ■'lesion,
. It hm  been shown that rat glomeruli' contain, renal 
tubular an^gene in a subepltheliai position and that antibody 
to ■■the'so antigens. may combine with the antigen at the 
hasementmembrane to form-an-.'MGH-type lesion (40). -,
In this w a y itis  possible that other antigens may bind to : 
#%e basement,membrane and# after induction of an antibody ' 
respons'b» GH may develop,
' Factore wMch may effect the binding of antigens to .
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bapem ént m em brane ar©.' î) the s ise  of the antigen, Z) the 
charge on the antigen amd 3) . factor© v/hidi m ay a l te r  the 
charge of tlie baoem ent membmm©, i -
Type l i t  H ypersenpitiv ity
This involves the  form ation  of antigen/ antibody im m une 
com plexes e ith e r in the w alls of blood vessels# p a rticu la rly  
w here  th e re  is  anybody excess? tin s is  called  an A rthus 
reaction , o r  the form ation, in  the c ircu la^dn , of im m une 
com plexes v/hich m ay subsequently deposit in  the t is su e s .
When im m une com plexes deposit in  the Iddney, they m ay 
cause dam age in  various ways; 1) the physical p roseiice  
of the com plexes in the m em brane m ay d isru p t the in teg rity  
of the  m em brahe, Z) im m une com plexes m ay in itia te  ce llu la r 
p ro life ra tio n  and/ or in c reased  basem ent m em brane production 
o r  3) com plem ent activation  m ay a ttra c t in flam m atary  and 
phagocytic ce lls  to the  s ite  of deposition with re su lta n t 
dam age, '
M ost types of GH a re  believed to Involve type III 
hypersensitiv ity  but evidence based  on- #©  detection  of 
c ircu lating  im m une com plexes o r  the io ca iisa tlo u  of antigen 
along w ith im m unoglobulin in the kidney has been  found 
Only in  iso la ted  c a se s , ■ ■ . '
■ T here  a re  a  num ber of occasions antigens have
been found. The n ep h ritis  of BhE  is  known to involve the
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formation of anilbodlé© to DNA and other nuclear antigen© 
(41). A,old einate© of kidneyn from patients xvlth SBE have 
been fotmd to contain higher conoentrationo of DNA antibodies 
than 'was found In, the serum and ImmmioHuorescence studies 
using pnrWed anti-DNA ha,v© demonstrated the presence of . 
DHA along , thé capillary loops of the glomeruli along vdth ' 
imrmmoglobnlm's.. There is ■therefore.little doubt, that SBE 
nephritis involves,-the. deposition of Immune complexes. 
Whether W s is the only-pathogenic mechanism Is un.clear 
.and the possibility b i a type II Involvement has already been 
discussed, . ,
Table I,. I shews a l i s t  of som e antigens known to be ■ 
involved In Im m nne complex GN e ith e r bo cause they have 
been  dem onstra ted  In-the kidney o r be cause spefclfic antibody 
has been eluted fron i the  Mdney, Many o ther antigens have 
been im plics^étbbnt not, as yet, proved to be  involved.
Characterisation of t!ie antigens would prove useful for 
two reasons#- I) elimination-'of the #%tlgen. could be-attempted 
or 2) If a pure nonTtoxIc form of . the antigen could be 
prepared,  ^th|s .could be injected into the subject in large 
amounts Changing tlie ratio of antigen to antibody and 
causing the dissolution of the deposited complex. Using 
thé chronic eerum .slclmess model of GH in rabbits, a 
huge excess of antigen v/as shown, to terminate antibody
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Table I * l  i Antigène known to he involved In Im m m e
- com plex glom ernlonephvitie
ANTIGENS REFERENCE RENAL MANIFESTATIONS
EXOGENOUS
BAGTEEiA:- . . '
STEEPTDGOCCi 42 acut« GN
STAPHYLOGOCei 43 - , not âoBcribod
SALMONELLA, 44 FGN,
ENTEROCOCCI ■ - 45 ' FGN
PNEUMOGOeOl 46 acuto GN
TREPONEMA 47 MGN
VIRUSES:-
HEPATITIS B 48 MON
MEASLES 49 normal
, ONCORNAVIRUS 50 normal
PROTOZOA:*
PLASMODIUM 51 various
t o x o p l a s m a 52 acnta GN
, e n d o g e n o u s
NUCLEAR ANTIGENS - : 53 various
TUMOUR ANTIGENS . , , MGN
RENAL TUBULAR
ANTIGEN . 55 ' ■ '■ ■ .MGN
............. '----■- ......... :---L--
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production and shortened the half life  of the antigen in the 
intraglom erular com plexes (
It i# probable that, while numerous and d iverse stim uli 
cause ON, the host's Immune response is  an important 
factor in deciding whether GN w ill develop and what form  
i t  w ill take. Two facts support this: a) a single type of 
GN may develop as the resu lt of various anUgenic stim uli, 
for example, #G N  may Involve treponemal antigens (47), 
A ustralia antigen (48), tumour antigens (84), renal tubular 
antigens (58) and others and b) the same antigenic stimulus 
may cause the development of various types of GN. This 
is  seen in the chronic serum  sickness model of GN in rabbits 
where animals given daily doses of bovine serum  albumin (BSA) 
exhibit at lea st three responses; a) the animal may make no 
antibody and GN fa lls to develop, b) it  may make much strong 
affinity antibody with the formation of large immune complexes 
which are rapidly removed from  the circulation and there is  
no damage to the kidney and c) it  may have an interm ediate 
antibody response resulting in immune complexes in antigenic 
excess which deposit in the kidney (57). The existence of 
such diversity within a single strain of rabbits suggests that 
even greater diversity could occur in man*
Much work has been done to establish the m echanism  of 
immune complex deposition in tissu es. Thé s ise  of the immune
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complexes formed i s  probably important in deciding whether 
deposition will take place. The s ize  of the complex is  
determined by the anidgen/ anybody ratio» the affinity of the 
antibody for the antigen, the c lass of antibody, the s ize  of 
antigen» the nnmber of antigenic sites on the antigen and the 
interaction of the complex with other factors such as complement 
and rheumatoid factor. In aCute serum sickness in rabbits 
(58) and guinea-pigs (89)» deposition of immune complexes 
within glom eruli and arteries occurs only where complexes 
greater than 19S are formed although these complexes are  
quickly removed from  the circulation* When preformed  
BSA/ anti*»BSA complexes of varying sizes  w ere injected  
into rabbits» only where complexes larger than 19 S were 
adm inistered did deposition take place (6o), Other proteins, 
such as keyhole lim pet haemocyanin ( S9) and aggregated 
gamma globulin, sim ilarly  deposited only where the molecular 
s iz e  was in e x c e ss  of 196. Although this indirect evidence 
suggests strongly that only complexes greater than 19 6 deposit, 
no d irect evidence is  available to substanüate this since ti^e 
s iz e  of intraglomerular complexes cannot be estim ated and it  
Is lik ely  that the s iz e  of the complexes w ill a lter once they have 
been deposited.
Evldenoe suggests that Increased vascular perm eability  
may a lso  be necessary for deposition. Colloidal carbon
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could b# m âd è 'to  deposit in  a rte ries#  'endocardium  and 
g lom eru li o i n d o e  by sim idtaneoue injeotlon of va rious 
vaeoaoiive- # # s ta n c # e 'e u o h  a s  ' h ietam ihe,' zerotohin  and 
ep inephtihe  o r  by Injeotibh o l  low lev e ls  of Im m une 
oom plexes (61). I f  vasoactive  am ines a re  caused  to be 
re leased , from  p e riv a sc u la r  m a s t cell# of gd inea-p igs, 
the  effect i s  tïie sam e (6Z). A ntagoulsts o l vaeoàctlve 
am ine# such a# au tlh istam iue# m ay inh ib it the deposition 
of com plexes m  the v e sse l w alls in  acute se ru m  sickness 
(63). The tim ing of the  h istam ine ad m in istra tio n  i s  c ritic a l 
(89) , i f  h istam lhe-i#  given to guinea-^pigs w ithin two m inutes 
of ad n d » is tra tio n  of p re fb rm ed  Immune com plexes, they a re  
deposited  \^ th in  the  glOmerUli, However, if  # e  com plexes 
S're injectW - m or*  & an two,- m inutes p r io r  to h istam ine  
adm inistration# deposition i s  m arkedly  reduced . Since 
- im niun# -Complexes' la rg e r  than 19S a re  rap id ly  rem oved 
during thi# p e rio d  w hile sm a lle r  com plexes rem a in  in  the 
c irc tdatlon , c r itic a l tim ing supports the  suggestion that 
only ; c o m p l ie s  la rg e r ’ # a n  19S m ay  be- deposited . ' i f  
p la te le ts  a r e  rem oved from  the circulation* deposition is  
" again  .'#upp#s##d ( # ) .
Therefore increased capillary perm eability probably 
plays a majjor role In the deposition of com plexes in the 
animal m odeis studied and platelets are likely  to be involved
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In tiiis m echanism .
W ork on thé  longer te rm  autologous im m une complex 
d ise ase  in r a ts  (64) showed that vasoactive am ine antagonists 
had no effect on the deposition of inunune com plexes a f te r  the 
d isease  w as estab lished . I t  is  possib le  d ie re fo re  tlia t in c reased  
cap illa ry  perm eab ility  induced by vasoactive  am ines is  only 
im portan t a t the ou tse t of the d ise ase  o r  in  c e rta in  types of 
d isease ,
The ro le  of com plem ent in the déposition of im m une 
com plexes has a lso  been considered . In  the acu te  se rum  
sickness m odel of GN* tiie pathogenesis appears  to be 
com plem ent independent. In rab b its , decom plem ented by 
c o b ra  venOm fa c to r  (CVF), im m une com plexes a re  deposited 
no rm ally  and the  ren a l le s io n  Is morphoXoglcaUy iden tical 
to  tha t observed  in  an im als which w ere  not decom plem ented 
(65) r although n ecro tis ing  a r te r i t ie  is  not seen  in de com ple­
m ented axum als. B ecause  CVF cannot be used  over a  p ro ­
longed period  of tim e, the ro le  of the com plem ent sy stem  in  
chZonic experim ental GN cannot be a sse s se d . In  m ost types 
of hum an GH* how ever, th e re  is  evidence of com plem ent 
activa tion  and one of the re su lts  of activation  is  the re le a se  
of C3a and G5a (66) which m ay cause in c re a sed  cap illa ry  
perm eab ility  by trig g e rin g  the re le a se  of vasoactive  am ines 
from  basoph ils . The com plem ent sy stem  th e re fo re  has the
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capacity  to a id  deposition of im m une eomplmseo.
Hydrodynam ic fo rces  m ay play a  ro io  in  im m une complex 
deposition. This is  reflec ted  In a re a s  %vhere deposition 
o ccu rs , that is ,  generally  a t filte ring  m em branes o r  a t 
p laces of turbu lence. In the kidney, in  p a rtic u la r, the 
a r te r io la r  p re s su re  is  high. If th is is  a rtif ic ia lly  increased , 
by induction of experim ental hypertension,' deposition of 
im m une com plexes Is  correspondingly  Increased  (63),
C ochrane and Hawkins (59) found no co rre la tio n  betw een 
d ia rg e  and the  ab ility  of various pro te ins to be  deposited In 
tissues* This w ork was done using p ro te ins of d ifferen t 
m o lecu lar w eights and charges In the p resen ce  of in creased  
v ascu la r perm eab ility . O ther aW hors (68) foimd tîiat when 
# e  charge on fe r r i t in  was a lte red , cationic fe r r i t in  penetrated  
fu rth e r  than  native  ferritin#  S im ilarly , when h o rse  rad ish  
perox idase  was considered  the cationic m olecules w ere 
excre ted  m o re  quickly than those which w ere  anionic (67).
Chai ge m ay th e re fo re  be  a  significant fac to r in  im m une 
com plex deposition.
I t  has been shown tha t im m une complex sa tu ra tion  of the 
hepatic  reticu loendothelial system  (EES) m ay occur in the 
acute se ru m  sickness m odel of GN In m ice  and that th is occu rs 
a t leve ls  of com plexes in  the sam e range a s  those requ ired  for 
the form ation  of GN (69). The EES m ay th e re fo re  bo im portan t
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in preveuling deposition of immune complexes normally and 
deposition may occur only when the EE8 is  in som e way 
deficient, has reached saturation because of a previous 
infection or because of the presence of a large number of 
circulating immune complexes*
Gelfand (70) has demonstrated the presence of C3b 
receptors in the glomeruli of humajii kidneys and has suggested  
that immune com plexes with bound C3b may be deposited in 
the kidneys by means of these receptors. In kidneys from  
patients with GN with C3 preSeUt in tlie glom eruli, tlie number 
of receptors is  reduced. Since these receptors are not 
present in various animal species which may develop 
spontaneous or experimental GN. the significance of tiie 
receptors is  unknown.
Thus several factors involved in  the deposition of immune 
complexes have been, to som e extent, elucidated. Most of 
the work has involved the acute Seruni sickness m odel or 
the administration of preformed immune com plexes. The 
situation in the chronic m odels of GN which are probably m ore 
analogous to human d isease is  by no means so w ell defined.
In the various types of human GN involving Immune 
Complexes, it is  therefore likely that deposition occurs due 
to a complex set of factors; a) the s iz e  of the complex, 
b) the number of complexes in the plasma, c) the extent of
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perm eability, fQ capillary Mood preecure, e) complex 
ment actlvatlom wMIe apparently not involved in Wie acute oermm 
& M m m ^  model W e the capacity to cause Increaadd capillary 
pe rm eab ility , f) the s ta te  o l the EIIS, g) hydrodynam ic forces*
li) charge and I) 0$h. receptor©#
Type IV hypercencitivity reactions involve cellular 
rather than  anybody mediated immimity, When thym us- 
dependent lymphocytes (T-lymphocytea) come into contact 
with antigene with which they a r e  cpocillcally sensitised , 
they Mftd to  the antigen and then undergo-a complex se r ie s  
o l interactions including cell transformation and mitosis#
During th le , soluMo fac to rs  called lymphoWne# are secreted  
whlcit have various effects (71), they may? a) cause the 
inhlbiUon o l m ig ra tion  of m acroplm ges and BMH in v itro , 
b) attract FMN and mononuclear phagocytes, c) cause lympho­
cyte tranafo rm ation  and d) release  cytotoxic factors, .Antigens 
therefore act as a  focus for inflammatory and phagocytic ce lls .
There Is evidence fo r the, ex istence of a  type IV reaction  
in various type# of human OH* The m igration inhibition 
assay  has been m ost often used to  te st  for delayed h y p er- 
sensitivity# RocKLln (7%) and Dardenne (fS) found tlm t 
lymphocytes from  padionts w l#  antl-OBM  d isease , on being
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incubated with GBM antigens produced m ig ra tion  inhibition 
fac to r (W F ) . Since anti-GBM d isease  m ay be induced by 
in jection  of antibody alone, type IV hypersensitiv ity  is  not 
n e ce ssa r ily  an  im portan t pathogenic m echanism  in  th is 
d ise a se . W hile in  one study, tîie reac tio n  w as found to  
be specific  fo r antl-GBM  d isease  (72) in the otiier, lym pho­
cytes fro m  pa tien ts with various types of GN re a c te d  in  a  
s im ila r  way to  the  antigen  (73).
Sensitiv ity  to  foetal kidney antigens in  a ll  pa tien ts with 
MÇN8 and in  Some with à  p ro life ra tiv e  GN has been found 
using the  MÎF a ssa y  (7% 75). - E yres,' uSIng a  cytotoxicity 
a ssa y  (76) found th a t lym phocytes from  patient# witli MGNS 
had an enhanced ab ility  to k ill foetal Mdney ta rg e t cells  
while %)eripheral blood lym phocytes from  pa tien ts v/itîi 
o th er types of ON did not d iffer significantly  fro m  norm al.
The hypothesis p roposed  was th a t foetal p ro te in s a r e  re ta ined  
in  som e ch ild ren  and becom e antigenic, resu lting  in  a  type IV 
reaction . Since the  antigens involved a re  tu b u la r antigens and 
the  tubu lar ce lls  appear to  su ffer no dam age, the pathogenic 
significance of the  reac tio n  is  unclear. The fac t tha t lym pho­
cytes a re  not generally  p re se n t in  the kidney in MCNS casts  
fu rth e r  doubt on tiie im portance of the m echanism .
Delayed hyper sensitiv ity  to  strep tococcal an tigens (73) 
has been dem onstra ted  in  various types of GN but th e re  Is
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no evidence that Contribute© :to &© pathogenesis.- 
Re cent work ■ has -b e #  done using a model of GN'in.whlch a 
snWephritogehio dose of rabbit anti-^rat GBM antibody Is 
■administered to ta ts  which have-boon injected with lymph " 
node c e lls  ftom \rats ptevlotisly immunised with rabbit 
immimoglobulin (77). ■ If "the- lymph node ce lls  w e re . 
partially depleted. of B. .cells (22% "reduced to.- 5%), • the' - 
proliferation ol, glomerular ce lls  and-tlie lnB;Uratlon of. ' 
'-'circulating xnononuclekr- cells was unaffected. ' , it  was ' 
Suggested tiiat'the;d|s'ease Involved'a typé ÎY  reaction.
Since 5% of B -celle rem ained  and no, titra tion ' of ' cells was 
done to define m inim um  dose and, -since-production of antibody 
to rabb it ImmiinoglObulIn would be likely  to be, enhanced by 
the Introduction of 'sensltiêed ' T -ée lls , th is w ork Is not 
conclusive evidence .of the -requirem ent fo r a. type IV .response.'
M ore recently* ’it-has- been shown th a t thé hyper ca lk d arlty  
fom%d in acu te  @ervm s i ckneoo of rabb its is  p r im a rily  the 
re s u lt  of a  m ononuclear cell in f il tra tio n '(78).., ■ The authors 
suggested tha t th e re  w ere  th re e  possib le explanations fo r 
-lids in filtra tion ; a) tha t I t was a  non-specific  event following 
'tis-sue damage# b) th a t the m onocytes bound v ia  th e ir-F c  
rec ep to r  to im m une com plexes in the g lom eru li, o r  c) that 
the m onocyte's'w ere p re sen t as--tlie re s u lt  of a  T cell -eespons©.' 
Since ' m ono cytes wer-e presen t-at'the- outset, of the  d isease
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and since p rç te in u rîa  re la te d  to the num ber of m onocytes 
but not to the extent of im m une complex deposition, the f i r s t  
two explanation» w ere  considered unlikely. The frequent 
p resen ce  of lym phocytes in the vicin ity  of the g lom eru la r 
m onocytes suggest© that a type IV reaction  m ay be involved 
in the hyper ce llu la r ity  and thus in the pathogenesis of acute 
se rum  sic lm ess of rabb its .
W hile th e re  is  l it t le  evidence to suggest that the type IV 
hypersensitiv ity  reac tio n  Is  of general im portance in  the 
pathogenesis of GN, tlie ex istence of such a  response  even 
if i t  is  secondary  to  t is su e  in jury , m ay affect the course  
of the d ise ase .
Thus a ll types of hypersensitiv ity  m ay be im plicated, 
to som e extent, in  GN* Typo III is  probably the m o st 
im portan t while anti-^GBM d isease  and perhaps o th er types 
of GN with subepithelial im m une deposits* involve p rim a rily  
a  type H resp o n se . No single category of GN can be a sc rib ed  
to  types I o r  IV although type I m ay be involved in  im m une 
com plex deposition . Type fV hypersensitiv ity  is  found n r  
m ost types of GN and i t  m ay be involved in  the pathogenesis 
of acu te  se ru m  sickness in rabb its  * I t is  not c le a r  what ro le  
i t  p lays in  tlie developm ent of human GN although i t  is  likely  
to  re s u lt  in  tis su e  dam age.
With som e types of GN, i t  is  not apparen t which type o r
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typos of hypéSBeneitlvity ay© involved. The pathogenesis 
of each  of the d isease  groups exam ined in th is  study will 
be considered  in  the in troductions to thé re levan t chapters*
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The Com plem ent System.
Glomerulonephritis Is an inflairànatory lesion and one of 
the major efiectors of inflammation is the complement system. 
This system has b e #  shown to be of pathogenic significance in 
experimental anti^GBM disease, (31) although it was not - 
essential for the developm ent of the acute serum sickness 
model of GN (SB). The role of complement in chronic 
experiràental OH and hmnan, OH-io not known but its frequent 
presence in the gldmeruli of ON ijatlents and its potency as a 
mediator ol inHammatlbn suggests that complement may bè of 
importance in human ON,
Complement was, f i r s t  d iscovered  when serum-was found 
to be capable of lysing bacteria (79). Bordet (80) noted that 
two substances were n ecessa ry  lor lysis; one was heat stable 
and was later called  antibody and the otlier was a heat labile 
substance winch he called  com plem ent.
The lytic action of complement, originally assumed to 
be its main function, is  now known to be only one of several 
important biological properties which mediate Inflanmiatipn# 
Witli tlie comparatively recen t advances In'ImowXedge, aided 
by the development of methods fo r purifying plasma p ro teins, 
many of the complex interactions and biological p ro p e rtie s  of 
many of the proteins wiiich constitute the complement system  
have, to some extent, been elucidated. '
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Com plém ent A ctivation
The com plem ent system , the in te rac tions ol which a re  
shown in  d iag ram m atic  form  in  figure  1.1, m ay be divided 
into two p a rts , a) activation  and b) the a ttack  sequence. 
A ctivation m ay take  p lace by e ith e r of two pathways*
The C lass ica l Patliv/ay
The c la ss ic a l pathway, a s  its  nam e suggest»* w as the 
f i r s t  to  be  d iscovered  and is  activated  when specific  antibody 
binds to  an antigen to fo rm  aii im m une complex* Once 
imm unoglobulin binds to the antigen, the C l complex, 
consisUng of th ree  p ro te ins, Ç Iq, C l r  and C ls , held together 
in the  p resen ce  of calcium  iosas (81), m ay bind to tixe im m uno­
globulin. Only c e rta in  imm unoglobulin c la sse s  m ay activa te  
C l, these  a re ;  IgM and th ree  subc lasses of IgGî ïgG l, ïgG2 
and IgG3 (8$)* The recognition m olecule i# C lq  and the 
activation  of G l re q u ire s  m o re  than one F c  fragm en t. G lr  is 
then activa ted  which in  tu rn  causes enzym atic activaU on of 
C ls  (84). gT s cleaves C4 into C4a and C4b (85). C4b has 
a  lab ile  m em brane binding s ite  and m em brane bound G4b in 
the  p resen ce  of m agnesium  ions binds 02. cT then cleaves 
C2b from  02  leaving C4b^a a s  an active enzym e on the  
membrazxe OhpEibie of cleaving C3 (86).
Since the activation  of Cls* 0 4  and G2 is  enzym atic, m any 
m olecules of C4b and C3a m ay be form ed by the  binding of a
C la s s ic a t  Patliw iiv 
Cl
Immune Complex
Ci
02 \
--------
C4 /
, _ J
AUernative Pathway
■C3bBbP <  C3bBb^ ■ C3bB < Mb
g "L.
Attack Sequence ____ *_____ __
OU, ■(, II, 9 0423b o r  C3bBbP
Coll lysis
■ _ J
Figure 1-1 Diagram of the interactions of the complement 
system
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single G lq  moleçulé* .
The Alternativ# Pathway
I t  was apparen t antibody, in som e cases* was not 
n e c e ssa ry  fo r  the com plem ent m ediated-iysis of ce rta in  
m ic ro -o rg an ism s (67) and that som e o ther pathway m ust 
be 'responsib le . fo f 'notivation..of com plém ent. ■ '
The p ro te in s which a re  known to be involved in  the alt*  ^
e rna tivé  patl%way a re  C3b# fac to r B, B, properdin# G3b 
inac tiva to r (C3MNA) andjB lH  (88) . C3b is  fo rm ed  in  
no rm al se rum  probably a s  the  re su lt  of low -g rade  continuous 
tu rao v e r (09). C3b binds to fac to r B in  the p resen c e  of 
m agnesium  ions and D cleaves fac to r B to  re le a se  a fragm ent, 
■'Ba, and leave  the a lte rn a tiv e  pathway, C3 convertasej- C3bBb. 
The binding of p roperd in  to G3b in c re ases  the stab ility  of the 
complex by retarding-'the. decay of Bb (90). As m ore  C3b 
is  produced# ,the:'cleavage of C3 en te rs  an am plification  phase. 
This is  p reven ted  in  no rm al se ru m  by the actions o f two 
regu la to ry  p ro te in s, CSblNA and p  lH . The m echanism  of 
th ié regu lation  w ill be d iscussed  la te r . W here, la rg e ' 
quantities of 03b  a r e  produced by the c la ss ic a l pathway, 
am p li#ca tion  of the a lte rn a tiv e  pathway m ay re s u lt  desp ite  
tiie p resen ce  of regu la to ry  p ro te in s . A lso, under c e rta in  
c ircum stances, C3b Is p ro tec ted  from  the regu la to ry  actions 
o f ^ lH  and CSbïNA, perm itting  a lte rn a # v e  pathway activation
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to prcgrees In an uncontrolled mmmor. . This may occur, ' 
in vivo, in tho prosonce of bacterial endotoxin© (91), nephritic 
iactor (92) and where there is a delicioncy of C3MNA (93) 
and in vitro in the présence of endotoxin (94) , immune 
complexes involving 5S rabbit IgG (93), immune complexes 
involving gtnnea-xng IgGl antibodieD.(96), rabbit erythrocytes 
(9V)* neurammidase'treated sheep, erythrocytes (98), cobra 
venom factor (99) and where G3blNA (89) or p iH  (100) have 
been depletéd.
Thus the two activation pathways .result In the formation 
ol G3 cleaving enzymeog C4b2a and C3EBSF respectively*
The .Attack Sequence
The’C3 çonvértase formed from either;'>path%vay may cause 
cleavage of C3 Into C3à, a small fluid phase molecule, and 
G3b which has a temporary membrane binding site (101).
C3b may bind to the converting enzyme to form a CS convertase, 
or gM?bT> (102,103), resulting in the formation of 05a, 
a fluid phase molecule, and C5b which may bind to membranes. 
Cleavage of G5 is the last enzymatic step in the sequence.
05b binds to G6 to form C5b6 which may then bind C7- 08
and 09 are then added to C5bW to form a complex capable of 
ceil lysis. To form the C5b-9 cytolytic complex, a dimer 
is  formed consisting of two sets of molecules each containing 
one molecule of G5b, G6, C7 and G8 and three molecule© of
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C9 (104) é A lternatively  G5b m ay bind G6 And>then C7 in 
the fluid phaao to fo rm  C5b67 which has the capacity to 
bind to m em branes on adjacent cell». With tlie addition 
of C8 and C9, these  cells a re  called "bystander" cells 
(105).
Control of Com plem ent A ctivation
A system  such as th is , with an enzyme cascade, the 
capacity lo r  in te rn a l am plification and a  spontaneous 
turnover, w ill req u ire  regulation. This Is afforded both 
in trin s ica lly  in the fo rm  of na tu ra l decay* and ex trin slca lly  
by regu la to ry  p ro te ins in the p lasm a.
In trin s ic  Control
3;’o r significant com plem ent activation, C4b and C3b 
each req u ire  to be m em brane bound. This ab ility  to bind 
to cell m em branes is  tran s ie n t (106* 107), and m ost 
m olecules which a re  activated  rem ain  ineffective. In 
addition to th is , GE and fac to r B decay quicMy from  th e ir  
resp ec tiv e  G3 convertases (108, I 09). This reduces the 
extent of C3 cleavage although C4b and C3b re ta in  the 
ability  to bind m ore  CE and fac to r B respec tive ly . G5b 
a lso  decays rapidly  (102).
E x trin s ic  Control
C l-in h ib ito r: C l-in h ib ito r (cT-INH) binds to C ls  which
is a key m olecule in c la ss ica l pathway activation  and* by
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th is  binding# iîdiibit# the activ ity  of O is: preventing  the
activation of G4 and CE. cTs and CT-INH bind In a i: l  
molar ratio to form a stable complex (110). Cl^lNH has 
no effect on-precursor C ls.
in 1963, the absence of a serum  inhibitor of C ls  was 
noted in  a patien t with hereditary angioneurotic oedem a 
and this was designated (III). One year previous
to this, L anderm ann (112) had recorded a deficiency of 
kallikrein inîïlbitor in the same disease. Cl -INH is now 
'imown-to inhibit proteins in several-interrelated'm ediato r 
pathways, such as 1) plasmin, 2) plasma kalllkrein, causing 
inhibition of Mnin production (113), 3) Hagemann factor 
fragm en ts, thus inhibiting coagulation,. 4) Hagem ànn fac to r 
preventing kinin generation and fibrinolysis (114) and 
5) Clr, part Of the complex containing C ls  (115). This 
binding does not compete effectively with the binding of Gl-INH 
to cT s. There is no known regulator of the alternative 
pathway analogous to Cl *^ INH.
C4 binding protein; E.eeently a new regulator of complement 
activation was d iscovered , the C'4«bmding protein (C4-bp)
(116) , This has been shown to form a stable complex with 
G4b and is necessary, 'along with C3bïHA, for the enzymaUc 
- inactivatioh'ol G4b. As the result of thé combined actions 
of CBblNA and C4*bp on C4b, the ;,cleavage products C4c
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ïôa? thii Itacliom thàn ia lor iho inactlvatio» o | G3b
(l^S* I26)i 1?h|f involves C4*^ bè tbo meçhaïiiem appears
$0 b# Ihe inactivatipîi ol C3b simce te th er
emaymaiie #g$è#pR  le mot necessary to prodhoe G4o m û  
044 in tbe '#i44 phase Inactivation of G4b (117).
p  lH^gXbbnlIn: p îH  a lso  fonction# to control G3b àlthongh
it# mode of action d iffers from that o f dâbîNA* It was fonnd 
to potentiate pi# Inhibl^on of haem olysis by G3bINA by 
bln#ng to 03b m olecnle# on sheep erythrocytes ( 122). 
p i n  alone had a slight Inhibitory effect but when present 
with GIblNA, inhibition exceeded the snm of the inhibit^ 
ions attrlbhtable to C3bl#A an d p  IB separately. A second 
effect of p  IB was to accelerate the decay of the alternative 
pathway 03 convertase on sheep erythrocytes, TM# effect 
was çansed by displacem ent of factor B by p  in  from  the 
convertase (127), BIB  was in#Bec#ve if  the convertase 
was on the snrface of rabbit erythrocyte# (97), on eymosan
(128) or sheep erythrocytes treated with nenraminidase (98),
This resistance of the 0 3  convertase of the alternative 
pathway on certain surfaces to regulation by p lH  is  assum ed  
to be the mean# byvWhich these surface# trigger the amplification 
phase of cO m plem te activation* The capacity of certain  
surfaces to causê ampliflcation Is due to their low sia lic  
acid content (97) ,
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The binding of C3b and p  IH is  reversib le and p iH  
may be displaced by factor B at high factor B concentrations
(129). Properdin* which is  KnoWn to stabilize the 
alternative pathway C3 convertase (90), a lso  enhances 
binding of p iH  to C3b (130). Because of the competition 
and the sim ilar e ffects of properdin On p lH  and factor B, 
it was assum ed that factor B and p  IH shared the sam e  
binding site  on C3b (13Q). However* since under certain  
m icro-environm ental condfHons p iH  is  unable to control 
C3 cleavage by the C3 convertase (97# 128)# it Is m ore  
probable that the binding s ites are <dose and that the 
competition is  caused by sterlc  hindrance.
Inhibition of Two inîûbitore of cBBW have been
described. One i s  a very low density lipoprotein (131) 
and the other# a glycoprotein# called the S^protein (132). 
Both of these act by binding to the transient membrane 
binding site  of C3b67 and thus prevent the binding of this 
m olecular complex to coll membranes (133).
Anaphylotoxip inactivator; C3a and C3a may be inhibited
enzymatically by a carboxypeptidase B which rem oves
the carboxyterminal arginine residue from  G3a and C5a
thus causing the inactivation of the anaphylotoxic properties
of the m olécule (134), The inactivation of C5a resu lts in
a sm aller m olecule G 3a. _ _  ^which retains its  chemotacticdes arg
properties.
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B iological F ro p e r tié s  of Com plem ent
Table Î - 2 shows a  l is t  of com plem ent components o r  
com plexes of com plem ent components w H ch have been 
shown to eU cit b iological e ffects. M em brane dam age 
is  th e re fo re  only one of a  num ber of consequences of 
coxnplement activation . Two m ain  ca tegories of biological 
activ ity  exist* a) m ed ia to rs causing in c reased  v ascu la r 
perm eab ility  and b) those causing the accum ulation of 
inflam m atory  ce lls  a t the s ite  of injury^
Table 1 # Z t , B iological p ro p e rtie s  of the com plem ent system
B FFE Ç T O â BîOBOOïCÀB FBOPERTY
C2 kinin 
C4b 
C3a 
C3b
C5b6789
...........................
in c reased  v a scu3.ar perm eab ility  
im m une adherence 
ahaphylotoxin activ ity  
im m une adhérence# a lte rn a tiv e  pathway 
activation, so lub ilisation  of im m une 
com plexes 
anaphylptoxln activ ity , chem otaxis
cytolysls
C2»kinin activ ity ; This is  generated  experim en tally  when 
activa ted  C l#  is  in jected  into human skin. Swelling occurs 
due to In creased  cap illa ry  perm eab ility  (135). This 
sw elling Is  not blocked by antih istam ine trea tm e n t no r is  
the  reac tio n  reduced In pa tien ts with acqu ired  G3 deficiency#
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suggesting tliat c la ss ica l pathway components a re  used. 
This resp o n se  m ay be involved in  the sym ptom s of h e red ita ry  
angioneurotic  oedem a.
The Im m une A dherence Phenom enon: - The im m une 
adherence  phenomenon involves the binding of com plem ent 
coated p a rtic le s  to ce lls  w ith com plem ent re c e p to rs  (136).
The com ponents involved a re  C3b (13?) and to a  le s s o r  
ex ten t C4b (138)# R ecep to rs fo r  these  com ponents a re  
found on m any cell types including e ry th ro cy tes , m acro  
phages, lym phocytes and po iy m o ^h o n u c lear leucocytes 
(PMN) (139). The binding of c o m p te e s  to e ry th rocy tes  
v ia  G3b re c e p to rs  g rea tly  enhances the phagocytosis of 
the com plex (136) and the binding of such p a rtic le s  d irec tly  
to phagocytic ceBo via C3b recep to rs  a lso  a ids the ingestion 
of antigens (140).
I t  has been suggested that the binding of lym phocytes to 
antigens v ia  com plem ent recep to rs  m ay be Im portan t in  
antibody production (141). The p resen ce  of no rm al antibody 
lev e ls  In a G3 deficient pa tien t however a rg u es against 
th is (142). The binding of G3b to the su rface  of B ^ lymphocytes 
m ay re s u l t  in  the  re le a se  of lymphohlnes which a re  chemo-^ 
tac tic  lo r  m onoeytee (14$).
When bind via th e ir  C3b recep to rs  to immime 
com plexes, se c re tio n  of the  granule contents re su lts  in  the
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release of various hydrolases important in the inflammatory 
response (144).
Solubilization of Immune Complexes; Precipitated immune 
complexes may be solubilized on addition of normal serum 
but not symosan or heat treated serum (145). The reaction 
is prevented if D, factor B or properdin are removed although 
it may proceed in the absence of calcium ions or classical pathway 
components. The process therefore requires an Intact 
alternative pathway although dissolution of complexes proceeds 
more quicldy if the classical pathway is also intact (146).
The mechanism is independent of antibody class and of the 
antigen involved in the complex (147) and it may involve the 
intercalation of complement components into the immune 
complex forcing a break-up of the lattice. As well as dissolving 
precipitated immune complexes, this process may remove 
complexes from the surface of lymphocytes and may be the 
mechanism by which immune complexes are removed from 
the kidney in immune complex GN.
Anaphylatoxln Activity; Anaphy la toxins cause histamine 
to be released from mast cells v/ith a resultant increase
in vascular permeability (148). The anaphyls»toxin activity
* ' ■ resides in the smaller cleavage products of C3 and C5, that
ia C3a and C5a. C3a and C5a bind to different receptors on
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mast .cello to give an additive effect (14-8) and CSa hue, been ‘ 
demonotrated by irAmunofUioresconce.ou tlîC coll surface 
(149). G 3a and C5a anaphylatoxiuo may be iaa'cllvatod 
ouzymatieally (134).
Ghemol-axls; , Various products of complement activatloxi 
have boon suggested as being chemotactic for PMH. ' Theoe 
are G3a (150, 151), G5a (152) and c!: i^W (153, 154) . Roccnt 
work -fiiiggesto -that C3a does not exert a chemotactic effect , 
on PMH at physiological concentrations and that G3a pre­
parations were contaminated with G 5a In previous studies 
(155). The chemotactic effects attributed-to C5bl? may also 
bo due to G5a contamination. CBa 1* a powerful chemotactic 
agent and It roWns a reduced amount of activity after 
treatment with carboxypeptidase B. The accuniidation of> 
PMN has vàrlouif biological consequences as ^ previously 
discussed; C5a.'may also cause the aemmulatibn of baso­
phil e (156).
5SJâ!âïBl£i The current view of complement-mediated 
cell lysis Is based on the "douglmut hypotheolo*  ^ol Mayer 
(15?) in which he suggested that products of complement 
activation are inserted into the cell membrane to form" a 
tranomembrane channel. The outside of. the channel is  
hydrophobic and thus binds with the lipid In the membrane 
and the inside is hydrophilic, .allowing passage of fluids into
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the cell and causing ly sle  . The lim ctlonal unit I  s . a d im er 
of the C5b-9 complex, each Gontalnlhg one m olecule of 
each of C5b» C6, G7 and CB and th re e  m olecules of 09  
(158). D espite  the fac t tha t the a trn c tu re  and the m olecules 
involved a^*e known, doubt atiU ex is ts  as to  the s ite  of tlxe 
channel, w hether i t  is  through the qomplem#^it components, 
beside them  o r  even w hether a channel is  n e ce ssa ry .
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B ecause of the frequent p resen ce  of com plem ent 
components in the glom eruli of pa tien ts with GN and the 
effectiveness of the com plem ent system  as an inflam m atory  
m ed iato r, i t  was considered useful to study com plem ent 
activation in  GN in  deta il. Many studies have exam ined 
b iopsies fo r the p resen ce  of im m unoglobulins and C3 and, 
in a few, re s tr ic te d  a lm ost exclusively to d ise ases  involving 
in tense com plem ent activation, e. g. m em branopro llfera tive  
g lom erulonephritis and acu te  post strep tococcal g lom eru lo ­
n ep h ritis , deposition of e ith e r c la ss ica l o r  a lte rn a tiv e  
pathway components and, occasionally  both, have been 
studied. In som e com m unications se ru m  lev e ls , generally  
only of G3, have been reported .
The purpose  of th is tliesis was to exam ine com plem ent 
activation  w ith p a r tic u la r  re fe ren ce  to six  m ajo r types of 
GN in  te rm s  of the  involvem ent of im m unoglobulins, the 
re la tiv e  im portance of the c la ss ica l and the a lte rn a tiv e  
pathways and the extent of activaUon of the com plem ent system . 
F o r  th is , the p resen ce  and in tensity  of deposition of im m uno­
globulins and com plem ent components within the g lom eruli 
and the serum  concentrations of com plem ent components 
w ere studied.
Since com plem ent activation  m ay rexu lt from  a deficiency 
in the control of tlie com plem ent system , the ro le  of reg u la to rs
55.
o i com plem ent activation  in  GN was also, considered . 
Com plem ent activation  is  controlXed'-by: a t le a s t four p ro tem a, 
CÎ-ÎN H . G4«bp, GSbXNA’and B ecause of the re la tive ly
rec en t d iscovery  of Cd^bp, ' onl,y'the- effe'cts.of C 1 -INH, ; 
GSbïNA and p lH  w ore considered in th is study.
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MATERIALS & METHODS 
Chemicals and other reagents
Chemicals and other reagents wore obtained from the 
following companies:-
BDH Chemicals Ltd. Sodium chloride (NaCl)
Potassium dihydrogen orthophosphate
(KH2PQ4)
dl-Potassium hydrogen orthophosphate 
(ICyHPO^)
Sodium barbitone 
Barbitone
Sodium dihydrogen orthophosphate 
(NaH^PO^ 
di-Sodium  hydrogen orthophosphate 
(Na^HPO^)
Glycine ■.
Sodium a ce ta te  
Acetic acid ■ .
Silica gel
Calcium chloride (GaCl )^
Ammonium sulphate (NH )^^S0 4 ) 
Agarose .
Potas sium th iocyanate (KCNS)
Acetone
May & Baker Ltd.
Si gma Chenil cal Co.
Ko ch-Light Lab. Ltd.
Hydrochloric acid (HCX) ,
Sodium hydroidde (NaOH)
Sodium carbonate (Nà^GOg)
Sodium bicarbonate (NaHCO )^
Magnesium- chloride (MgClg)
Tri orna base (trie)
Cyanogen bromide-(CHBr)
Flupracein isothiocyanate (FïTC)
Mono ethanoîamine
Ethylenéglycol-bls -(B -am ino-ethyl ether)
N, «tetra-ac.etic acid (EGTA)
Ethyl enedi amine tetra-acetic acid (ED TA) 
Bovine serum albumin (BSA)
Hydrazine hydrate
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E vm # MedlOàl Ltd* 
Scientific
Difoo L abovatorle#
F itw
CItemloal®
K odak'L td.
Macfaa^m* Smith
ByltWh PotK'oIOum 
Chomtcal#
Meifck
Service Laboratori©» 
]uta. . ' . ,  ' '
Taab Laboyatorlo#
Woilcomo Reagent© Ltd
Miiea LabomtorioG - 
Imcorporated '
Park J>mi§:ik do*
B r i t i#  Oxygen Go#
N m o i.«abotatotiei
Olbco Bttrope
Im perial Ghemlcal, 
IndoeWem
O lycetol
Potaeeium  Iodide (M) 
fodino (1^)
Freimd*© complote a^lnvant (FGA) 
Fr©wd*$ Incomplète a^uvaat (FIA)
gephadex 025  
Sephàroeo 4B . ,
High Speed E ktachrom e 
Ektachrome 200 p m tm u im m l
Anaocthetic otl^er
.?40F Methylated Spirit*
deletin
M amltol
OlntaraM ehyde -
P ig  silver powder
Tiooae Telt #  OTG Compe%md
G elatin  capeele## #lme 00 
L iquid n itrogen  
8 cm  plhetio  p a lr l  dlehe# 
Sheep■ Wood cell#
Solid m th m  dioxide
58.
Buffers'- and
All Imffers w ere  w ade In dlstllled^waters.* except w here 
stated mid pH acljmfjtment#* w here n eeeesary , w ere  m ade 
W n g L O N H C L o T l.O N N a O H .
: Buffer# used fo r a a tis e ra
e g o lN a C l
0. 34 g o£ KH^Pd^
1 .2J g O fK j^ P d ^
dissolved ‘hi one Mtro of distilled water
5 # 8 m l of 5*3%Na2CÔij 
w# 0 m l 6f 4.2%  m n c d ^
a ^  us ted  to pH 9# S
V eronal
4 2 .S $ o fN a C l
l , B l .g of sodium  harbitone 
B. 8? g of barbîtôïie
d isso lved  separately^ added together and m ade up to 1 litre
in distilled water
VB8 O.OIM EDT
1 X VB8 ':-
O. O&M tri sodium EDTA
BarbitOne-HCL pH 8 .4
e S m lo fO .lN H C l
9* 0 g o f sodium  harM tone 
0*002 M EDTA t r l  sodium
Die solved sep ara te ly  and added together, ad justed  to 
pH d, 4 and w ade up to 1 l i t r e  la  d is tilled  w a ter
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0 . 2M phosphate buffer, pH 7 .2
144 m l of 0 .2M Na^PO^
GlygittO’^ HGl buffer, pH 2* 8
74 .7  m l of Q vlM glycin ew .oJ lN  NaCb.' ■ 
2 4 . 4 m l o f 0 . l N H C l
O. liVl acetate buffer In l.OM NaCX, pH 4 .0
17 m l of p. 1KÎ sodium  ace ta te
SS’.ml of 0. IN ace tic  acid
E4ch d isso lved  in  Î . OM NaCI and added togetlier
T rie  buffer in  i;OM NaCl, pH 0. Q
23 m l of 0 .2 m  tris
- S. 64 g of HaCl ■
Added dissolved and made to 100 m l in distillmd water
B uffers and o th er p repara tions for im m unoflnore s cence
E ther Alcohol -
sop m l of anaesthetl'c' é ther
500 m l of absolute industria l alcohol (p repared
by* drying 740P m etliylated sp ir its  over s ilic a  gel)
95% Alcohol
950 m l of industria l alcohol (p repared  a s  above) 
50 m l of d is tilled  w ater
T ris  buffe re d  g lycero l# pH 6. S 
2. 5 m l of 0* IM tr is
" 1. 7 m l  of O .lN  HCl
Made to 10 m l'in  rll s tilled  w ater and added to 90 m l of 
g lycerol
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A ll buffer© in thW ©ectlon w ere  p rep a red  In © terlle 
-dMonlèed w t e r ;
A m L m Z t i  : ■ ' ‘ ■
. 400 m l qf 5 % VB8
f  - '';v '20 aü Of.W %golaiin, ;..-- -s •■
-:! ' -''Ma4e to 2 t t t r e s  l«  deionised  w ater '*':•. _
- _  ■ '  .
O.'OIM JSBTAGVB". »H t . 4  - ■ - ,
■ .. • - .'. 7 57. S m l of 0 .0@6M' BDTA (pH to  'f. 4 w ith MaOfi) 
■ -Madé .Up to 500-m l witli'G’/B'*' -
- , : . ' ■ 400 m l of S x V B S
. ■ ■ - 10 m l of 0 , 03M CaCij>
, 20.ml!)f O .lM M gCig"
20 mi of 10,% gelatin  '
. ', Made to' 2 l itrS s  in  tleionlded w ater
a p ™ L . s i & i .  - , .
100 g of D glucose 
■ lO .m lefO .O SM C aC lj!
20 j» l e f o .  ÎM MfiCla
M ade to  2 l i t r e s  in  delonlsotl w ater
50 ml of GVB'*"*' 
50 ml of BST,?'!'**'
0 , o m ,  E s g A / g r c ’
’ 230 m l Of 0 .086M E B m  to  7 .4  w ith m O #
.Made up to 500 m l with GVB*
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m ù B
loo ml of 50% glticooe 
5.95 g of-NaCi
4 parts, of 20% Mannitol 
1 p a r t  of ■
.Potassium iodld©/ lodîné..i^Xidlsing
6.25  g of KI
6,3  g of Xg..
dissolved in 100 ml of 0. IM phosphate buffer, pH 6.0
0. IM Phosphate
88 ml of 0. ZË NaH^PO. 
la w  of 0. %  Na^HPO^
mad© up to 200 ml W déioniàéd water
6 2 .
■ Anti sg e ra  ^
'Source; Anti s e ra  fo r th is study w ere obtained from  the 
foUowiug so u rc e s :-  ■ - - ■,
F.tTC conjugatecl rabb it anti «human IgM )
FÏTÇ conjugated rabb it anti «human C lq  )
FiTC conjugated rabb it anti-hum an 03 ) Hoechat
FIXO conjugated rabb it an ti-goat imm unoglobulin ) Pharm aceu tica l#
rabb it an ti-hum an G Is  )
rabb it an ti-no rm al hum an se ru m  ) 
rabb it anti-hum an p roperd in  )
rab b it anti-him m n fac to r B )
W m t  a n tl- te « ia «  GÎ-INH )
rabb it an ti-hum an ^ I H  )
rabb it anti-hum an C lq  )
rabb it anti “hunrian C4 )
■ rabb it anti^hm nan C3 )
rabb it an ti-hum an C3bIHA) P ro f . P . j .  Lachm ann
. goat an ti-hum an  05. ) D r. D.R* Schultze
FÏTG conjugated sheep a n ti-rab b it globulin - p rep a red  as described
P re p ara tio n  Of rab b it globulin; The globulin frac tio n  of 
BOO m l of rabb it se rum  w as p rec ip ita ted  udth 33% sa tu ra ted  
ammonium' sulphate^ fo r one hour and centrifuged fo r 15 
m inutes a t 1000 g a t  room  tem p era tu re . This p rec ip ita te  
was washed tw ice ih  50 m l of 40% sa tu ra ted  am m onium  
sulphate a t  room  tem p era tu re , red is  solved in 50 m l of 
phosphate buffered  sa line  (PBS) and re  centrifuged to rem ove 
undi8splved m a te ria l. The p rec ip ita tion  was repeated
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twjiçè ■before the globtdin fraction în 20 ml
" of PBS ♦ ‘flitp- üoîitiîon-warn <1h?lyo od £qw , 40 IvmtB agalnal two
cimngoo of two lltro o  of PBB a t  4%h lyopWIWod and s to re d
■ 0 '
at 2^0 c*  ^ ch>at glubutlsb fos? diaraoto%4i%aUon of $n#-
goat glol>id|ns wae pvêp^*^o4in thlo way also,
A Bteej? -ma w # « w a  w m -  
mwoW lnyly and ' nubouteoously with I m g of rabbit gloM its,
isi I ml of P.BS and mmûeâÛQ>û #  I tnl of Frmmd% 
complota adjiwanf; (FCA) * Tho ohoop wae boaotoi after 
oi% mà eight WokQ with 1 mg o f antigen d isso lved  In I m l 
of PBS and emüleWWé in  t  m l  e€ Imcomglot©
adjuvant (ïïtA) * %o anbnal wac Mod on wooko nîine and 
twu The m tW êw n  obtained vms oboprbod o&d oh # y# o tW # #  
according &o #%o motliodo bolow and# onoo ^Wvrn to bo pure# 
wan ooiijugatad to fluo^osooW  laotM ocyanatq 0T T 0) by the 
■ following method* ■ •
Dry FITC at a- con centrale# oi 30 pg FXTC por I mg of 
aWbody was added to-the pW #od antibody, at a Oonoontyatlon 
of 10 m g / m l, containing 10% • .corbonnto buffer, p lî  9* 5 mid 
tbo stetteo  wap rotated on a Matbasa miner for on# hour 
at room temporatee, ‘Tho FITG, bound to protoin# w%# 
ooparntod from  froo dyo by paooage over o. 8opWd#% 025  
"oouroo oolumu, dimouoioaio *« 200 % 10 m m , 4» 3PB8, Th#
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labMîtttg ratio t i t  M m t ù x M ^ ù m e  to protein wae eatlmnWd 
u g # g  the formula#
-L m w m g  i w #  •« + M .
, t m t m i  & t  protein- C p
Where A  ^  a h n m h u t i d t  at A max lor FfTG I. #• at 490nm 
Ù p .  «■■ cdnccntratloa #  pmWn W ng per ml 
X ?? a. cdnstanL 2* @. lo r  F2TG
-Tho lafeollliig râtlO"of FITCia ohoep tmU*Tabblt gtobulln
wa# found to be 2 .0 . . ^
GharacterWailon of.antiborii'
'All àntl.âera were tested i n t  înonoepedUclty h f  double - 
d ilto lon ga l precipitation (160) end Immunoeleotr ophor##!# 
(161)* Where necessary' ahrorpMon teohnlquo# w»r# employed
■ to -«nOtiro i h u t  all antieere. v m t m  ^-aonospeoMo.
•XjotMe iHHtiolon. g e ljo reo W ta tiô à : • .• M icroscope sUrle© •
(22 X 76 mn) v/oro eeatod With S ml of 1,6% agaroo# dlaaelved 
"In-VBS containing 0*01M ED TA end holes# of diameter L7mm# 
were out In the ogaroae a© show# In llgare 2 1^# ' Each an## 
serum for te#t was'piaoei in tl%# centre well m û  normal 
hmnan m m m n  or the relevant- animal - oermm and '
antigen propagations wore placed In the.peripheral well#. ■ 
PmriËod cuitlgen p rep a ra tio n s  Were obtained a# Indicated ' ' 
.J/'fJ'-' Di% D. Pasrott.■tgM 1
\Figure 2-1 In this double diffusion gel precipitation test, 
rabbit anti-human C3 was placed in the centre 
well, with a purified C3 preparation in the top 
well and normal human serum to the right of that, 
A single line of precipitation was found between 
anti - C3 and purified C3 antigen and this shared 
complete identity with the single precipitation 
line between anti - C3 and normal human serum.
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%ga )
)
c l e  .. )
C4 )
Hroperdin )
factor B )
03  ' )
05 )
Ct-INH )
C3MHÀ )
p m )
D r. K. W haley
In  th© cas© of ©ach antieoriim  used fo r Imnnmofluoresceixcè 
o r  rad ia l im m unodlffusioa, only one line of p rec ip ita tion  
was apx^art e  betw een the an tise rum  and P orm al human 
se ru m  and th is  line  shared  com plete identity  with the line 
betw een the  an tise ru m  and the pure  antigen p rep a ra tio n  
except with sheep a n ti-rab b it globulin and rab b it an ti-goat 
globidin w here th ree  lines /w ere distinguished against the 
re levan t antigen p rep a ra tio n  and thé re levan t norm al se rum .
All human antigens used Were shown to be pu re  by double 
diffusion gel p rec ip ita tion  and im m xm oelectrophoresie against 
antibody to no rm al human se rm n  by the m ethods shown h e re .
C lq, Cis* :G 4/properd in ,'':factor B\"-C3V C5//Cnr-INH,
CSblNA and p  IH had fu rth e r been shown to be pu re  by sodium 
dodecyl sulphate polyacrylam ide gel e lec tro p h o res is  run 
under non-reducing  conditions.
Im m unoelec trophoresisÎ M icroscope slides w ere  coated 
w ith 3 m l of 1* 5 p e r  cent agaro se  in barb itohe HCl buffer# pH 8 .4 .
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W ells and troughs w ere cut using a  Shandon im m unoelectro - 
p h o res is  cu tte r a s  shown in  figure 2-2 and the ag aro se  in 
these  rem oved by suction. N orm al human se ru m  was 
applied to the cen tre  well and p u re  antigen to the outside w ell. 
T hese  slides w ere  then placed in a  Shandon th in  lay e r 
e lec tro p h o res is  tank m odel Q77 with barb itone-H C l buffer, 
pH 8 .4  and with wicks m ade from  surg ical lin t. The 
antigens w ere  then subjected to a po ten tial d ifference  of 
IBOv with a  c u rre n t of 20mA for one hour. A fte r rem oval  ^
a n tise ru m  was .applied to the troughs and d iffu s io n  allowed 
to take p lace  in  a  hum id cham ber fo r 48 hours a t room  
tem p era tu re . In  each casé  except the following only one 
a rc  was seen against norm al human se rum  and th is was in 
an identical position  to the a rc  seen against the p u re  antigen 
p rep ara tio n  and was in an app ropria te  position  fo r that 
antigen. With sheep an ti-rab b it globulin and rab b it an ti-goat 
globulin, th re é  lines w ere  v isib le  against the re levan t norm al 
se rum  and thèse  w ere  in  the app ropria te  positions fo r ïgG, 
IgA and IgM. No pure  antigens w ere availab le.
A bsorption of anti s e ra ; A bsorption of a n tis e ra  is  done to 
rem ove antibodies of unwanted sp ec ific itie s . I t  m ay be 
used in  two w ays. If  an  anti se rum  to a given antigen is  
cpntam inatèd with speciR city  fo r one o r  m ore  o ther antigens, 
then the an tise ru m  m ay be Incubated with a p rep a ra tio n  of
Figure 2-2 In this immunoelectrophoresis test, normal 
human serum was placed in the top 3 wells, 
zymosan treated human serum in the fourth, 
purified factor B antigen in the fifth and normal 
human serum in the sixth. Anti-normal human 
serum was placed in the top two troughs and anti - 
human factor B in the bottom two. The single 
arcs against purified antigen and normal human 
serum show the anti serum to be specific and mono 
specific and the two arcs found against zymosan 
treated serum verify the specificity since factor B 
is  cleaved in the presence of zymosan.
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the iîiapproprla tè  an tigens. The contam inating antibodies 
w ill complex with these  antigens and, II the antigens a re  
in an insoluble fo rm , the com plexes m ay be rem oved by 
centrifugation. A lternatively , in  o rd e r  to p re p a re  sm all 
quantities of ve ry  pu re  antibody, a pu re  p rep a ra tio n  of the 
hpprppria ie  antigen m ay be p repared , insolubilized  and 
incubated with the an tise ru m . All p ro te ins except specific 
antibody a re  rem oved by washing and the pu re  antljjodi .^ is  
elu ted  from  the insoluble antigen. T hree anti s e ra  requ ired  
purifications with sheep an ti-rab b it im m unoglobiüin both 
m ethods w ere  employed and with anti-hum an p roperd in  and 
antl-husnan fac to r B, only the fo rm er m ethod v/as used.
P u rifica tio n  of Sheep a n ti-rab b it globulin 
GlUtaraldehyde po lym erisation  of human Colm frac tion  H : 10 mg
of hum an Colm frac tion  H {supplied by the P la sm a  P ro te in  
F rac tiona tion  C entre, Edinburgh) was d isso lved  in 10 m l of 
PBS and dialyaed against PBS a t 4^0 fo r 16 h o u rs . To the 
Cohn frac tio n  #  was added 1 m l of 0. ZM phosphate buffer pH 7, 2 
and 3 m l of E. 5% glutaraldehyde. A fter two hours, a t  room  
tem pera tu re , the po lym erised  p ro tein  was hom ogenised and 
w ashed sev e ra l tim es in 10 m l of PBS by centrifuging a t 
1000 g a t room  tem p era tu re  until the supernatan t was free  
of p ro te in  a s  ve rified  by the optical density  reading a t E80 nm.
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A 10 tn l aliquot o£ the oheep an ti-rab b it an tis ©rum was m ixed ., 
with 10 mg of glutaraldohyde po lym erised  hum an coim frac tion  
H on a M atbnrn m ixer fo r 1 hour a t room  tem p era tu re  and 
then centrifuged â t 1000 g fo r IS m inutes a t room  ten ip era tu re  
thus rem oving antibodies c ro ss  reacting  wltii human g lobulins.
Iso la tion  of pu re  antibody: Using the m ethod d esc rib ed  for
cohn frac tio n  II, 20 mg of rabb it globulin w ere  po lym erised . 
B efore  use, the po lym er was tes ted  under eluting conditions 
by m ixing with glycine-XdCl buffer, pH 2. 8, centrifuged a t 
1000 g and washed tw ice in  FBS. To th is po lym er was added 
10 m l of an tise ru m  and the mixture was ro ta ted  on a Matburn. 
m ix e r fo r 1 hour a t room  tem p era tu re . The m ix tu re  was 
cehtrifuged a t 1000 g and the p rec ip ita te  w ashed in 10 m l of 
FBS until the supernatah t contained ho p ro te in  a s  verified  by 
an optical density  reading a t  380 nm . The final p rec ip ita te  
was then suspended in 5 m l of glycine-HCl b u ffer pH 2 /8  to 
elute the  s p e c if  c antibody bousad to the rabb it Im munoglobulin.
This was centrifuged a t 1000 g, the pH of the supernatan t' 
c o rrec ted  to pH 7 .0  with I . ON sodium hydroxide and dialysed 
against.tw o l i t r e s  of FBS fo r 16 hours. The anti se ru m  was 
then lyophilised, red is  solved to a concentration of 10 m g/ m l 
in  FBS fo r conjugation to FITG as above.
?din: The an ti-p roperd in
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antlsei’imi wap eoï3.teaiaüiated with anti«ïgG, 'Aa ixîsohibl© 
propexdbx-froo 1^0 immtmoabeoyboat waq p rep a red  aud the 
amiloériim. absjorbetb- ,
Propaa*ation of a ,oopharoao 4B/lf^€y Inimtmoabsarboî^t (163); .
Twenty mi'itUltrafj of a  10 m g/ nil aolntlon of. p roperd in  f re e  ■
■■■■ . "■ ■ ' ■ - , ïgG (cupplied by D r. K. Whaley) w ore dlaîyaed a t 4. C fo r
16 hours agairidt 0, IM NaHGO .^ 10 ml of Bepha.rciao 4B
wore washed five times i n  distilled, water, centrifuging at
1.000 g for five minuteo at room temperature. In a fume
cupboard/ 2  g  of cyanogen bromide wore die solved hx ZO m l
of d istilled  w ater and thia waa m uwd with the washed Sepharoso
4B malntalM ng the pH a t  11.0 with MaOH until the pH wao
stable* 'This m l# u re  was Washed under vacuum  with I l i t r e
of NaHGO^ a t O^G and t h e '’activated*' tSopharOae 4B was ' .
■mi'Ketl with the ÏgG p repara tion  and ro ta ted  on' a M atburn m ixer
fo r 1.6 hour's a t  4^G. The IgG/ Sepharose 4B im m unoabsorbont
was washed once in HaHCO^, pH 6 .0 , centrifuging a t 1000 g,
and suspended in l.OM  m onoethanolam ine %M 6. 0 'to block
.excess p ro te in  binding s ites  on the ’’activa ted  ” Sepharoso.
' O 'This was rb ta ted  fo r Z hours a t 4 G and crashed th ree  tim es 
in 0 . IM acetate '.buffer in l.OM sodium  chloride pH 4 .0,tJiree 
tim es In 0. IM tr ie  buffer in Î* OM H a d  pH 6 .0  and th ree  tim es 
in  O.OIM tr ie  in  0. Ï5M NaCl with O.OOIM E 0T A  pH 7.6, 
centrifuging, on each occasion, a t 1000 g fo r  ftve m inutes.
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Equal volume 0 ol rabbit anti “human properdin and the - 
ÏgG Immunoabsorbei'it were mixed and rotated lor one hour 
at room temperature. The Immimoabsorbent was removed 
by centrifugation at 1000 g for five minutes. The anti- 
properdin antisera was then found-to be mono spécifie by 
the criteria employed above.
Purification of rabbit anti-human iactor B (163); ' To remove 
contaminating antibodies In the anti-human factor B anti sera, 
normal human serum was depleted of factor B by addition
of an equal volume of 1 molar potassium thiopyanate (KCHS)
- ' odrbpwice. This was incubated at 37 C for 45 minutes and . 
the KCNS removed by dialysis against PBS at 4^G for l6  hours. 
This depleted serum was then diluted to a protein concentration 
of approximately 10 mg/ ml, using the formula that an optical 
density reading of 1.0 at a wavelength of 280 am approzcimates 
to a concentration of 1 mg/ ml. The KCHB .treated serum 
was then conjugated to S©pharosa 4B as was described for 
ÏgG above. ■ .
Equal volumes of rabbit anti-human factor B and the
'
KCNS treated sérum/ 8©pharos© 4B immimoabsorbent were 
mixed and rotated for one hour at room temperature. The 
immunoabsorbent was removed by centrifugation at 1000 g for 
five minutes and the anti-factor B'antiserum was shown to be 
pure by the criteria employed above.
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Àcleorpilon of antiaeraî ' Adaorption Involves the nàiï op'ociflc 
attaclmieilt of soluble substancos to protolns. \ CoxyUgaiion, 
to FïTC éausos an liicx^ease.m the net ncgaüvo' change of 
some serum protoins.and these, may bind to tisano oeétions 
resulting In.excessive background'otaunng,- These higlxly . 
negatively chargedjproteijxs may be t'emovod by one of two ■ 
methods, either by ..adsorption with tie sue powders or by Ion 
exchange 'chromatography. ' The former- method was. found 
to be'effective'and convenient, and was therefore used for 
't!ie adsorption of’ciH FITC eonjugatod tmtlsora before' thèse '
. wes-’d'employod;In the /bimiimofluôrêscénco -tost. Pig Hver 
powder was.washed, twice In PBS, centrifuging at 1000 g for 
Hvq mlmites and then Incubated with the antlDorum for one 
hour at room tbmpéràtùre on a Matburn mlzier. This " ,.
• mixture was; centrifuged at 1000; g for five minutée .'and • 
the procedure repeated vdth the supernatant. The •super - • - 
.natant,' after the second-adsorption, was centrifuged a • 
second time to remove any trace of livor powder and wao 
■ then aliquotted and-stored. ■. '.
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Renal Biopgy Studies
One lirnxdred and ionv renal biopsies used in this study 
were obtained from hospitals in the Glasgow area. So that 
subsequent analyses would be meaningful, only biopsies 
which fell Into a distinct pathological category (1) were 
considered and biopsies which fell Into categories containing 
fewer than ten biopsies were ezceluded from the study.
The categories are. shown in Table 2, 1.
Table 2.1: Diagnoses
Diagnosis Number of Biopsies
Membranous glomerulonephritis 22
Mem.br anoproliferative, glomerulonephritis 19
Focal glomerulonephritis 28
Heno ch-8 dionlelii. nephritis 14
Systemic lupus erythematosus 10
Minimal change nephrotic syndrome 11
These biopsies were examined for the presence of the 
following proteins: ÏgG. îgA, IgM, Gîq, Cia, G4, properdin, 
factor B, C3, C5, ct-IN H , CSblNA andBlH. Biopeies 
which fell into a distinct pathological category but which were 
discarded because of the small numbers had the following 
diagnosesÏ focal glpmerulOBclerosls - 8 Mopsiea, rapidly 
progressive glomerulonephritis - 4 biopsies, a,nti-glomerular 
basement membrane diaease - 5 biopsies, acute diffuse pro­
liferative glomerulonephritis « 5,biopsies and diabetic nephro­
pathy « 3 biopsies.
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R enal |mimmo0uoresceiiLCê Methods
Freeslng and storing of biopsy matcidal; The renal biopsies 
obtained ware genora'lly about bum niiUimotreo in dia-metcr 
and two to five millijnetros' in length. Follovdng removal 
from the body, the biopsy was immbroed immediately In 
Tisaite-Tok II contained within a gelatin capsule. The biopsy 
was aligned horizontally within' the upright capsule, frozen 
in liquid, nitrogen and stored In' à sterile bijou bottle until 
required. When biopsies were recut after a period of 
storage, at least one test was repeated, usually 03, In 
order to check for tissue deterioration. In tine few cases . 
where some deterioration was noted, the blod.cs were discarded, '
Immunbfluoresconco test; The method usecl.waa a modification
f.tW'inew'+iarmJwrM»*
of that suggested for uoq in the immimofluoroQ eonco trial 
for the International Study of Kidney Diooaao In Children.
ITsing' II Sloe cryostat, 4ji so étions wore cut from the 
embedded renal Mopsloa and air dried for 30 minutes.
Soctiono wore washed twice for a total of 20 minutes in PBS 
while chaking cm a GrIfÛn flask shaker*. These sections 
•.woro'thcB fixed for 10 minuteo in other alcohol at 4^C 
followed by 9Bfà alcohol for twenty minuteo at 4^C and 
washed three times in PBS for Î5 mhiutoo, ' The glass Glides 
were dried leaving tite sections moist and the sections were 
incubated with one drop of the relevant anti serum ixi a
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hum id cham ber fo r  30 mWutoe a t room  tém p era tu ro , TMo 
was followed by throe waohoo in PBS for 20 mlmitoo. When 
the  in d ire c t too t was asod  socUoAO w ere  incubated w ith the 
Bocond la y e r  antibody and waohed ao above. Sectione w ere  
tlien m ounted in  t r ie  buffered g lycero l pH 8, S. and otored 
in  (he d a rk  a t  4^C*
C ontrol oectionà from  oacI% kidney w ere  te s ted  each 
time:'* - . .
(a) One section  wao incubated with PB 8 ra th e r  tlian an ti-
s e ra  during each lucubatioi^.
(b) Soctlouû w ore Incubated with PBS during the E r s t  
inciibation and then with the re levan t second la y e r  
an tieerùm .
■ (c) Sections w ore Incubated with no rm al rab b it oorum
o r  no rm al goat eerum  as app rop ria te  and with the , 
're lev an t oocond la y e r  an tieerum  In the second 
incubation#
.M icroscopy and Photogrémhy: The m ic ro scope  used was
à  liOit% Orthpluss %1 wltli a  high p re s su ro  m e rc u ry  vapour 
lam p, HBO 200, ligh t courco, a  B038 heat f i lte r , a  4 m m  
BO 12 intorforégicé E lto r, an  inbuilt b a r r ie r  E lto r  a t sotting 3 and 
a 8upiÀomo*^tary b a r r ie r  E lto r, K510, Thio dyatem  Ic 
designed to  %llow only ligh t below a wavelength of 490nm to 
reach  tho tisauo  and only ligh t above SZOnm to ro ach  the 
eye p iecos olnce tho pealt of FITC abso rp^on  io a t  490nm 
hnd th e  peak  of om ission  ia  #  SZGnm,
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The specim ens w ere wiiMn 24 hours of
being sW ned although no doWrWratlon was noted on
■' . - o -  '■■ ■' ' ' ■ ' ■WWragè at 4; C jn  the dark for up to two wooke, SocUono
wore usually viewed ticlng selO wldo^'Eold eyoplocoo and
a 3S# objooEvo low * OMy w hore locall&iatlon of staW ng
was dlfEciÊt was oil omorslon zAlOO objecEvo lono used,
'All Doctlons wore asoeoGod fqr.'latoaolty o f oW k on a
scoring  Byotqm of «oro to  foûr; -^oyo « nogatlvo, one « tra c e ,
two^wèàk, three » moderate and four :^  lnte%%Ge, The
sectlbhb wbrq a lso  doeq'ribod according to pattern of
staW ng; Q a. c ap illa ry  loop, M o m oeanglal, 8 « segm ontol,
F (9 focal ànd P perlpheraL
A ll photography was done uslh^  5 Lelt@ orthomat camera
attaclrniont# Tlined expooureo wore preferred to autom atic
expOGuroG In order to record the Intensity of staining In each
oectlen# F or m o #  of the work, tlie Elm used wao High Speed
B%<tachro%ne ùpmted to 400 ASA, with an mKpomure tim e of
two minutes but latterly Ektachrome 200 profeoslonal Elm
t^rated to $00 ASA ^ t h  an exposure tim e of 30 seconda wao
used. A ll black and white prints ■■were made from colour
transparencies ,
76.
D eW ls of Methods
Fixation ; . Fixation Is a  prooeos by whlch the  m olecules
vEtixin tiseuo are-atahU lsod thus inhibiting tlxo diffusion of
InGOlubW eubetancea and pifovonting autolyaie and baotorW
docoiTxposltlon of
V arious-fixing ioolmiquos wore tooted witliln thé immmio-
EUbreocenoe oyetom an ohown in table 2, 2. Twenty sections
fro m  each  of nine biopoiee w ore cat# Theoe biopeiea w ore
chosen to repreoent the range from negative to otrongly
poolEve biôpoieô and from  kidneyc with sev e re  pathological
damage to kidney# with mild diaeaee, Four eectione from
each biopey word Exed by each of the five  fW ng m ethods and
Wo of each four Wéi ô^ then stained with FITG conjugated rabbit
and-humUn IgG antiaerum and Wo with FITC coiijugated rabbit
antl-human C3 an#Bernm. IgG and C3 were chosen because
they are the ;two.proteins moot commonly found in  glomerUlo-
nopliritie#' A ll aeçtiono were r # d  without knowledge of the
procedure whl ch they had undergone and ecored on the baeie
of three- criteria;-
1) intenslty of atainlng; scored 0 to 4 
Z) quality  of ataîniugî , -.ocored 0 to 5 
3) background aW ning l sco red  0 to  4
Since come Exativee caused staining patterns to be
'haAy and diffuse, quality of staining was an index of dietinctneee
of o taW ng. When aesoBaing quality of ataln, only Miose
V7#
sections which w ere  positive w ere  considered.
The m ean sc o re s  fo r the in tensity  and quality  of sta in  
and the background in tensity  fo r each fixation m ethod a re  
shown in ta b le '2 .2 .
Table 2. 2; A ssessm en t of various fixation m ethods
F ixative
Î No F ixative
E ther alcohol a t 4 C 
P (10 m inutes) 95% 
alcohol a t 4°C (20 
m inutes)
E th e r alcohol 
. (10 m iim tês) 95% 
alcohol (20 m inutes) 
both a t  room  tem p.
4 95% alcohol (30 m inutes)
In tensity  
2 .4
2.2
1.6
1.7
5 A cetone (5 m inutes) 1.6
,1'  W I*.
Mean Score
Quality I Background
3 .9
3 .9
3 .8
3 .9
X s
1,9
1 .4
1 .5
1 .5
I 7 Ï
It can bo  seen from  tab le  2 .1  that m ethod Z is  second 
only in in tensity  of staining to metliod 1 w here  no fixative 
was used# F ixation  however allows sections to foe kept 
longer and a lso  in c re a se s  adhesion of sections to the g lass 
s lid es . F o r  these  reasons #nd a lso  because backgroiuKl 
staining was M gher in m ethod 1, m ethod Z \m s chosen in 
p re fe ren c e  to m ethod 1. Background staining w as low er 
fo r  m ethod 2 than fo r any o ther fixing m ethod and th e re  was
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à t l e a e t  a s  m uch quality  of stain ing a s  fo r the  o th er Exativos* 
th e re fo re  m ethod Z was chosen.
.Antisera; ■ All rena l h iopsiee a re  tested  rou tinely  fo r the 
p résen c e  of IgG* IgA, IgM, C lq , C4 and 0 3  by the d ire c t 
m ethod using FÏTC conjugated anti s e ra  to  each of these  
p ro te in s . The d ire c t teclm ique was em ployed because of 
the speed and convenience n e ce ssa ry  fo r a  rontino -test, 
because  com m ercial con jugated 'an tisera  "are read ily  
availab le  and because  i t  allow s com parison with & e re su lts  
of o th er lab o ra to rie s  slxtce the  d ire c t is  a lm o st u n iversa lly  
em ployed in  rou tine lab o ra to rie s .
In  th is  study deposltilon of Cls# properd in , fac to r B, 
CÏ-ÎNH, CSblNA and p lH  was studied by the in d ire c t 
im m unoÈ üorescence technique, The sections w ere  incubated 
E r s t  w ith rab b it o r  goat an tise ru m  to the re lev an t antigen, 
w ashed and incubated  witli antibody to rabb it o r  goat globulin, 
a s  .appropriate* conjugated to FITC . T here  a r e  two m ain 
reaso n s fo r using tlie in d irec t m ethod;-
a) I t  req u ire s  conjugation to a  E uorochrom e only 
Of a n tise ra  used in  the  second incubation.
b) I t  i s  m ore  sensitive .
B efore  use# a n tise ra , shown to be pu re  by double 
diffusion and im m unoelO ctrophoreel 8, w ere  fu rth e r te s ted  
within the^im m unoEuorescoace.system . '
A ll a n tis e ra  w ere  Incubated fo r two hours a t  room
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te m p e ra te ©  ;a |te r: being diluted in  the  ap p ro p ria te  pure  
antigen, bovine se ru m  album in a t  a  cbneentration of Smg/ m l 
o r  PBS* , T his ; m ix tu re  was oentiifuged a t 1000 g fo r 15 minutes^ 
a t  room  tem p éra tu re  to  rem ove''any p rec ip ita te  'wMOh m a y  
hàvè formed;"".:' A n tiee ra  àbeorbed' In  th is  way w ere  te s ted  . - ■ '
by ■ImmimoEuoreaOenceAgainst a t least'tw o  positive  b iopsies ' 
e ith e r  .by- .^tho; d i re  et -o r  tn d lre o t  method-' a s  ap p ro p ria te  * ;
AÜ',.sections w ere  read'- w ithout knowledge of tlie procedure:- 
.which Wtey^hadundergone and sco red .fo r intensity*  ^ Staining ; 
w as e lim in a ted  in  all: 'caees by p r io r  incubaEon wltl% specific   ^
an tig en ,{Sgüré' 2*3) and  was not dim inished by Incubation 
with bovine:',serunr albumin* T herefore , vvitîiîn the sensitiv ii^  
of the ■ bnmUhOEuores cen ce - te s t  .employed# a ll a n tise ra  w ere  
shown to be spêclÈ c. ..... '
To checlt^te .specificity,of thO' Fl'TG staining,, tissue 
sections from a t  toast two positivé -biopsies' We.re Incubated 
with antisera Tromvthe sam e-species as the.FlTG conjugated 
antisera .èmployéd-lh the immimoEuorescence te s t but tîiese ■ ■
antisera v/ero'not conjugated to F.ÏTC* After washing, ' 
tixe sections were then Ineubated with the appropriate FITC 
conjugated àntiSeruni* ; Again # e  staining-was totally removed* 
Incubating sections initially A^tli anti sera  of other speciEcib.es 
caused nb reducüèn in  intensity of staining when compared 
with sections''treated normally*,
X L)SO
Figure 2-3 The top photograph shows the deposition of IgG 
from a patient withMPGN. The photograph below shows that 
the staining on an adjacent section has been completely blocked 
by prior absorption of the anti se rum with purified IgG antigen.
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AU antisera were titrated before use to ascertain the 
optimal concentration. Thio was .considered to be that 
concentration which gave highest intensity of staining.v/ith 
the lowest background staining. Doubling dilutions of each 
antiserum were Incubated with sections from at leaet two 
positive biopsies as described above. All sections were 
read without knowledge of the procédure which they had 
undergone. -In each case the optimal dilution was found at 
least two dilutions from the end point of staining.
oAll anti sera were stored in small aliqu-ots at -20 C 
and thawed only once.
Choice of fluorochromei Of all thé Euorochromes available 
FITC remains the most useful for .the fluorescent antibody 
technique for several reasons
a) It has a high 0uoreocene© efficiency, that
.is the ratio of, light emitted to light absorbed/^bigh,
b). It is easily conjugated to antibody and does not 
interfere with the antigen/ antibody union.
c) it remains attached to antibodies during long
term storage at 2^0 C.
- . cl} UnboiBid dye is easily removed because of its 
low molecular weight.
fe) Commercial products are readily available. 
Mounting; .-Fluorescence efficiency increases with increasing 
pH up to pH 8.0 (approximately). For this reason, glycerol
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W pB 5 with W o bWfèr wa© aeèd.
--I# Embed bWpGleè In Tleeue^Tek üva gelatin çàp^nle and
anap*freéae Immediately in  îlt|ipdcl-nitrogen#
■ ' : o ' • ■' ' ■' " ■2. S t e e  a t  *79 G In a  ü4calêd c e n W w r.
3. Gut froàen  sèatiànG. ,
4. / 'A W d ÿ y T w B O .m in n te ,.
5. W a a h in P B ^ f^ Z x lO W h n te e ,
4, Fl% in  à t e r  àlcohol a t  4^G, 10 minute*
;7* _- €entlnùè, fixation in  95% alcobbl ât 4®C* 20 minutoe*
" Waab In S :& S minutee#. - 
9#. ïnoubaté'wltb a n # # e #  In humid container, 30 minutes. 
10# Waob in PBS, 3 x T minute#.
Il#  - E epoat mwp# 9 and 1.0 fo r  in d ire c t te  et# "■
12, Mount in glycerol, buffered to p# 8/ S 
IS. Examine oeètlons and photograph.
14. Store àt 4^C In dark.
82,
Serum Studies .
.. — '— ■
Clotted blood samples were obtained, where possible, 
within 24 hours of renal biopsy. These were obtained 
from the following disease groups:-
Table 2.3; 39laghoses Of patients from whom serum 
samples were obtained
Diagnosis
Membranous glomeruloaephrltie 
MembranoproUferative glomeridonephritl s 
Focal glomerulonephritis 
Henoch-Schonlein nephritis 
p y stem ic  lupus erythematosus 
Minimal change nephrotic syndrome
Number of Sera
11
17 
14
4 
10
5
Serum samples were obtained from 50 healthy blood 
donors, courtesy of Dr# I . Wallace, Regional Blood 
Transfusion Service, Law Hospital. These were used 
to estimate the normal range for each complement 
protein studied*
The serum concentration of the following complement 
proteins was measured in each diseased and norm al 
serum sample; Glq, C ls, G4; properdin, factor B,
C3, C5, cT-INH, CSblNA and plH .
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R adial Immunodiffusion Method
The a n tise ra  fo r rad ia l immunodiffusion w ere  those 
used in the im m unoEuorescenee te s t a p a r t from  rabb it anti" 
human G lq  and rabb it anti-human G3 which v/er'O supplied 
by Dr* K. Whaley* All an tiee ra  had been checked fo r 
m ono-speclE city  by double diffusion gel p rec ip ita tion  and 
im m tm oeloctrophoresis a s  above. ,
Suitablo volum es of monos'pecific axitisora, prev iously  
estim ated  by titra tio n , w ere  added to 40 m l aliquots of 1. 5% 
ag aro se  in VBS containing 0*0 IM ED TA and 3. 3 m l of antibody 
im pregnated  c^g'arose w ere poured into 5 cm p la s tic  p e tr i 
d ishes and le f t  to solidify a t room  tem p era tu re . These 
pkitos w ore s to red  in  a  humid cliam ber a t 4^G until requ ired . 
W ells w ore cut using a  needle of ,1*3 m m  in te rn a i d iam ete r 
fo r a ll  p la tes except tliose fo r C lq. w here a  needle of 1.7 mm 
in te rna l d iam ete r was used. The agaroso  plugs w ere 
renaovcd by s uction and the w ells w ere filled  using a drawn 
ou tc lass  cap illa ry  tube. E ach sérum  sam ple was te s te d  In 
duplicate. A pool of norm al human s e ra  was allquoted and 
sto red  a t -70^G* T hree w ells in each rad ia l immunodiffusion
' i- ; . i ,
plate  w ere filled  with dilutions of th is pool; imdiluted (100%) 
50% and 25% (dilutions w ere  m ade in PBS)* The serum  was 
le f t to diffuse fo r 48 hours a t room  tem p era tu re  in  a  humid 
a tm osphere .
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W here antigen and antibody m eet in  optim al p roportions, 
diffusion of spéciE c antigen stops and a  ring of p rec ip ita tion  
is  form ed a s  show'n in  figure  2-4. The a re a  w ithin the ring  
: is  p roportional to die concentration of antigen applied to the 
w ell. When, the squares, of the d iam ete rs  of the 100%, 50% 
and 25% standards a rc  plotted against concentration on lin e a r  
g raph  paper, a  s tr ig h t line is  obtained. The in te rce p t of th is 
. line on the y - ax is apxiroximateo to the square  of the d iam eter 
of the w ell and the percen tage  .concentration of th e  se rum  
p ro te in  under te s t  m ay be read  from  the graph against the 
square of. the diameter of the ring size# Results w ere analysed  
using a  H ew lett-P ackard  Dchk Top Computer m odal 9800,
The programme p rin ted  the co rre la tio n  coefficient of thé •
•. standard  line., the in te rcep t On thé y -ax ls  and individual " 
concentration  in  te rm s  of percen tage of the norm al pool and 
in j.\g/ ml. , Only re su lts  from p lates whose standard  had a 
: co rre la tio n  coofEcieht greater, than r  si 0. 997- wer© accepted# 
'-'D uplicates w ere  calcu lated  séparat'clÿ  a n d 're p e a te d  if  they 
d iffered  by m ore  tlian 10% in  tîxe final concontraiion and sam ples 
' giving''readings 'of .g rea te r ' than -110 % ' 6f d%e. 100.%'. .Standard w ere  
repeated  a fte r 'd ilu tio n  in-PBS, '
N orm al'-R ange .. . ;, Tho' concentration pf each of .the p ro te ins 
-studied was measured in each of the 50 normal é e ra  in te rm s  
;,of ' percohtago of .thé:''Standard ■p.ool. '
X 1-7
Figure 2-4 This photograph shows a radial immuno­
diffusion plate in which Cl-INH levels were 
estimated. The plate was filled  from the 
top left and each sample was tested in duplicate. 
The well in the centre of the plate was filled  
with the 50% standard with the 100% and 25% 
standards immediately to left and right of it 
respectively.
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' The range fo r each component was te s ted  fo r norm ality  
using t h e ^  t e s t  fo r no rm ality  ( 165). As a ll ranges w ere
•: ■ ' -,v 4.
found t© be norm ally  d istribu ted  the m ean - two standard  
deviations was calculated and used a s  the no rm al range. 
Serum  concentrations of each component, except C3bINA, 
w ere  converted,-to p g / m l using re fe ren ce  s e ra  supplied 
by D r, P, Sclxur and D r. K. Whaley and the normal ranges 
a re  shown below*
C lq 283-672 ug/ m l
q ie 24-49
C4 149-550 M
properdin 13-41 M
fac to r B 111-303 n
C3 769*1794 tt
C5 84-170 11
Cl-IN H 121-303 II
C3bINA 55-123% Of normal
p m 156-356 pg/ m l
C3 N ephritic  fac to r a ssay
All m em branopro lifera tive  GN (MPON) s e ra  and a ll o ther 
s e ra  with G3 leve ls  below the norm al range w ere  exam ined fo r 
the p resen ce  of nephritic  fac to r (NF)*
One hundred m icr© litrea of te s t  se rum  w ere  incubated 
with 300y d  of norm al human serum , e ith e r in the p resence  
of 0, OiM FGTÀ with 0..01M m agnesium  chloride o r Ç), DIM 
ED TA fo r lO m inutes a t  3 7^C. As contro ls, a  known 
positive  and a  known negative w ere included each tim e.
A fter 20 m inutes, the reaction  was stopped by the addition
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of ZOO jjî of 0. IM ED TA at O^ G. Magnesium ÉGTA 
allowed only activation of the alternative pathway while 
ED TA inhibited all complement activation. The residual 
C3 was measured by a haemolytic titra.tion of C3 and the 
percentage utilization of C3 due to alternative pathway 
activation was calculated for each sample.
Ten.normal serum samples wero each tested on four 
occasions in order to establish the lower limit of normal.
The mean of these results was 93.0% with a standard 
deviation of. 13., 7%, The lowest result was 63% residual 
C3 and this was accepted as the lower limit of liormal.
When the GN sera were tested only 3 MPGN sera were 
positive and no borderline values wore found; the highest 
of the three subnormal values was 43 per cent and the others 
were nine and four per cent residual G3. .
Haemolytic C3 assay '
The following reagents, required for this assay, were 
supplied by Dr* K. Whaley; rabbit anti-sheep haemolysin, 
hiunah Cl and human C2.
Preparation of EAC4 cells ( 166): 2. 5 x 10" sheep erythrocytes 
were washed twice in 100 ml of PBS, centrifuged at lOOOg for 
ten minutes, and resuspexided finally in 0. OlM ED TA/ GVB~
'  ' ■ 9at a concentration of 1 x 10 cells per ml (250 ml). An equal 
volume of rabbit anti-sheep haemolysin at a dilution of 1/ 100
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(previously titrated) in 0# OIM E33TA/OVB was ;added,and 
tlxo îinxturo wa.o incnbatod at 37 C .for 30 minutés. This 
v/ao contrlluged at lOOOg lor,ten .minutes and' re suspended - 
in 500 mi BOYB . To those cello was added % x 10*^  units . 
of human-GI ixi 500 *mX of DGYB***' smd these were incubated 
at 37% for IS minutes, ùenttitiigeâ for IS minutes at lOOOg, 
reoixoj>onded in 500 ml PGYB' '^ and cooled to 0% . To 500 ml of 
EACI coils, thus prepared, was-added a one in ten dilution of
5Ç
norm al hum an-serum  in  0. OIM ED TA./ GVB and the m ix ture  
was incubated a t 0^0 fo r 15 m inutes while shaking* The cells
£3
w ere  .then washed tw ice in 0 , 04M EDTA/ GVB to d isso c ia te
b -to the C l complex, centrifuged a t 0 C a t lOOOg.for IS m inutes,
   I*
m ade tip to a volum e of 500 m l in  0*04M ED TA/ GVB' and 
incubated a t 3?^G fo r 30 m inutes to decay C2 from  the EAC42 
complezï. Tho cells w ere  washed onco i n  0. 04M ED TA/ GVBs? 
and tw ice in  DCA/B centrifuging.a& 1000g fo r 15 .minutes.
The cells w ere  then in tho EAC4 otato*
P re jm ra tio n  of EAGÎ4 caliB (166); To 10 m l of EAG4 cells
0a t 0, concentration of 1 x  10 in DG¥B w ere-added Z, 000 units 
of human 01 i n  10 m l of DGV33 and th is m ix tu re  was incubated 
a t  37 G fo r 15 minutes* The 33AG 14 ce lls  w are  centrifuged àt 
lOOOg fo r 5 m inutes and m ade up to 10 m l in DGVB^;^.
Oxidation of humara C2 (06) and p repara tion  of E A C 1 4 ^ ^  2 ce lls ; 
Ton m ic ro litre s  of po tassium  iodide/ iodine oxidising agent
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(Kl/ ï„) were dilutee! lu 2 ml of 0* IM phosphate buffer, pH. 6. 0
and 50 pi pf this was:added to 50 pl of human C2 containing
Zf 000 units. ■ This'mixture was, incubated for five minutes
at room teuiperature and then made up to 10 ml ixi DGYB 
'■ ■ ■ 
and mixed with 10 ml of EAG 14 cells, in .DGYB . Oxidation
of GB, in tMp way has been shown to increase the stability
of the complex. The cells and oxidised G2 were incubated
a t $7^C for 15 minutés and the EAG14%^2 cells were centrifuged
a t lOQOg fo r .five minutes and made to a final concentration
8 ++ of 1 X 10^ cel^s in  DGVB .
Preparation of C3 depleted serum .(E3). ( 16 ?) : To 10 ml of 
normal human serum was added ,2. 5 ml of 0V3M hydrazine
Ùhydrate and tliis was incubated for two/hours àt 37 C, adjusted 
to pH 7.0 and dialysed at 4^G against 1 litre of PBS.
C3 Assays 50 ul of a 1/ 400 dilution of C3 nephritic
- ' ' \  ■ " ' ' 
assay product in 0.04M ED TA GVB was incubated with 50 pX
of a 1/50 dilution of the C3 depleted serum (E.3) in 0.0 4M ED TA
GYB*^  and 100 pl of EAÇ 1 4 ^ ^ 2  cells at a concentration of
1 X 10 in  DGVB^^ fo r  one hour a t 37 C. Two m l of PBS
were added at 0^0 and the tubes centrifuged at lOOOg for five 
minutes. The optical density of the supernatant was measured 
at a wavelength of 41-to'n. As a control, to test the effect 
of the R3 reagent, the G3 nephritic factor assay product was 
replaced in the G3 haemolytic assay by 50 jul of 0 .04M ED TA GVB
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and 'the  optical d e n s ity  reading of th is reagen t blank'w as 
sub trac ted  from  'a ll/te s t  read ings before the percen tage  of 
res id u a l C3 \Vas calcu lated . The concentration of the E3 
.reagent had been titra te d  prev iously  to give le s s  than 10% 
ly s is  in the above a ssay . - "
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Stat&Gtical Tests 
I) Moan aW  Standard devlqllon
The moan and standard deviations of seto of values were 
caleuleic4 uoing a Hewlett PaoWrd calculator, model 9800.
Z) y? T ect for norma ll#  (165)
This te s t  was used to a sc e rta in  w hether a  se t of values 
was no rm ally  d is trib u ted  iu o rd e r  to  es tab lish  which s ta tis tic a l 
te s ts  weye ap p ro p ria te  fo r fu rth e r  analysis of the groups.
The b a s is  of the te s t  w as to  divide tho observed  values into 
su itab le c la ss  in te rv a ls . Using the m ean and standard  
deviation of the observed  values, the expected nm nber of values 
in  each c la ss  in terval was calculated  assum ing th a t tlie values 
w ere  tru ly  no rm ally  d istribu ted . The observed  and expected 
num ber of values In each c la ss  in te rval w ere  then com pared 
using the  X  te s t  witli the Null H ypothesis th a t tiaere was no 
d ifference  betw een the expected and the observed  re su lts .
The num ber of deg rees of freedom  v/as calcu lated  a s  the
?num ber o f c la ss  In terva ls  m inus 3. IK  ^ tab les show the leve l 
of p robability  that the observed  re su lts  v a ry  significantly  from  
the expected.
The norm al range for the se rum  concentration  of each 
component when analysed  in th is  way, was found to be 
n o rm ally  d istribu ted . The serum  level© w ithin the d isease  
groupa» however, w ere  often no# norm ally  distributed. This 
was p a rtic u la rly  tru e  fo r MPGN and BLE. F o r  th is  reason  
se ru n i lev e ls  w ere  analysed  using the m edian te s t  and the
91.
fjpoarman rank correlation teot.
3) Median Test (1,69)
Thio toot vmp used to oeo l£ the corum levelo  o l any single  
GQmplomùnt compo-nont lu any group varied significantly from  
normal# The param etric stitdenKt t t e #  could not be employed 
clnco many o£ the cots of valueo %vere not norm ally distributed. 
The null hypothesis was that the two gronpo were from populat­
ions having the sam e median# The values in the two groups 
to be compared wore combined and tine median of this combined 
group found. ' The two sets of scores'-were ti^en split at the 
combiaied median and set in the table below.
Group X Group n
Number of scores above combined A B
median
Number of scores below combined ■:, G . D
median
Since tho combined sample size was always greater than 
SO the % test: corrected for continuity was used to analyse 
the results#
The formula is ;-
# N(IAS-BCI - . f  ) ^
(A+B) (C+D) (A+G) (B+B)
2y /  tables were used to find the level of probability tîiat 
the two groups were from populations having the sam e median.
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4) Spearman a^ amk (1691
■ The-Speatman rank çorfeiation'^é$t is need to meaenre 
the level ol as so elation between two sets of paired variables 
wMeli'.are on an orclinal scàle or'which are  ;on .ah interval 
scale but a re  not normaiiy distributed. The analysis .was 
carried  out using thé, appropriate'program m e i n  the "Statistical 
Pack lo r tlie. Social Sciences" àtMiie University of Newcastle 
computer using a term inal at the University of Glasgow.
This te s t was need to assess the correlations between ' 
serunr lovelà .of each component v4thin,each disease group 
since sets Of values were often not norm ally'distributed. ' 
Correlations between intensities of staining of each 
component, within tîî.e glomeruli in  each disease, group were 
also analysed in this way. Tissues which-were negative 
for any antigen were given a score of ^erO'-for that antigen 
and ranked accordingly.
CHAPTER 3 
M e m b r a n o u s  G l o m e r u l o n e p h r i t i s
. ' 93.
M em branous G lom erulonephritis '
Introduction
The te rm  m esiibranoue g lom erulonephritis (MGN) 
was used  to d esc rib e  a  pathological entity  involving thickened 
basem ent m em branes and asso c ia ted  with nephro tic  syndrom e 
(170), D ifferentiating betw een MGN and MCNS a t  one ex trem e 
and MPGN a t the o th er was g rea tly  sim plified  by the  introduction 
of the m ethenam ine s ilv e r  sta in  (171) , This showed that, 
ra th e r  than  being uniform ly thickened Üie basem ent m em brane 
had sp ikes p ro jecting  outw ards and round s ilv e r  -negative 
m a te r ia l. By e lec tron  m icroscopy, the s ilv er-n eg ativ e  
m a te r ia l was found to consist of e lec tron  dense d ep o sits ,
L ittle  o r no ce llu la r p ro life ra tio n  is  p re se n t and th is has 
led  som e pathologists to p re fe r  the te rm  glom erulopatîiy.
Im m unofluorescence stud ies have shown tha t the cap illa ry  
loops a re  studded with deposits which sta in  fo r IgG* T here 
is  debate regard ing  the deposition of com plem ent com ponents. 
Some au tho rs have freminently found G3 deposition  (172-175) 
while o th ers  have seldom  found it  (176), The stage of the 
d isease  m ay be im pprW nt since Z ollinger found th a t b iopsies 
taken ea rly  in  the course  of the d isease  w ere  often negative 
fo r G3 w hile 03  Ayas frequently  p re se n t in  b iopsies taken a t a 
la te r  stage (177).
The evidence fo r an immune complex pathogenesis is
' 94.
a s  follow s:-
a) The deposition  of IgG and C3 roimd cap illa ry  loops is  
in  a  position s im ila r  to that of e lectron  dense deposits* 
h) T here  is  a  close s im ila rity  in  m orphology betw een MON 
and the Heymann m odel of ON (178) and d iro n tc se rum  
eiqloiess (65) -  both im m une complex d ise a se s .
'ey In  $LE, aIm ow n irmnnsie-complex d isease ; one pa ttern  
of g lo m eru la r lesion  is  indistinguishable from  that of 
.MGN (5:3). /  .
d) ■ V arious antigens have been found to bo deposited  in MGN 
b iopsies in the  sam e d istribu tion  as  IgG (see  tab le  1,1).
e) iim m m e complexes, have occasionally  been found in tiie 
s e ra  of MGN patien ts (179^ 181,. 191). ■
, In co n tra s t to  th is  supportive evidence however,
a) Im m une complexes, generally  , cannot be found-in serum  
(1 7 9 -m i,) l9 l) .
b) C irculating  lev e ls  of com plem ent components a r e  generally  
not reduced  (173, 182) although in  one study two of 17 patien ts 
had reduced C3 concentrations (183).
c) The inflammation^ norm ally  assoc ia ted  with a  typo III 
hyi^crseneitivity  reaction , e, g* in filtra tion  of polym orphonuclear 
and m ononuclear leucocytes, is  not evident in the g lom eru li.
D espite  th is , the balance of evidence v/ould appear to 
favour an im m une complex pathogenesis. The possib ility  that
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km m m o com plexée m ay fo rm  within the  cap illa ry  loop In 
MON ra tliq r tl%an being dopoeited from  the d r W a t lo n  v/ae
é i ü e i m m ê  III the Introduction (40) * . If this in  the case It 
would accoimt for the general absence of circulating Immimo 
complexes and also, to some extent# for 18io ahsencq of 
reduced  serum com plem ent levels*
M âlâs ls ls .
Im m tm ofluoreocenco étudiés w ere  p e rfo rm ed  on rena l 
M opsles obtained fro m  32 MON patients* A ll o f th ese  had 
proteinuria at the tim e of biopsy ranging from  1 g to 1@*7 g / 
34 hou rs (m oan &$ 7 ,3  g / 34 hours)* Berum  oëéaUnlne 
lev e ls  a ll  fe ll  w itldn tlie no rm al range,
B etw een 1 and i o  g lom eruli (m ean o 3» A ) w ere  
examined by ImmimoBuoreacence In each biopsy end eorum 
samples wore obtained at the time of biopsy from 11 patients.
& of ImmunefdobulInG, com plem ent and
The num ber o f b iopsies positive  and the m ean  Intenolty of 
aWlnIng fo r  each  p ro te in  ossamlned Is  shown In tab le  3 .1  
(see  over).
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D p o s i t io n  of
%gG waa .foimd* a  h%h %nWR8&^# a ll %3 
blopeloa, IgA w as %ot ^eptwKtcé W amiy and I^M  w&^ pyosent 
la  only fou%* o f (18%) Wdaoys
Foiwtoon of 19 WopuWe (V^ %) woyo poqWyo foy G4 
Although G,1 ouboompoROAta \% yo fo#%d 1% OM&y alg& o f BO 
Wop$loô(^0%)*
a s s f f i l i l a i i s l a M ® i s a t e J ? M œ î j ï ^
.'. l a  fquF. o f twoAfy blopaiom (B0%) i^^oro wao dopOK*l#<m of 
pyopoWhx# ' / .TMa vmo of low moaa WoAolty»;. 5"*aeto3r .B waa 
not foimd.
DopooWoA o f 0 3  and OS
Twenty oao of Z% Wopotoo (98%) woyo pogiWvo fo* botl% 0 3
and 0 8 , TW W onglty of 0 3  wa0 Wvosr than la  other groupa
/
whore 0 3  waa froquontly foimd (a '^apondW %), 
£ S H 2 lte^ ® iJ& * M JE :S S sfeS .' ,
Dopoaltioii OÎ Cf-H®* •wt'î.e eeéj.i }a JS ô f 20 (?S%) imûJM'B 
&% 18 of (90%)# . GSblNA w^a not dotootod la  any MON 
Wopolôw,
 ^ lloWg thO'%oarm%n rW h  ooyyelatloa toDt* tW  W on^lU os 
Of'aWnWg of'.each protoW attidWd wa@ ^mpAred wW% the
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in tc n a M e a _o f a ll o ther#  (T ab le  3 , 2) , Bessaiioe o f the  csmaU 
num ber o f b iops ies p o s itiv e  fo r  îgH» -.C lq  m \û  p ro p e rd in  And 
the absence o flg A ,' fa c to r B and C3bXNA# no s ta tis tic a l 
analyses v/ere. p e rfo rm e d  on # e  re s id ts  o f these, R rep resen ts  
Spearm an c o rre la tio n  c o e ffic le #  and p the p ro b a b ility  o f 
e lg îilfle a n ce ,
Significant correlations are shown in red*
T ab le  $»Zi  ' C o rre la tio n s  in  h ito n a ltlo s  o f s ta in la g  between the...........  ...................  isi£’t^ v*(^ iie-*<enEwefi3HriWweww.ti#>«tn/«-4V»tW'*         * ............... ' '   -------- '      ' ' '
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HS ÎS no t s ig n ific a n t 
The c o rre la tio n s  o f sdaosEcaî pathway conm onents
The m tem sities o f dopes itian  o f C ls  and C4  d id  no t show 
s ig n ific a n t c o rre la tio n s  w ith  tlio  in te n s itie s  o f any o th e r p ro te in .
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The co rre la tions of G3 and C5
The in tensitie s of deposition of C3 co rre la ted  witli those 
of IgG and C5.
The co rre la tions of the control pro teins
The in tensitie s  of C1*INH deposition did not co rre la te  
with those of any o ther component, while the in tensitie s  of 
JBIH deposition co rre la ted  with those of IgG, C3 and
The concordance betw een deposition of the control p ro teins
of com plem ent and the components whose activ ity  they regulate
Cl-IN H
Table 3. 3 The concordance between b iopsies positive  fo r 
C ls , C4 and CT^XNH
C ls /  CÎ-ÎNH
No* of 
Biopsies C4/ CÏ-INH
No. of 
B iopsies C ls /  C4
>To. of 
Biopsies
:1 s  f  CÎ-INH*!* 5 C4 + Cl-INH-f 12 Gls+ 04+ 6
:1 s  4 CÎ-ÎN H - \  1 " C4 + CÎ-IN H - 2 C ls+  G4- 0
:1 s  - CÎ-INH+ 10 C4 - CÎ-INH*!* 3 C ls -  C4+ 8
:1s - Cl-XNH- ■ 4 C4 .  CÎ-IN H - 2 C ls -  C4- 5
l Total 20 Total 19 Total
^7
Table 3 ,3  shows the concordance between b iopsies positive 
fo r and those positivefoir C ls  and C4. C ls  and CÎ-INH
w ere found together in only five biopsies while, in  ten, CT-INH 
was p re sen t without C ls . B e tte r concordance was seen between 
C4 and C l -INK, with 12 biopsies being positive fo r both. In
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two, G4 w m  w ithout OÎ-iMH àùd In' th re e  Ç Ï-IN îï w m  
deposited  in  the aW enee of G4* AU b iopsies, with deposition 
of C ls , w ere  posiU ve-for C4* In eight, ■ how ever, C4-wàs 
p re se n t w ithout C ls ,  ’ ,
p a I
Table $i~4 ' 'The concordance
03 , G4, 05 , p roperd in
n  o iopsies
and p m
c 3 / p m
No, .of
biopsies # / p m
No* of 
biopsies 0 5 / BIB
No, of
P /p iH
So. o£ 
M o p a l,,
C 3+)3m + IB c 4 + ^ m + 12 G S + p iB f 17 P + p iH f 4
C 3 4 p m - 1- c 4 + p m - 2 , c 5 + ) s m - a P + p îH - 0
G3- p i B f 0 C4^ p i m 5 G 5 -p iB 4 1 p . p m + 14
G 3 ^ p m # ■|- 0 4 -  p m - 0 0 5 - p m - a P - p lH - 2
Total 
U.___ _
ao
L .,...........
Total 19 Total 20 Totai 20
Table 3 .4  shows tiie  oonoordance betw een M opsles positive  fo r 
p  m  and 03# 04 , 05  and p roperd in . Of Uio twenty b iopsies 
exam ined fo r deposition of €33 and p m #  both p ro te in s  w ere  found 
:tn 18# in  one' 0 3  was found alone wnd In one n e ith e r w as p re sen t, - 
0 4  and p m  w ere  p re se n t together inTB b iopsies . ■ In  two# 0 4  
was found in Uie absence; of p lH  and  in  five p  IB  w as deposited  
without 04# Concordance was shown between b iopsies positive ■ 
for A m  and C5 in I t  b iopsies, in two C5 was present without 
IplVi and in one ^ I B  without C5, |B1H was found in  a i t  four b iopsies 
positive fo r ■properdin.
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Tluî stalling jiattorn for eaçhproteîiiwlMn pa ch Mopsy 
was apàesùççl separately ». I$% a ll #0#s# for-, all proteins#, ■ ' 
except IgM# aWWng was fowid in a diffuse granular oapUlary 
loop pattern# . IgM#' where .present deposited segmentaUy.
C lose examination of tlie patterns of C ls  and CÎ-INH and C$ 
and'.pIH (Figure 3-1)# on adjacent seetions, showed.identicai 
patterns of distribution#
Berum saranlee . , .
The oc*hcentratloa of each oompdnent In th e  se ru m  of each 
of I I  pa tien ts  Is shown on figure  3-Z.» . .
The concentrations of c la ss ic a l .pathway com ponents ■
The m edian  lev e ls  o f G lq  and C4 w ere  'S ignificantly raised- 
in  MGN w hile C ls  va lues did not d iffer slgniJ^cantXy from  
norm al# No suhaorm al concentrations w e re  found fo r  any of 
the c la ss ic a l pathway components studied# - 
The concei^tratlons of a lte rn a tiv e  pathway components
Neither properdin nor factor B value® as a group varied ' 
significantly from normal* Four factor B .concentration® 
and one properdin level were above normal. No subnormal 
values were found-in the. MGN group ..
The median values for both C3 and GS concentrations were 
significantly raised# No values were found below the normal
V -
■-
<». r
/
X 6 ,50
Figure 3-1 The top photograph shows a glomerulus stained 
for C3 and the photograph below shows the same 
glomerulus on an adjacent section stained for plH.
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range and high vmlnas, ■ particulaidy of C% wérç common.
The coBcentraÜonc of ttie control protéine
A ll  MGN patien te  Ka4 c f-IN H  concentration® above'tho  ,• 
no rm al range , The CSbïNA m edian did not d iffe r  e lgn i# tm ntly ' 
fro n i norm als ... One G3M N A 'concentration \v&S bôfow %nd ' 
an o th e r above the  no rm al range,.; A lt but th re e  concentrations 
w ore ra ised 'a n d  the m edian y#lno fo r J |IH  w as sIgnWcmntly ■ 
raW ad*. - ' :
The correlsRiona betw een aerm n\concen tra tions of com plem ent
.gm esaÊ B m am lJB m je  ,, : .
' The .co rré la tions betw een the se ru m  concen tra tions of ■ 
each of thé com ponents 'studied w ere  calcu lated  using the 
Spearm an-ranlc co rre la tio n  to e t and- the remidts a re  shown in  
tab le  3 .5 ; . - .R rep resen ts . thO-Spéam nan. ranl^, co rre la tio n  
coefficient and p  .rep resen ts tl%b p robab ility  of sigïdfi-cance,
As can be ; seen, very-few olgnllic*ant corrélatlono wore found.
C5 CSbLna 
% of STE
piH 
K/ m l
C lq  
M g /m l
C Ï-IN H  
M R /m l
C ls
M g /m l
04  
M g /m l
-600
-800 -300 -600
-3000
-80
-400
#  # #-50
-600*
-60 * •150 -4JP
--400,
-40 -200
#  *  #
-200-20
-200-20 -50-100
-200 -10
0 , 0 1 1O.OI t 0 .0 5  I O .O ltNSNS NS NS
F i g u r e  3 - 2  T h e  c o n c e n t r a t i o n s  o f  e a c h  p r o t e i n  s t u d i e d  i n
e a c h  o f  t h e  1 1  M G N  s e r u m  s a m p l e s  a r e  s h o w n .
T h e  s h a d e d  a r e a s  r e p r e s e n t  t h e  n o r m a l  r a n g e s  a n d  
t h e  h o r i z o n t a l  l i n e s  r e p r e s e n t  t h e  m e a n  c o n c e n t r a t i o n  
f o r  e a c h  p r o t e i n .  T h e  r e s u l t s  o f  t h e  m e d i a n  t e s t  
a r e  s h o w n  a t  t h e  b o t t o m  o f  e a c h  c o l u m n  w i t h  a r r o w s  
i n d i c a t i n g  w h e t h e r  t h e  c o n c e n t r a t i o n s  a r e  s i g n i f i c a n t l y  
h i g h e r  o r  l o w e r  t h a n  n o r m a l .
N S  =  n o t  s i g n i f i c a n t .
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The cos'rjDlationB of- oI% ,èeIe;A l^#w w  comni         — —         - "
TWre was & weak %%ver@e eoyyolat&oa bôtwoçA momm eoAcmtrat"' 
Wne of C4 a%d facW:" B# No othoy coryelaUoRS w ofo foimd,
!^he <^3fWaUoA0 o f tlxo a lto m atlv o  m tW a v  eom wàe^ite
No 8lgpüÛqa%t eofW atioAi^ woyo foimd fro m  those Wmt w ore 
fo r  C4 8W  fo o te r B . - - . "" v
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63 and CD eon cont ration*^ did not correlate’ with-any'other ' 
com plem ent j:>rotoin»
The cdrrolaticno of . the control protomsi .
W eal; c o rre la tio n s  r/cxo found bctw oon con cent ration c o f 
GÎ-ÏHH and 03 andp IH* botwoeapHI and Gls and iavoxGoIy 
between C3MNA and C4. A stronger correlation wao found 
botvveon conccntxationo of CSblNA and factor B.
Tho x’olationchip between mexiim concentrations and lntcnoity' 
of nlomcriüàr deposition of compiomont components and control proteins 
TJsing the Spearman ranlt correlation toot, the Intensity of 
deposition was compared, with serum, conceiitration a t time of 
biopsy of each compdnont except for factor B, CBblNA, Clq and 
properdin, which were not deposited or pros ont i n  too few blopoios.
The results a re  shown In table 3,6. ■ Jl x‘oprosonto the correlatloïi 
coefficient and p ,-■ th e ,'probability of significance.
Table 3. 6 The correlations between serum concentrations and
intensity-of deposition of each complement ■ component
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P
Glo 0 4 03 05 Cl-IN H IBIH
-0.61
N8
i)frW#«S#wwWc»S*"l'»K»7#*4-'TXW
0 .20
N6
0# 51
NS
-0 ,09
NS
0.42
MS
-0 .4 6  
NS
NS « not significant 
No significa^it assoc iations w ere fom>d betw een se rum  levels 
and in tensity  of deposition of any compound in MON#
' " , ■ ■ ' . : 105.
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I# ^ a g Iem@rW,ar m iû t i im  of com plem ent acllva tion  -' \  ' '
The finding. @1 fine gxanûlE r-dep'oslMon o f immtmoglobtilins,
'■partie idarly  of XgO, in  a ll  b iopsies is  -in ag reem en t w ith o ther ' : 
s fe lio s  (lî3ÿ  1Ÿ3, 177# 104)*- Thio satiaEes, one of the c r i te r ia  
of an  im m une compies. cHaease. ■ None of th e -biopsie# in  thl# ' 
gyoitp contained deaionatrab le  qnantltle# of IgA altltongh deposition ' ' 
o f IgA ha# been found oooaelonally in  o ther atndle# (173# 17$).
Slneo IgG bzw une compleifteo activate tlte claoalcal pathway, tlie 
dopoaitlon of OS in; a ll but One blepéÿ and the; e o rre la tio n  between 
the intensity, of deposition o f IgG and'03 {7’able 3,2)# enpport# ' .;
the'viet/'that the IgG found in,the Wdney is  eompleKed. to antlgeho ■; - ' 
in th e  fo rm .o f 'to m m e  eom plekes.
The Involvem ent of the  c la ss ic a l nathwav ■ ■
.•-ïn--^ thè m ajo rity  of MON blop#ie.0*-'îlTtere was evidence, of . ..
clao'sical pathway activation#- 61 Subcomponent# w e re  le s s  
frequen tly  fOtoid'than.C4. Several factor#  m ày be re#pon#ible 
for. titles*
a) T here  m ay be dî0:erence# in the antibody- potency of thé. 
'■antl*dls, C'I.q. and an ti"  G4 anti s e ra . This woifLd explain why, 
in  anotlier study (173) 70 p e rcen t of biopsio# w ere  positive  fo r 
C lq , com pared wltîi 30 p e rcen t in  tliis study (T able 3 .1 ). However, 
tlio resu lt#  of B e rg e r  (176) a g re e  with the finding# h e re .
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■b) ï t  is  a lso  possib le  tha t an tigenic de te rm inan ts on C ls
m ay be m asked by other' components § Cl*“ÏH H .iskno\vn to  do
c) A ctivation ' of a  single GÎ m olecu lar com plex m ay re su lt  
in ti%© de|>o#itknyof many G4 molecules-(IOb)* ' It is  therefore 
posalblo that, m  biopsies apparently negative lor C l eubcomponents, 
these were promeut in amoimte çnlficiént to activate C4;btit not to be 
demonstrated by immtmoEuor©açenco, TMs may occur particularly
where oomplomoat aclivatioh lo limited, ■
d) The binding of C l to  Immmioglobidlia is  known to be weak
a t  phyBiological ionic s treng th  (106) and C l im ij  th e re fo re  d isso c ia te  
fro m  the Cl'-IgG com plex leaving  IgG  and C4 In the kidney*
■ The ipyolyem ent of Ew a lte rn a tiv e  pathway ; —  ,
P ro p e rd in  w a s  deposited, in  four of 30 b iopsies and fac to r B 
w as found in  non©* ■ SilBCO MOM is  norm ally  ;as sociated- with 
.immime com plex depoiiltion and c la ss ica l pathway activation , few 
studies have exam ined the  g lom eruli of MÇIH, b iopsies fo r deposiEon 
of a lte rn a tiv e  pathamy components* ' W eptberg (187) failed  to  
fisid propO'Min In foiir bidpsloe examined# while in  another study#
27% of MGN patien ts had g lom eru làr deposition of p roperd in  (lB7a) -.
In  pnè .df the  p roperd in  r>o£îitive b iopsies, c la ss ic a l patiiway 
com ponents w ere  not found and th ere fo re  €3  deposition m ay have 
been the exclusive re s u lt  of activation  of the a lte rn a tiv e  pathway* ■
In the o tîier theee p roperd in  positive  b iopsies , c la ss ic a l pathway
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component# properdin together. In
tiieee caeee# the alternative patW aÿ may have been activated  
direetly by eome factore in the iddney or plasm a or as a  reenlt 
of rè^ ù itm en t by the claeeleal pathway# The eernm CSblNA 
concentration waa markedly reduced in one of theee three 
,pa tien ts (36% of normai# E gùre  $*A). A bsence of G3bîHA 
i e  imown to cause opontanooue activation of the olternaEve 
pathway in vitro (89) and in vivo (93)* It in poGsible that 
reduced leyoie of C3bINA may be associated wiEi increased 
alternative paüùsày activation* Gorrelatione between 
concentration# of 63bINA and C3* factor B and properdin in  
Other disease# suggests that such a relationship m ay ex ist  
(188# 1967 ■ 197) * In this one patient therefore activation '
0l;the alternative pàthtmy may have been due to low  leve ls of 
C3bINA allowing amplification of activation, - 
’•: I t  mnst a lso  be ccmeiderCd that properdin m ay bind to  C3b
nlonè (1^9) nr to the C3b/ B lH  complex (190). It is  therefore 
possib le that. deposlEon of properdin in the glom eruli does not 
represent activation the alternative pathway but m erely the 
prês*mce o f CSb* This w ill be d iscussed  in $nore detail in  
Chapter 9, jProsence of fhctor B would be a surer indication 
of alternative pathway activation although the absence of factor B ’ 
does not.exoiude the possib ility  of alternative pathway activation 
as factor. B decays rapidly from  the C3bBb complex (109),
.5  ' 108,
The te rm in a l sequence
In four b iopsies, C3 w as found In the absence  of e itîier 
cdassioal o r  a lte rn a tiv e  patiw ày com ponents. T here  a re  
se v e ra l possib le  explanations fo r this*
a) C3 m ay be cleaved independently of com plem ent 
ac tivaùon  by p lasm in  o r  o ther p ro tea see ,
b) C3 m ay be trapped  in  the kidney In i ts  na tive  fo rm .
N either of these  is  like ly  to be genera lly  responsib le  fo r
C3 deposition since IgG was p re se n t in  a ll  four b iopsies and 
tlie co rre la tio n  betw een IgO and G3 (Table 3 .2) suggests that 
the p re sen c e  of 0 3  is  re la te d  to  com plem ent activation*
c) The m ost probable explanation is  that since  03  activation 
is  n n  enzym atic p ro ce ss  (107), psh&ll qtutntitieB of C42 cause 
considerab le  cleavage of €3* Thus, in  som e c ases  undetectable 
quantities o f '6 4 .m ay be p re sen t resu lting  in  signlE cant G3 
deposition.
d) I t  is  a lso  possib le  tha t C3 m ay rem ain  in  the kidney 
a f te r  the rem oval of C l subcom ponents and C4 o r  a lte rn a tiv e  
patliway com ponents.
MGN is  d ia ra c te r ls e d  by extensive im m unoglobulin 
deposition# 03 , how ever, is  not alw ays found in  the g lom eruli 
(173, 176,177) and, in th is  study, although p re se n t in  a ll  but one 
biopsy, die in t^ s l t y  of 03  staining was w eaker timn in  m ost 
o ther d ise ase  groups (Appendix I)# Serum  lev e ls  of com plem ent
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Components, are; generally  no rm al o r  ra ise d  in MON '(Figure 3*3) 
(183^ 184). These two fa eta anggest th a t com plem ent 
açtivatioh  in  .MON is  not m arked .
' F a c to rs  which m ay affect the .rate of com plem ent acEvaEon
In MGN a r e f **
■ a) The num ber of im m une com plexes present* V arious 
im m une com plex assays,,genera lly  fa il to  de tec t clrcu laE ng 
im m une com plexes in  MGN (l79-»li-l, 191). " The inab ility  to 
d em onstra te  immWie co.mplexes m ay m ean th a t they a re  not 
p resen t, th a t they a re 'p re s e n t  b u t in  InsufE cient quan tities fo r  
detection  o r  tim t.thè .assays used  & #  to d e tec t the  type of 
com plex Involved in  MGN, If  t!%e àsèunrpÉon tiiat MGN4s 
an Im m une com plex  d ise ase  is  c o rre c t then i t  is  possib le  tlmt 
sm all quantiti.es.of complexes, are-deposited, w itliln the kidney 
perhaps oyer m any %^bnths, Com plem ent'.activation m ay 
-therefo re  be  slight# in te rm itte n t 'o r  bo ti:.. ;
b) The. ability, of im m une com plexes'to  a c tiv a te  com plem ent 
is  ano ther fac to r and  m ay Involve the eice of the  com plex (193)$ . 
..#%e antibody affiïdty (193) and tîie c la ss  and su b c lass  of antibody 
(83), ' • T here  Is  no data  availab le  from  tM s study to  a s s e s s  th is  
poss ib ility , .
- c) The position  of .immune com plexes in  MGN m ay affect 
com plem ent activation  w ithin the 'kidney* The e lec tro n  
dense  deposits# assum ed  to  be im m une com plexes, a re  deposited
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M a  àub©|>|thel|al poslilon 'and  a re  therefo re-no t In  d ire c t 
çOBfast.--wî^Jh0 p îaan iâ . ■ T his-nm y're su lt.în  loas e lE ciont 
a'ctivàtloit*
. Thé pathogenic signiEcanco-of com plem ent activation  in  
MON cannot b e  a s s e s eeé -d lreç t|y  since  experim ental' %nodols 
of th is  d ise a se ’a r é  lo n g -te rm  m odels and •complem ent depletion 
cannot b e  m aintained  over the  req u ired  period ; The absence 
'of m arked  ce llu la r  p ro life ra tio n  and iW lltra^o n  of inE am m atory  
ce lls  -puggestS' tha t com plem ent activation  m ay no t be perfo rm ing  '
Its  usual ro le  m  b iflam m atory  m ediator* • I t  Is p o ss ib le  that 
.'It m ay p lay 'a  ro le  in-deposition o f Immune com plexes althongh.
In tlie acu te  se ru m  slc lm èss model#' im m une com plex deposition *
. was a  '■ com plem ent independent p ro ce ss  (68), . 'The m ain  m orpho» 
log ical change In MGN. Is the .thickening of the basem ent m em brane. 
This m ay o ccu r In  response  to the p resen c e  of im m une com plexes ' - 
a t  the  subepithellal a sp ec t of the  basem en t m einbrane , ■ Com plem ent 
Is  no t known to  be  involved in  th is  p ro ce ss ;
In trag lo m e ru la r evidence of regulation  .of com plém ent activation  
In o rd e r  to .estim ate the regu la to ry  InÔ uence of OÏ-ïHlî#
CSblNA and p lM  In t!ie-glom eruli, ' four fac to rs  w ere  considered;*
. a) ' The presence'.o f control prbtein# in  the lddney,
. b) The concordance betw een b iopsies positive  fo r 
control p ro te in s  ami those  p ro te in s regulated ,
c) The co rre la tio n  betw een the in tensity  of deposition of 
tlie control p ro te in  and the  p ro te in  which I t con tro ls.
I l l
d) The correspondence In p a tte rn s of deposition of C ls  
and C l-tN H , C3 and CSbîNA and C3 a n d p lH .
The role of CÎ-1NIÎ
CT-INH was frequently present la MGN biopsies (Table 3.1)
and w here  both G ls  and GÎ-INH w ere deposited the p a tte rn s of 
stra in ing  w ere  v e ty  s im ila r . The concordance betw een CI-INH 
and C ls  how ever was poor (Table 3 ,3 ), and th e re  was no 
co rre la tio n  betw een the In tensities of deposition of th ese  two 
p ro te in s  (Table 3* Z)* The fact that gT^IHH was p re sen t m ore  
frequently  than C ls  (Table 3.1) may have se v e ra l possib le  
explanations.
a) G i-IN H  m ay m ask  antigenic sites on the CTg molecule? 
i t  has been shown that th is  m ay occur (115).
b) The an tl-C ls  anti s e ra  used  m ay have been le s s  potent 
than the  ànti-CÎ*IHH a n tise ra .
c) I t  is  possib le  that c t-IN H  is  regulating  ensym es of o ther 
hum oral m ed iato r patliway8, such a s  the coagulation, fib rino ly tic  
and the klnin sy stem s (194).
The fa ilu re  of to  p reven t fu rth e r com plem ent
activation is  shown by the deposition of 0 4  and 0 3 . Since 
the com plem ent system  is  p rim a rily  a defense m echanism ,
It is  unlikely tha t regulation  by C1*INH would re su lt in  the 
to ta l inhibition of com plem ent activation. The p resen ce  of 
C4 th e re fo re  need not suggest a  deficiency in  regulation  by
cT-ihh.
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T herefo re  the evidence from  this study for the ro le  of Cl^INH 
in  m odulating c la ss ica l pathv/ay activation te s ts  on i ts  p resence  
in  the kidney and the s im ila rity  in  the d istribu tion  p a tte rn s of 
CÏ-IN H  and C ls . ^
The ro le  of C3bINA
CSblNA was not p re sen t in the glom eruli of any MGN biopsy. 
T here is  th e re fo re  no evidence that i t  p a rtic ip a tes  in  tlie regulation 
of com plem ent activation in MGN. CSblNA ac ts  enssymatiçally 
and is  not consum ed during tlie inactivation of G3b (195). Its  
absence in  the kidney is  th e re fo re  not unexpected in view of its  
action.
That p lH  binds to CSb in the kidney is  suggested by the 
frequent deposition of p iH , the close concordance (Table 3 .4), 
the good co rre la tion  between in tensitie s of deposition of C3 
and p iH  (Table 3. 2) and the s im ila ritie s  in  the d istribu tion  
p a tte rn s  of C3 a n d p lH  (figure 3^1). Evidence against the 
ro le  of p lH  as a reg u la to r of G3b is  the frequent p resen ce  of 
C5 (Table 3.1) and the co rre la tion  betw een;G5 and p lH  (Table 
3. 2) , This m ay reE e c t the m utual dependence of C5 arid p  IH 
on C3b deposition.
In MGN, th ere fo re , th e re  is  som e evid,ence fo r the 
regulation of C ls  by CT^-INH and p a rticu la rly  C3b by piH ?
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W t thé ro lo  of : In  any d laeaqe w here
ïm m tm e compièxéA âye prê#0a% a# lo likely  to W  the câee In 
MON, thé  abeencç 'ô f m arked  ' com plém ent acE yatlon Is  clreum *
■atantiai évidoBce euggesting that- effective regulation  of com plem ent 
a5^lvatloù l i  occur ring.;;; y
E vldonce .of com plém ent activation  In tlie  ^c ircu la tion  
The Glaa sica l -Fatliway ■ - y  - r  V /  . *
In  MGN, '# e r #  was no rêdnctiqà  i n  the se ru m  concentration 
of ehy of # 0  G l^m im i:pkthw $,f components' (md m anÿ in creased  
conceatràtlons. w ere  found (figure'3-*B). The p ro te in u ria  p re se n t 
in  M te'urine of a ll  patien ts in  tills group has no t re su lte d  in  a.
' reducti'on in the  'serum  concentrations of com plem ent p ro te in s. 
In c re a s e d 'le y e ls ’probably re su lted T ro m ,in creased  syn thesis 
ra th e r  tiian reduced, catabolism  since'Som e activation-w as shown 
to  have taken-place; .
The A lterna tive  P a thw ay ' ' , °
T here  w as no ev id# ice  o f com plem ent activation  via. the 
a lte rn a tiv e  patiiway,, a s  no reduced leve ls  w ere  fo.un?! and again . 
se v e ra l concentrations w ere  in creased , ' ■
Evidence of regu lation  of com plem m t activation  in  the c ircu la tion  
■ T here  is  l i t t le  evidence In favour:of the ro le  of control 
pro teins; in  the  c ircu la tion  in  MGN/- One patien t, however, 
had a reduced  G3bINA level- and tiie 'corresponding biopsy was
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oàe Of #  of p ro p erd in . ï t l e p o a e tb le
therefqré th%t %# C3biNÂ loyel slldwod aotlvation of
thé.alternative patli%?ày* ' The hormal sérum lèveîs of 03 m<â 
jR&i&tCMC 33 t&wat zwpqr &ctl%n%tlt%a v4il<db t&d %ük&<:0TaM&8
mot marked. There, wore à# roWcod p i  H or Ci-IOTT 
eomoemtratlomB -
-,.. ■ Several sIgmlAeamt eorrelatioma wore present between 
aportpRi (apüicwBSükred&lowiD <>* <>oôiipdkBirie2%t (x>2oqQ(x&omü%i aw&d cwBMdkecül 
prpteiBBf The o é rre la tiq n  found botwoon C3MNA and fae to r B- 
.lovels {Table 3*5) has been found In other stmlies (18B, 196» 197,
Î98) where If was snggeeted that OSMNA, by mmrting a modnlatory 
Inflnence over». and .causing ■ catabolinm of C3b, prevented 
utilisation of faetot B» All other correlations were at the five 
per cent probaMMty level and, since at least two correlations 
would be expected 4%^  to chance at tlilo level, care must be . 
taken In .Inte^retlng these. The correlations between concentrations 
■of' CÎ^IHH and both C3 and plH# and C is and plM may have arisen 
due to ehanco/Or.to some,•common factor controlling the synthetic 
rates of the'proteins *■ The negative correlations between 
concentrations’ of €4  and both factor B and CSbiHA are difficult ' 
y to explain. Since concentrations of factor B and G3bïHA show 
■ a positive correlation, it Is not surprising that they should 
Share.a •similar relationship with C4, The inverse relationship 
may be duo to some fac to r whieh causes Increased 04  sysithosis
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and W dM # symthooW of C3WNA and factor B or v ice versa, 
or bo duo to  n  sparing of C4 In :^ Ti6 prosonco o f altornatlvo . 
pathway aetivatloni - , T his Is. imlikoly in  view  of the lim ited  
ovidonco of altom atlvo pathway âçtlyailon In MGN. It is  
also  posaiMe that ■those oorrolatiOna being at tho five per cont 
probability loyol, aroéo duo to oMnco*
The ro latibhsh ip  botwoon deposition and se rtm i Ooncontration 
of complomOAt components ■ '
No s ig n iû cant oorro latione ■wore found between the Intensity  
o f deposition and (ho so rum  eonaentratlons of any p ro W n  studied. 
The aW eneo of euoh co r re la tione  m ay have eovoral poeelble 
'explanations,,
a) Sorutn concontrâtione ro É e c t’tho Im m ediate extent of 
complement activation  while inm iunofluorescence m ay dem onstra te , 
wIthW ih e  kidney,  ^the p roducts of previous com plem ent activation,
b) Immame com plexes, witldn ' the dddney, may- re ta in  
' the  ab ility  to  ac tiva te  com plem ent a f te r  (lie rem oval of 
im m une com plexes from "the circu lation . I t  i s  a lso  possib le  
in  MON-that Im mune complexes: fo rm ed  In s itu  and w ere  
th e re fo re  n ev er p re se n t in the circu lation ,
c) In c reased  syiîthesis o f ■components m ay have m asked
the hypocomplex'nentaemic tendency' Induced by Im mune co.mplexes.
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SUMMARY
1. %n th is  study, therW ore, MON was not found to  Involve . 
m arked  com plem ent activation  and voaàono fo r th is
• _ w e re  dlo'cuoBed, ' -
2. Complement activation was found to bo primarily via 
th e  çlB Suim l pathway and co rre la tio n  re s u lts  suggest 
that IgG waâ the m ain  tom im ogiobulln  claea Involved,
3. . The 'deposition 'o-f p topm M ti in  four Mopoioo auggécta, th a t
the  alternative , pathv/ày may: he- involved to a  lim ited  extent" . 
and so v o m l m ethods of activation  w ere  d lacuesed , ' ■
4, The assoc ia tion  between^ deposition of 03 amd-plB* In te rm s  
of biopaloo pooi#ve and d istribu tion  p a tte rn s  of each  was 
good. Although w eaker, th«&re wan alcO evidence to suggest 
tha t w as p re se n t in  response  to  deposition of C ls*
5, C3bINA w as not p ré se n t In any MGN biopsy and reasons 
fo r  th is  w ere  discussed*
6, Serum  'concentrations of control p ro te in s  show tha t no .
.-■ g en era lised  deficiency of these.w as responsib le  fo r the
. ' ■ com plem ent activa tion  p re se n t In MON. ■ The lim ited
am ount of activation  In the p resen ce  of im m une com plexes 
suggests that com plem ent activation  w as being tregulated 
efficiently . .
CHAPTER 4
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MembyanoproUferatlve Glomerulonephritig 
In troduction
MembrandpyoUferatlve giomerulonophritis (MPGN) was 
originally includad within the chronic GN group and gained 
separate diseaee status around 19.65 (199, 200). There are  
a variety of alternative nam es, in d u in g  m esangiocapillary  
GN (201), persistent hypocomplementaetnic GN (199), chronic 
lobular GN (202) and mixed membranous and proliferative GN 
(203),
H istologically, diffuse changes are apparent with increase  
in both the number of glom erular cells and the amount of 
m esangial m atrix. The capillary loops appear thickened and, 
using a periodic acid silver methenamine stain, the basement 
membrane appears double in places. Hplthelial c e ll crescents 
may be présent in som e glom eruli.
Using electron m icroscopy, the apparent splitting of the 
basement membrane has been shown to be caused by the inter­
position of m esangial ce lls  between the basement membrane and 
the endothelial cell. The results of electron m icroscopic studies 
have permitted further subdivision of this d isease (204) into a 
subendothelial type and dense deposit d isease. These have also  
been designated types I and II respectively (205). In the sub- 
endothelial type of MPGN, electron dense deposits may be 
seen prim arily along the endothelial aspect of the basement
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m em brane and within the m esangitim  while, in dense deposit 
d iseas e, e lec tron  dene e m ate r ia l  i s deposited within tlie
basem ent m em branes of cap illa ry  loope and a lso  of Bowman*»
■
aippule and tubules.
In the subendothelial type of MFGN, C3 is  alw ays p resen t 
(206^.209) and is  usually  deposited in a p e rip h e ra l g ranu lar 
cap illa ry  p a tte rn  .and m ay a lso  be found within the m eeanglum , 
IgG and IgM m ay be deposited in association  with C3 (207«209) 
do m ay p roperd in  (208) . In  som e biopsies, with subendothelial 
electron dense deposits, th e re  is  no apparen t de%)osition of 
immunoglobulins. ' In the dense deposit v a rian t, C3 is  again 
always present (206, 208, 210) and is  found in d isc re te  deposits 
within the m esangium  and m ay a lso  be found in a  "ribbon-like" 
p a tte rn  round the cap illa ry  loops. IgM and IgG m ay be p resen t 
in tra c e  am ounts (206, 207), Davis, however, using the m ore  
sensitive  in d irec t teclmiqué frequently  found IgG and IgM (E ll) . 
3?aetor B has been dem onstra ted  in dense deposit d isease  (210) 
but, su rp rising ly , significant am ounts of p roperd in  have not 
been found (208, 209).
M ost MPGN patien ts have m arkedly  reduced serum  
concentrations of 03  (205,'208, 209, 21E-E14). Properdin 
and fac to r B levels m ay a lso  be reduced (208, 209, 213), 
jLow se ru m  concentrations a re  seen  p a rticu la rly  in  patien ts 
who have c ircu lating  03 nephritic fac to r (HF) (208).
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The pathogenesis of MPGN is  unknown, W here im m une 
com plexes a re  found in the c lrcidation  181) and eub-
endotheiiai e lec tron  dense deposits a re  p re se n t along with 
cap illa ry  loop deposition of im m unoglobulins, i t  i s  probable 
that im m une com plexes play a  ro le  in pathogenesis. Not 
a ll patien ts witti the subendothelial type of MPGN however 
have evidence of imm unoglobulin deposition (306, 307) suggesting 
tha t the subendothelial deposits m ay not alw ays rep re se n t 
im m une complexes^ In the dense deposit type of MPGN, 
subendothelial deposits and cap illa ry  loop deposition of Im m uno­
globulins a re  infrequently  found (305, 306, 308, 210), xt is  
th e re fo re  unlikely that im m une com plexes a re  the only fac to r 
involved in  the pathogenesis of MPGN.
Since m any MPGN patien ts a re  hypocqm plem entaem ic, it  
has been suggested that the hypocom plem entaem ic s ta te  m ay 
re s u lt  in the developm ent of GN (316), Two in d ire c t p ieces 
of evidence argue in favour of th is ; 1) In pa tien ts with NF, 
m ost com plem ent activation  is  independent of the  kidney since 
OS lev e ls  do not "r\ieafter nephrectom y (217) and 2) NF is  
found In som e patien ts with p a rtia l lypodystrophy who have no 
evidence of ren a l d isease  (216). Both of th ese  suggest the 
possib ility  tha t MPGN patien ts m ay be hypocom plem entaem ic 
befo re  the onset of GN. This p red isposition  to GN m ay e ither 
be a  d ire c t conséquence of hypocom plem entaem la o r  be the
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re s u lt  of p e rs is te n t infection resu lting  from  the com plem ent 
deficiency* R ecent evidence from  experim ents in  m ice  
w here  » hypocom plem entaem ic s ta te  was m ain tained  fo r up 
to  twelve m onths did not re s u lt  in  the fo rm ation  of nodceab le  
ren a l abno rm alitie s  suggesting, a t  le a s t  in  thl» m odel, that 
hypocom plem entaem la, of Itse lf, did not cause GN (31$),
Since im m unoglobulins are..not alw ays p resen t, if  the d lscaee  
is  a ttrib u tab le  to  p e rs is te n t li%fectioh, then the  m echanism  
m u st involve som ething o ther than im m une com plex deposition.
The com position of the in tra -m em branous dense deposit 
in the' dense deposit typé 'of MPGN not knov/n. I t  is  possib le  
tha t G3 m ay;be one of-the components, but, since in som e 
im tients th .ere 'ig  no deposition-of CS roimd the cap illa ry  loops 
(209) G3 is  unlikely to  be the solo component. Until the 
com position of tlw dei>oéit is,known, i t  is  unlikely that the ro le  
which the deposit p lays will, bo 'understood.
'It is  p robab le  that no sing le  pathogenic m echanism  re su lts  
in  the  form aU on of MPGN since th e re  a re  a t  le a s t  two d is tinc t 
•histological appearances. A lso som e patien ts have evidence 
of im m une com plex deposition while o th ers  do not, and only 
som e patien ts have detectab le  N F. One unifying fea tu re  Is the 
extensive com plem ent activation  un iversally  found and It lo 
possib le  th a t th is  is  Involved In the pathogenesis of MPGN.
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M ateria ls
îm m im ofiuorescence studies w ere perfo rm ed  on rena l 
b iopsies obtained from  19 MPGN pa tien ts . Two of these  had 
no p rb te in u ria  a t the tim e  of biopsy. In the o th ers  p ro te in u ria  
ranged from  0. 5g to lOg p e r  34 hours (mean » 3, 9g/ 24 hours). 
Serum  creatin ine  leve ls  ranged from  70 to 961 y im oles/ I 
(m ean * 301 ^ m o le s /  1) with nine elevated values.
Between one and 13 glom eruli (m ean « 5. 5) v/ere exam ined 
by Im m unofluorescence in each biopsy. E lec tro n  m icroscop ic  
data w ere  availab le from  ten  b io p siesî nine w ere  found to be 
of the subendothelial type while the tenth was a dense  deposit 
type. Serum  sam ples w ere obtained from  17 patien ts a t the 
tim e of th e ir  biopsy.
Advanced fo rm s of the nephritie  of SIjE  and HSN ( 1 )  
m ay be m orphologically  indistinguishable from  MPGN, th e re  was 
however, no clin ical evidence of system ic  d isease  in any of the 
19 patien ts In the MPGN group.
R esu lts  
Renal B iopsies
G lom eru lar deposition of iinm unoglobulina, com plem ent and 
control p ro teins
The num ber of b iopsies positive  and the m ean in tensity  of 
staining fo r each p ro te in  studied is  shown in tab le  4 ,1 .
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D eposition of imminioglobulinB
îmmimoglôbulln» w ere  deposited in 15 of 19 b iopsies (79%).
In five, IgG was foimd without IgM, in six.IgM  without IgG and 
in  five IgG and IgM w ere deposited together. Both IgG and 
igM w ere  p re sen t in the four b iopsies positive  fo r IgA. T race  
àmoim ts of IgM w ere found in the biopsy fro m  the patien t with 
dense deposit d isease . Ho o ther Im munoglobulins w ere detected . 
The corresponding se rinn  sam ple contained H F. Of the o ther 
HF positive  patien ts, a ll th ree  imm unoglobulins w ere  p resen t 
in  one and only IgM was found in the o ther.
D eposition of c la ss ica l pathway components
At le a s t  one c la ss ic a l pathway component was found in 14
, ' . . ,  -V - ■
of 19 (74%) b iopsies. D eposition of c la ss ic a l pathway components 
was not apparen t in  the dense deposit d isease  biopsy but C lq  
was found in  one bf the o ther NF positive b iopsies and C ls  
and C4 w ere  p ré sen t in  the o ther.
D eposition of a lte rn a tiv e  pathway components
F a c to r  B was found in two b iopsies in  th is  group; n e ith er 
of these  was NF positive . P ro p erd in  was deposited  in 12 of 
16 b iopsies (75%) including two NF positive b iopsies but was not 
found in the tiiopsy from  the patien t with dense deposit d isease . 
P ro p e rd in  was deposited in both b iopsies positive  fo r fac to r B.
124.
D0pogHj.ûn of G3 and G S
C3 was p re se n t in  a ll b iopsies with high in tensity  of staining 
(appendix 1 ) and  C5 was found in 12 of 16 b iopsies (75%).
Deposition of the control p ro te ins
cT-XNH was deposited  in eight of 15 (53%) b iopsies .
C3blNA was found in  tra c e  am ounts in b iopsies from  four 
patients* The se ru m  sam ples from  these  patien ts did not contain 
neph ritic  factor* jjSlH was p re sen t in a ll b iopsies with com paratively 
high in tensity  of stain ing  (appèndix 1 ).
C o rre la tions in in tensity  of staining betw een the p ro te ins atudled 
Using the Spearm an rank  co rre la tion  teot, the in tensity  of 
staining of each p ro te in  studied was com pared with the in tensity  
of a ll o th e rs . The re su lts  a re  showii in tab le  4, Z. R rep re se n ts  
the  co rre la tion  coefficient and p the probability  of significance* 
B ecause of the sm all num ber of b iopsies positive  fo r  IgA, fac to r B 
and C3bINA, no analysée w ore perfo rm ed  on the  re su lts  of 
these . S ignificant co rre la tio n s a re  shown in  red .
(see  over).
T able 4# 2 'C o rre la tio n s in  in tensity  of stain ing betw een tlie 
p ro té ine  ■ ettidjcd
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The c o rre la tio n # o l d a s  i le a l  pathway com ponents
T here  w ere  sign ifican t co rre la tio n s be tw een ! the in ten sitie s  
of deposition  of C lq  and IgG, IgM and C4. The in ten sitie s  of 
O le  etaining co rre la ted  w ith  those of 05  and a  s tro n g  co rre la tio n  
waa found betw een the  in ten sitie s  of deposition of C4 and IgG.
The co rre la tio n s  pf th» a lte rn a tiv e  pathway '
T here  w ere  no significant co rre iafions botwoen the 
In tensifies of deposition of p roperd in  and those of any o ther 
p ro te in  studied. . '
The c o rré la tio n s  of 03  and G 5
The in lenslfies  o f deposition of 0 5  c o rre la ted  with those 
of 0 3  and 0 4 .
The co rre la fions o f  the control p ro teins
The in tensifies of deposifion of 0 Î  -INH co rre la ted  
significantly  with those of IgO and IgM and a ll th ree  c la ss ic a l 
pathway components* T here w ere  a lso  sign ifican t co rré la tions 
betw een the in tensifies of deposifion of p  lH and IgM, G Is , 03 
and 0 5 . Thé co rre la tio n  betw een the in ten sitie s  of staining of 
p iH  and IgM dem onstra ted  an  Inverse  re la tio n sh ip .
The concordance betw een deposifion of contro l p ro te in s of 
com plem ent and the components whose ac tiv ity  they regu la te  
Gl^INH
The concordance betw een b iopsies positive  fo r C l-IN H  
and C ls  and G4 Is shown In tab le  4* 3.
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Table 4* 3 - The concordance betw een blopglea positive  lo r  
C la . G 4andC Ï^IN B
C ls /  CÏ-INH
No* of 
B iopsies C 4/C Î^ÎN H
No*' of 
B iopsies C 4/C 1S
No. of 
B iopsies
C ls  4 CÏ-ÏN H 4 6 G4+ CÏ-INH4 8 G4+ C ls4 7
C ls  + CÎ-^INH^ 3 C44 CÎ^INH- Z C 4f C ls - 3
C ls -  CÏ-ÎN H 4 Z C4- CÎ-IN ÎÎ4 0 C4- C ls+ 1
C ls -  c i - im i* 4 C 4- G Î-ÎN H - 4 C4- C ls - 3
Total 15 Total 14 Total 14
T h ere  w as oonOordahoe betw een biopalea positive  fo r 
C l#  and c l* m B  in  10 of 15 biopsie# (67%).
In two, GI^ÎNH wa# p re se n t without C l#  and in  th ree  C l# 
was found without B e tte r  concordance was found
betw een C4 end C l ^ INH. C4 w as p ré sen t m o re  often than 
C l#  although cn on# occasion  C ls  was found in the absence 
of C4*
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C3bINA
In table 4 .4» the concordance between C3bINA and 
the proteins with which It Interacts Is shown* ÇSbïNA was 
not found in the absence of C3, C4 or p lH j C3 and ^  IH being 
present In a ll b iopsies, in  one biopsy, C$blNA was found in  
fixe absence of C5 and properdin and In another in the absence  
of properdin.
p m
The concordance between biopsies positive for p  IH 
and € 3 , C4, Ç5 and properdlh i s  shown |n  table 4 .5 .
Table 4* B The concordance betw een b lo o sles  positive  fo r  
ana  g  3» C4» CS and  PrO perdin
0 3 /p lH
Ho. of 
biopsies c A f p m
Ho. of 
biopsies c B / p m
No. of 
biopsies P /p lH
Ho. of 
biopsie#
c z ^ p t m 16 c 4 + p m + 10 12 p + p i m n
C3+ jfilH- 0 c 4 + p m ^ 0 C54jÔlH- 0 p + p m - 0
C3- p iH + 0 c 4 - p m + 4 cs*. p n u 4 F -p lH -f 4
C 3 -p iH - 0 C 4 -^ 1 H - 0 C 5-jp lH - 0 BIH -/ , 0
Total 16 Total 14 Total 16 Total 16
S in ce^ IH  was present in a ll b iopsies in this group, no 
other component was found in the absence o f^ lH . ^ IH  was 
found in  the absence of 04» 0 5  and properdin In four ca ses .
Comparison of immunofluorescence patterns
The uniformity of distribution pattern seen In MGN was
y 130,
not p re e m i in  MPGN. M ost p ro te ins In the m ajo rity  of 
b iopsies Btaiàed with a  predom inantly  p e rip h e ra l cap illa ry  
loop p a tte rn , . while In dtlxers the - predom inant/d istribu tion  
was m esan g ia l. When p a tte rn s  of C ls  ahd C l-lN H  w ere 
eonsideréd, in  th re e  b iopsies the staining fo r both was in a 
p e rip h e ra l eapiU ary loop d istribu tion , in  one m ainly m esangial, 
and, In the rem ain ing  two b iopsies positive  fo r  both p ro te in s, 
c l s  w as found round p e rip h e ra l cap illa ry  loops w hereas GÎ-1NH 
was found not only round p e rip h e ra l cap illa ry  loops but a lso  
in  the  m esanginm . The p a tte rn s  w ere th e re fo re  Identical In 
fo u r o f s ix  b iopsies and the predom inant p a tte rn  was the sam e 
in  the rem aining  two. When adjacent sections w ere  stained  
fo r  C ls  and CÎ-ÏHH, the  a re a s  staining fo r  each  p ro te in  w ere 
found to correspond  closely  (figure 4-1).
CSbïNA w as found in  a  segm ental p e rip h e ra l cap illa ry  
loop p a tte rn  in  the four b iopsies w here i t  was p re se n t (figure 4-2). 
In  th re e  of fixes#, C3 w as deposited In a  diffuse p e rip h e ra l 
cap illa ry  loop d istribu tion  and. In the fourth , the staining was 
in  a  diffuse cap illa ry  loop plus m esangial p a tte rn . CSblNA 
w as th e re fo re  found in  a rea#  w here G3 was a lso  present*
S e r ia l  sections w ere  not a n a l y s e d .
The p a tte rn s  of d istribu tion  w ere iden tica l fo r C3 andJBIH 
in  l l  of the  16 b iopsies positive  for both. In  the  rem aining 
five, ^ IH  was found round the cap illa ry  loops and in  the
V | | V .
■f:- r  . . . . ' 4
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Figure 4-1 The glomerulus on the right was stained
for C ls and the same glomerulus on an adjacent 
section is shown on the left, stained for Cl-INH.
x u s o
Figure 4-2 The segmental peripheral capillary loop 
deposition pattern of C3bINA in an MPGN 
biopsy.
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wMle 0 3  w as deposited  only round cap illa ry  loops. 
Figure 4^3 allows tho-staining pafitm s of p lîf  and 03 In # «  
same glomerifins on adjacent seofions# The arm# of disltlbntlm 
a re  seen  to b e  a lm o st Iden tical,
th e serum, omoentration of eaoli oomponmt in each of the 
i t  samples Is shown In figure 4*^ 4*
The concmtratimS. of <da#sical pathway pompenents 
There was no significant difference betwem levels of 
classical pathway components m û  pormnl serum levels using 
the median test, One patient HF# had enbnormal 
concentrations of 01% 01# and-04  while two HF negafiv# 
pafients had reduced concentration# of either Olq or 04*
Raised level# of each-.component were frequently fomd*
. Properdin levels did not vary significantly from normal 
and no reduced levels were fomd* Factor B levels a# a g r o #  
were reduced {p> 0 .# )  and one nephritic &ctor positive 
sample had a reduced factor B' concentration.
% e concentration of d'3 and CS
concentrations were- elgnlficnntiy lower than normal 
Willi six  values below the normal range and a single raised 
value* A ll fiiree HF positive pafient# îiad reduced 03 level#*
« g f e
Figure 4-3 The glomerulus on the right was stained 
for C3 and the same glomerulus on an 
adjacent section is shown on the left 
stained for p  IH.
Clq C ls 04 C3 C5
Pg/ml
C3bina 
fo of STD
-600
-800 -300 -600-3000
-80
-400
-50
-400-800 -60 -150300 -400*- 200#-2000
- 30-
• i •
: % -
*  #  #% * m 4000
■ -1 0 0
-200
-20
-10
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Figure 4-4  The concentration of each protein studied in 
each of the 17 serum sam ples from MPGN 
patients is shown. The shaded areas represent 
the normal ranges and the horizontal lines 
represent the mean concentrations for each 
protein. The values from the NF positive 
patients are shown as squares. The results of 
the median test are shown at the bottom of each 
column with arrows indicating whether the values 
are significantly higher or lower than normal.
NS * not significant.
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0 5  did m t  slguàllcantiy^ ïyom  aosrmïil although
two w ore helow thé ra n g e ,
Thé concentrations o£ the control T^rotéine
The m edian  ÇI^ÎNH value was signiticantly  ra is e d  and 
no subnorm al values w ere  found* C3bîNA and p  IH levels 
a s  a  group did not va ry  significantly  from  norm al although 
th e re  w ere two low CSblNA concentrations, including one from  
a  KF positive  patien t, and one low B lH  level.
The co rre la tio n s  betw een se ru m  concentrations of com plem ent
The co rre la tio n s between concentration  of each
of the com ponents studied w ere  calculated  using the Spearm an 
rank co rre la tio n  te s t  and the re su lts  a re  shown in tab le  4,6*
R m the co rre la tio n  coefficient and p « ttxe probability  of signiA cancé' 
S ignificant c o rre la tio n s  a re  sbown in red*
(Table 4 .6  overleaf) *
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T able 4* # Thé, , the ■ iérum co&eeùtmtlôae
pt.feo. P » # * # #
G%)s c b €l*ÎWfH C$hmA
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E
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0 .1 4
p
P
E
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0.01
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0.01
0 .19
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E
P
E
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pathway qùmpoAénta and' th# c la ss ica l pathway oompWent# 
noted above, p ro p erd ià  eoncentTat'ipné- co rre la ted  with thos# 
of fac to r B and C$ and fac to r B levels co rre la ted  with 03  and 
C3 concentra tions.
The c o rre la tio n s  ■ of C3’ and CS ' • ■;
The concentrations of.0 3  co rre la ted  with those  of C ls ,. €4 , 
p roperd in , fac to r B and  G5* ' ievei# a lso  co rre la ted  w ith , 
those  of fa c to r"Bé'
The c o rre la tio n s  of the control: p ro te ins
, T here  w as a  significant. C orrelation betw een concentrations, 
ol CI«1HH and. both fac to r B and jBlHi- 'C^biNA lev e ls  co rre la ted  
with ieye is  .of, G4#- G3 and CS a h d p lH  concentrations co rre la ted  
with C le , properdin* fac to r B,, C3 and concentrations.
The re la tio n sh ip  betw een s.ernni.. concehtrationa.and In te h iltie s  o l 
g lom ern la r deposition of com plem ent components and control
Using the  Spearm an rank co rre la tio n  teat* the in tensity  of 
deposition was com pared with the se rn m  concentration  of each 
component e^oept fo r fac to r B and CSblNA which w ere  p re sen t 
in  too few b iopsies i The re s  wits a re  shown in  tab le  4.7*
E  rep re se n ts  thé  c o rre la tio n  coefficient and p re p re se n ts  the 
p robability  of significance.
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Table 4 .7  The c o rré la tions between serum  leve ls and the
in tensitie s  of deposition of each com plem ent component
c l q  , CIS C4 P C3 05 Cf-INN
R "•0 * 22 0. 58 -0 .32 0. 11 -0, 56 -0 .31 0 .34 -0 . 13
p. ; , NS : <0.05 NS : NS. <P.05 NS NS NS
NS » not significant 
T here  was a significant co rre la tion  betw een the se rum  
concentrations and the in tensitie s  of deposition of C ls  and an 
in v e rse  co rre la tio n  betw een se rum  leve ls and in ten sitie s  of 
deposition of C3.
’ ' DISCUSSION . ■ . ■ ' ■
In trag lo m eru la r evidence of com plem ent activation  
The involvem ent of immunoglobulins
The deposition of imm unoglobulins in  th is  study, com pares 
w ell with the re su lts  in o ther rep o rts  (20 6.*20 8). IgG and IgM 
w ere  found in equal num bers of b iopsies but not n e ce ssa rily  
together (table 4 .1 ). Only one biopsy of the ten  exam ined by 
e lec tron  m icroscopy  was of the denee deposit v a rian t and. In 
tills only tra c e  am ounts of IgM w ere found* This is  consisten t 
with the  findings of o th ers  (206, 210).
The involvem ent of the c la ss ica l pathway
C lassica l pathway activation  was evident: in  14 of 19 
(74%) b iopsies (table 4 .1) including those from  two patien ts with
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c ircu la ting  NF* Immunoglobulin# w ere  p re ie n t  in  13 of 
th ese . In th ese  patient## activation  of th f  c la ss ic a l pathway 
m ay have been due to  Im mune com plexé#. This is  substan tia ted  
by the significant co rre la tio n s betwéén the in teneitle#  of 
deposition of both C lq  and C4 ÿdth IgG and C lq  with IgM 
(table 4 .2 ). I t is  a lso  possib le  that the c la ss ic a l pathway 
m ay have been activa ted  by the ra th e r  unique im m une complex 
form ed by NF and the a lte rn a tiv e  pàthway C3 convertase  (219),
In one biopsy, significant quantities of C ls  w ere  deposited 
in  the absence  of imm unoglobulins and th e re  w as no evidence 
of c ircu lating  NF a t  the tim e  of biopsy. T here  a re  various 
p ossib le  explanations to account fo r th is a) activa tion  of C ls  
by p lasm in  m ay occur (220), b) th e re  m ay be a  non-specific  
trapping of m olecules caused by increased  cap illa ry  pe rm eab ility  
o r finally  c) i t  Is possib le  that NF stab ilised  C3 convertase  
caused the activation  and deposition of C ls  p r io r  to the rem oval 
of the biopsy a t  which tim e  NF was no longer p re se n t in the 
c ircu la tion , NF m ay appear and d isappear in the c ircu la tion  
p a rtic u la rly  in  the subendothelial type of MFON (205),
The fac t tha t n e ith e r the Intensity  of deposition of im m uno­
globulins no r c la ss ica l pathway components c o rre la ted  with the 
in tensity  of deposition of G3 (table 4,2) m ay suggest that# while 
c la ss ica l pathway activation  is  probably dependent on the 
deposition of im m unoglobulins, th is activation  does not control
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the  extent of activation  of C3, O ther explanations will be 
d iscu ssed  with re fe ren ce  to the ,a lte rnative  pathway.
The involvem ent of the a lte rn a tiv e  pathway
The deposition of p roperd in  in 12 of 16 b iopsies (75%) 
including two b iopsies from  patien ts with c ircu la ting  NF 
suggests that activation  of the a lte rna tive  pathway is  frequently  
p re se n t in  MPGN# The possib ility  of the p resen c e  of p roperd in  
in  the absence  of activation  of the a lte rn a tiv e  pathway will be 
considered  fully In chapter 9* Immunoglobulins and c la ss ica l 
pathway components w ere  p re sen t in ten of these  12 b iopsies 
and tlie a lte rn a tiv e  j^ thw ay  activation m ay have been secondary 
to c la ss ica l pathway activation  in these c ase s . D irec t 
activation  of the a lte rn a tiv e  pathway m ay occu r p a rticu la rly  w here 
NF is  p re se n t in  the c irculation , a s  was the case  in two pa tien ts .
In the o ther two b iopsies, th e re  was no evidence of imm unoglobulin 
deposition although C ls  was p re se n t in one biopsy. F a c to r  B 
was p re se n t in  both of these  b iopsies . I t  is  th e re fo re  likely  
that activation  was independent of the c la ss ica l pathway. A nalysis 
of the corresponding se ru m  sam ples failed  to de tect c ircu lating  
NF. The m echanism  is th e re fo re  not known. I t  is  possib le  
that NF was p re se n t in the serum  p rio r  to the investigation  
and caused deposition of C3b in the glom eruli and the C3b thus 
deposited  would re su lt In fu rth e r activation. G3b form ed as a  
re su lt of c la ss ic a l pathway activation  In the c ircu la tion  o r by
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som e Other m e in s  could s im ila r ly  deposit In the kidneys.
:The absence of p roperd in  deposition in  the biopsy of 
the patien t with the dense deposit v a rian t of MPGN is  a 
findihg consisten t with the re su lts  of o thers (208, 209).
The m arked  deposition of C3 and low se ru m  concentrations 
of G3 suggested that intensé; activation of the com plem ent 
system  w as taking p lace. NF waS p resen t in  file c ircu lation  
of th is pa tien t and is  rep o rted  to  be frequently  found in  th is 
d ise ase  (208). A ctivation is  th e re fo re  likely  to be by the OT' 
stab ilized , a lte rn a tiv e  pathway C3 convertase. The m echanism  
of activation  in the g lom eruli in  dens# deposit d ise ase  rem ains 
unc lear; perhaps the question could be answ ered  if  the com position 
of the intram em branouB  deposit w ere  known*
Like the c la ss ica l pathway components, the in ten sitie s  
of deposition of p roperd in  failed  to c o rré la te  with those Of G3.
This fa ilu re  of e ith e r m echanism  of activation  to c o rre la te  
with the in tensity  of deposition of 03 m ay have re su lted  from  
the fac t that both pathways w ere involved to varying extents in 
d ifferen t b iopsies . I t  is  a lso  possib le  that G3, pe rhaps a s  C3d, 
rem ained  in  the kidney a fte r  components of e ith e r  pathway 
of activation  had been rem oved. The use  of anti s e ra  specific  
fo r C3b and G 3d, if  availab le, would have been  ab le  to c larify  
th is .
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MPGN is  ch a rac te rized  fey in tense com plem ent activation  
a s  dem ohstra ted  by reduced serum  concentrations of C3 
(figure 4-3 and re fe ren c es  205, 209» 212^214)» and deposition 
of C3 in  a ll b iopsies (table 4 . 1 and re fe ren ces  206-210), The 
in trag lo m eru la r deposition of 03 In kidneys w here im m uno­
globulins a re  deposited  and subendothelial e lec tron  dense 
deposits a re  found is  m ost likely  due, a t le a s t  in p a rt, to 
activation  in itia ted  by im m une complexes- C lrculafing  im m une 
com plexes have occasionally  been repo rted  (180, 181), The 
subendothelial position of the  Immune com plexes m ay allow 
m ore  efficien t activation  in  MPGN com pared to MGN. It is  
a lso  possib le  tha t the type of complex which deposits in  a  
subendothelial ra th e r  than a  eubepltheUal position  is  m ore  
efficient a t  activating the c la ss ica l pathway*
Diffuse deposition of G3 and o ther components w here 
significant quan tities of imm unoglobulins a re  nob p re se n t 
is  m ore  difficult to explain. Severa l possib le  m echanism s 
m ay exist!
a) The s ta te  of hypocom plem entaem la m ay p red ispose  
a  pa tien t to  infection. If b a c te r ia l endotoxins, fo r 
exam ple, w ere  to reach  the kidney, then activation  of the 
the a ite rn a tiv e  pathway m ight re su lt,
b) I t i s  conceivable tha t the, a s  yet undefined, substance
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w ithin the basem ent m em brane in dense depooit d ieease  m ay 
be capable of causing local am plification of C3 tu rnover.
No evidence ex is ts  fo r th is .
c) Com plem ent activation  m ay occur in the c ircu la tion  and 
products of tha t activation  m ay deposit in the kidney* If 
C3b io deposited, in  th is way, then activation  could take 
p lace  in  situ , p a rticu la rly  if  the regulation of C3b by p i l l  
was inhibited by the p resen ce  of NF.
d) B asem ent m em branes from  glom erulonephrltic  patien ts 
have been shown to have an abnorm ally  low s ia lic  a d d  
content (214). D eficiency of s ia lic  ac id  on a  m em brane 
allows uncontrolled activation  of C3 to occur (97).
A ctivation of the a lte rn a tiv e  pathway m ay th e re fo re  be due 
to biochem ical changea In the basem ent m em brane.
The In tensity  of com plem ent activation  in MPGN suggests 
that th is activation  is  involved In the pathogenesis of th is d isease . 
Both types of MPGN a re  a sso c ia ted  witîi inflam m atory  changes 
and i t  is  likely  the  com plem ent activation IS effective in contributing 
to th is . The ro le  of com plem ent in  the subendothelial type of 
MPGN, w here th e re  is  evidence of im m une com plexes, is  
IpOs'sibly secondary to an im m une complex pathogenesis. In 
dense deposit d isease  and a lso  in the subendothelial type with 
no evidence of Immune complex deposition, p a rtic u la rly  w here 
NF is  p re se n t In the circu lation , com plem ent activation  o r  the
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.©ffeeti?' o l hypoçomploméntaemW  m ay be tW  p rim a ry  fac to r in  ' 
’thè diaease* Evidence -from the hypoCOmplementaemic m odal 
(218) dlsctiaisad in  the in troduction to  th is  chap ter suggests that 
o tlier fac to ra , such a s  Infection, m ay a lso  be Involved* 
In trag lo m eru la r evidence o l ragitlation o i  comblemeoi: ac tiva tlo iiL '
■' The role o l control proteins In the Idciaieys of pa tien ts 
w ith MFCiH was a ssessed  using the lour criteria  outlined In 
chapter 3, ■ . _
The ro le  o f 'c W m i
The presence o l G l-IH H  in  approxim ately  ha lf of the MPOH 
biopsies (table 4# 1), %e significant co rre la tio n s  betw een the 
in ten sitie s  of deposition of C ls  and .C1-ÎNH (table 4, B) and the 
s im ila r it ie s  in distribution patterns of C ls  and c l- IN H  (figure 4-1) 
suggest that OT-INH is  involved in regulation of, c la ss ica l pathway 
com plem ent activation . , ' Concordance resu lts showed a better
dti- ’ - ' «nf->
re la tionsh ip  b©tween-C I -ÏHH and C4 than betw een C l-IH H  and 
C ls  (tab le  4# 3), This was a lso  found In the MON b io p s ie s ,
The role q f GSblNA
' CSblNA was deposited  in  four of the 15 b iopsies exam ined 
and, since G3 wad found in  all MPGN biopsies, CSblNA was not
-found in tlie absence Of G3. - Although'the p a tte rn s  of d istribu tion  
of C3bINA were s'egmental com pared' with the diffuse staining
1.42.
p a tte rn  of C3# the A reas  positive fo r GShlNA w ere  aleo 
positive  fo r G3. The absence of OS In-two and fac to r B in  
four b iopsies positive  fo r C3bIHA m ay suggest effective 
regulation  of G3h by CSblNA in  these  t is su e s . F a c to r  B, 
however, was p re se n t In only two MPGN b iopsies .
The a sse ssm e n t of the ro le  of C3biNA is  th e re fo re  based  
on i ts  p resen c e  In only four o f '15 b io p s ie s ,a i l-w S iic h  contained 
CS, and the com patibility of the d istribu tion  p a tte rn s . Altiiough 
fa r  from  conclusive»' there, is  m ore  evidence fo r tlie reg u la tio n  
of G3b by CSblNA in  MPGN than In o ther groups studied with the 
exception of HSN> •. ' ;
The ro le  of B lH
ÿBlH was p re se n t in  a ll  biopsies» as was 0 3  (Table 4 .1 ) .
The concordance betw een 03  a n d ^ IH  was th e re fo re  com plete 
(Tablé 4 .3 ). The in tensitie s  of deposition of p lH  c o rre la ted  
significantly  with those of 03  (Table 4 .2) and the d istribu tion  
p a tte rn s  w ere  a lm o st iden tical (figure 4-3) * The absence of 
p roperd in  in  four and O S in four b iopsies (th ree  w ere  negative 
fo r both) m ay suggest that effective reguiatlon e ith e r  byjB lH  
o r  som e o th er factor# perhaps C3bINÂ was taking place- 
However» p iH  deposition co rre la ted  both with that of p roperd in  
and 05  and th is  m ay re fle c t m utual dependence of JBIH# 
p roperd in  and 0 5  on G3b*
p lH  was deposited in  th ree  patien ts with Circulating NF.
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Since NF p reven ts the d isp lacem ent of Bb fro m  CSbBl^P by 
p lH  the deposition of p iH  in patien ts with NF appears  anom alous. 
p  IH deposition has been rep o rted  in  the g lom eruli of a ll patient® 
with the subendothelial type and the dense deposit type of MPGN 
in one study (26Ï)» No inform ation  on the p resen ce  of NF wa« 
published but It is  likely  tha t i t  was p re se n t in the se ru m  of a t 
le a s t  som e of these  pa tien ts . T here a re  sev e ra l possib le  
explanations lo r  i ts  p resen ce .
1) p i n  m ay com pete with NF to bind to C3b fo rm ed  e ith e r 
via the c la ss ic a l o r  a lte rn a tiv e  patiiways. The c la ss ica l 
pathway m ay be activa ted  by the im m une com plex form ed 
by the binding of NF to c SBb EP (219)*
Z) In trag lo m eru la r com plem ent ac tiva tion  m ay be independent 
of NF.
3) p lH  m ay be binding to som e o ther p ro te in . The good 
co rre la tio n  between, and s im ila rity  in d istribu tion  of 03 
and p lH  deposition in the to ta l group would a rgue  against th is . 
T here fo re  the evidence fo r tiie regulation  of C3 by p l U  
in  MPGN is  based  on its  p resen ce  ànd good concordance between 
b iopsies positive  fo r C3 and p lH , tl%e co rre la tio n  betw een the 
in ten sitie s  of depositions of these  two p ro te in s and the s im ila rity  
in th e ir  d istribu tion  p a tte rn s . I t  seem s likely  t h a t^ lH  plays 
a ro le  in  regu lation  even w here NF i s  p re se n t.
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Evidence of com plem ent activation  in  tlie c ircu la tion  
The c la ss ic a l pathway - % '
Serum  level#  of c la ss ic a l pathway com ponents have been 
found to be reduced in  the s e ra  o f'som a patients» In m ost 
stud ies (EO6-20S* 213). ■ In th is  otudy, low values of c la ss ica l 
pathway com ponents w ere found in th ree  pa tien ts  (figure 4-4) 
one of whom was HE positive .  ^ In  each  of these  cases, 
c la ss ica l pathway com ponents and im m unoglobulins w ere  
deposited  in  the corresponding biopsy. Serum  concentrations 
of C ls  and G4 co rre la ted  with G3, leve ls  suggesting tha t c la ss ica l 
pathw ay-activation h% the Circulation:m ay affect the  03  concentration, 
I t  m ay a lso  occu r due to  a  common synthetic s t im liu s . T here 
w as good co rre la tio n  a ico  betw een concentrations of a ll 
d a s s ic à l  pathway components and a lte rn a tiv e  pathway components, 
p a rtic u la rly  fac to r B . This m ay e ith e r  ree ri^ tm cn t
of the alternative-.pathway by  the c la ss ica l , pathway o r  again  
som e common synthetic  stimulus# A fu rth e r possib ility  linking 
■ tlxe c la0sicp l and;alternafive  pathways is  the activation  of the 
c la ss ic a l pathw ay by HE stabiU sod a lte rn a tiv e  pathway 03 
convertase  (219) w here HE Is p resen t.
The a lte rn a tiv e  pathway
W hile onlyom MPGN sam ple had a subnorm al fac to r B 
concentration, the leve ls  a s  a  whole w ere  significantly  reduced 
(figure 4 -4). ' These findings a re  In ag reem en t with o th ers  (208,
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209, 213). T here  w ere, however, no reduced p roperd in  
levels and the group did not v a ry  from  norm al. This is  a t 
va rian ce  with the re su lts  of o thers (BOB), L eveie of p roperd in  
and fac to r B in th is study co rre la ted  with those of C3 and a t a . 
h igher leve l of significance than did C ls  and C4 concentrations 
(table 4. 2). - These co rre la tio n s suggest'tha t the activation  
ol the a lte rn a tiv e .patliway is  responsib le  fo r significant C3 
c le a v a g e ,, A common synthetic  ethnu3.us,may a lso  account 
fo r the relationship-betw een C3 and both p roperd in  and fac to r B ,
The T erm ina l Sequence .■
In ag reem en t v/iti i^ o th ers  (205, 208, 209, 212-213), C3 leve ls  
v /ere significantly  low er than norm al with six  values below the 
norm al range, including a ll th ree  patien ts with H F. The 
re la tionsh ips betw eeh C3 and the components of the c la ss ica l 
and a lte rn a tiv e  pathways have been d iscussed  above and suggest 
that activation  of both pathways m ay be responsib le  fo r C3 cleavage.
Evidence of regu lation  of com plem ent activation  in  the c ircu lation  
The ro le  of Gl-IHH '
ClVlNH concentrations a s  a  group w ere  significantly  ra ise d  
(figure 4-3). The absence of co rre la tions betw een levels of
CÎ-IHH amd c la ss ica l pathway components a re  a t variance  with 
the correlatioais been in  the intensity-of deposition of these  
com ponents. This m ay suggest that:
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I) TWs
I# A fik e ly  Wine# level# qf teiasaicâl pathway components 
. V a te  only oocaslonally  teduced^;.
E) GÎ-ÎNH^^ m ay he uséd  in  o ther pathw ays.
3) In c reased  oT-lNH synthesKs m ay m o te  than  com pensate 
fo r  utilizafion* This i s  m o st likely  since  C l-IN H  leve ls  
a s  a  g tôùp w ere  significantly  ts is e d .
The ro le  of dShlNÀ ■
, ■' GShlNA leve ls  did, not d iffer -sigïdllc&htly fro m  norm al ' 
although two snhnorm ai values w ere  found. In  n e ith e r of the 
-/corresponding h iO psies'w as G3hlNA;depofiited. The strong  
,  ^co rre la tio n  he tw een  G$ and GBhlNA'^md # e  w eak e r one betw een 
/ C4 and C,3hiNA suggest th a t the leve ls of C3blNA ihfiuenee 
', C 3 activation,.In :the cirou lation . • Such .co rre la tions. have been 
reco rd ed  by o th ers  (222) in  a  HE negative group* In  th a t group# 
C3blHA concentrations a lso  co rre la ted  with fac to r B and p roperd in  
./ le v e ls , ' -■ G3blKA',:and fac to r B concentrations co rre la te -in  
no rm al se rm n  (19$) ànd th is  significant co rre la tio n  m ay be 
/-;|kpected. since. G 3blHA# by controlling G3b, has a  sparing  e fiec t 
o n 'fac to r B,'.' The absence of co rre la tio n s betw een se rum  
concen tra tions. of G 3bIHA and fac to r B a n d  p roperd in 'In /th is  
" -'Study m ay  b e  due to the HE positive, s e ra  since  o th e rs  (222) 
have shown that .■ co rre la tio n s do not oxis.t betw een ç  BbîNA and 
, ,/G3#.. prCperdIn .and fac to r B lev e ls  in  HE positive  s e ra .
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The ro le  of p lH
levels, a s  a  group, did not vary  significantly  from  
norm al and only one subnorm al value was found. The concentrations 
ol^U H  co rre la ted  significantly.w ith those of G3» p roperd in  and 
fac to r B (table 4* 2), suggesting th a tp l M  çonceiitrations m ay 
influence the extent of a lte rna tive  pathway activation . The 
absence of a significant co rre la tio n  between concentrations of 
yB lH and C3bINA in  MPGN has been .previously rep o rted  (222).
The rela tionsh ip  betw een deposition and se rum  concentrations 
of com plem ent components
C3 v/a,s the only component v/hos© in tensity  of deposition 
c o rre la ted  inversely, with the se rw n  concen tra tions. It. is  
imlikely tha t the se rm n  concentration was d irec tly  affected by 
the quantity of 03  deposited in tine kidney since, p a rticu la rly  In 
HE positive  jpatients, extensive activation is  Icuoto to take place 
in the circulation , as dem onstra ted  by degradation products of 
C3 (223) and the ab ility  of NF positive s e ra  to cleave G3 in norm al 
se rum  (92). W here immime com plexes a re  p re sen t in the 
c ircu lation  i t  i s  a lso  probable that c la ss ica l pathway activation 
will take p lace th e re . The extent of com plem ent deposition is  
m ore  likely  to .reflect, the situation In the serum ' than cause it*
The positive co rre la tion  between In tensities ol deposition .. 
and o© rum :concentrations of C ls  is  m ore  difficult to  explain.
Xt imay a r is e  due to  chance o r m ay re fiec t som e m echanism
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for increasing synthesis in response''.to utilisation» Since 
all components do not show éuch a correlation-this latter 
mechanism would require to be peculiar to G I.#*
Eeasons for the -absence ol correlations for other 
components have been suggested in chapter 3,. -
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SUMMARY '
L  Com plém ent activation  In MPGN was Intense and occu rred  
both v ia  the classical and the a lte rn a tiv e  pathways* No 
d ifference was fouiicl in  the 'yeiatlve Im portance of each 
' pathway. , The m èchanlsm s of açüyation  w ere  d iscussed .
2, T here  was reasonab le  evidence .for th e  ro le  of G l-IN B  m  
tl%e regulation  of C ls ,  based  on a  r'easonable. concordance 
betw een b io p s ie s ,po$i#ve;for- C'T^XNH and C ls and a sign ifican t 
c o rre la tio n  betw een Ih ten fifie s  of deposition-of C l?IN H .
and G le . T here  was a lso  a close s im ila rity  i n  the d istribu te  
ion p a tte rn s  of tliese two p ro te in s. Although no co rre la tio n  
was found betw een se ru m  c o n c e n tra te s  of C l^IN Ii and C ls , 
absence of reduced  CÎ^ïNH levels suggests tliat deficiency of 
C l-IN H  was not responsib le  fo r c la ss ic a l pathway activation ,
3, The ro le  of C3foïNA in  regulation  of 031? w as no t so w ell 
substan tia ted . Evidence fo r the régulation  was based on its  
p resen ce  in  fopr of 15 b iopsies and s im ila r it ie s  in  d istribu tion  
p a tte rn s  a s  w ell a s  a  significant co rre la tio n  betw een se ru m  
lev e ls  of C3 and CSblHA.
4, Good evidence v/as found fo r  the ro le  of p lH  in regulation  ol 
C3b w ith a  good concordance between b iopsies poeifive fo r G3 
and p  IH, significant co rre la tio n  betw een in tensifies of 
deposifion of Ç3 and p lH  and d o s e  s im ila r itie s  in the distribute 
ion p a tte rn  of these  two p ro te in s . The serum çonçentrafions 
of G3 and p lH  a*so Correlated significantly.
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5, B ased  o n ‘fiTt© ii#orm atioB  frqnv tills study* com plém ent 
activation, w as mo:?e in tense  in MPGN than  in  the  o ther 
d ise ase  groups studied. Ther.e %vàs a lso  m o re  evidence
In MPGN than in  the  o ther groups,
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Foca l ' C liom erulonephritia 
I n t r o d u c t i o n  . r -  = '
In e a rly  c lin ical dags#i£ications, the te rm  focal glomorulo-- . 
nophrltio (FGN) was ascribed to any dlseabe- involving haematmia 
without hypertension 'o r g ro ss  p ro te in u ria  ( I ) , ■ The d isease ," ' 
although genera lly  healing qul’ckly, was re c u rre n t ••■and exacerbation  
often followed an infection of the upper re sp ira to ry  t ra c t .  When 
pathological evidence becam e availab le, i t  w as found that a  
clinical presentation of haem hturla  was generally  aBsociated 
with focal and segm ental g lom eru la r clianges* B iopsies from  
p a tien ts  who have o ther clin ical p resen ta tions have since been 
shown to dem onstra te  a  focal g lom eru la r lesion , FGN m ay 
a lso  be found In a  v a rie ty  of system ic  d ise ase s  such a s  ShE  
(53), Henoch-Schonlein n ep h ritis  (1) and anti -g lo m eru la r 
basem ent m em brane d ise ase  (3v7a).
The focal and segm ental lesions usually  involve p ro life ra tio n  
of m esang ial ce lls  and in c re a se  in m a tr ix  and m ay be found in  
assoc ia tion  w ith segmental cap illa ry  n e c ro s is . E p ithelia l cell 
crescents m ay be a lso  present, ' By e lec tron  m icroscopy , e lec tro n  
dense  deposits have been identified in  tlie m esangium  and a t  the 
subendothelial side of the basem ent m em brane. T hese have been 
shown to bo m oot p reva len t in cases w here immunofluoreacence 
staining for Immimoglobulino is  s trongest (224)-,
Unlike the focal segmental pattern seen  by ligh t m icroscopy.
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im m uttoliuoreseence studleD often show e a d i  glom erutu# to have 
diffuse deposition of im m unoglobulins and com plem ent com ponents. 
D eposition is  genera lly  m osangiui and tlie predom inant immune* 
globulin c la ss  de tected  is  ïgA alone o r îgA in assoc ia tion  wltli 
IgG (224 227), This is  p a rticu la rly  tru e  when FGN is  p re sen t 
in  asso c ia tio n  with re c u rre n t haom aturia . One group has found 
deposition of IgG and/ o r  IgM m ore  commonly U m i ÎgA (228).
C3 is  a lm ost alw ays p re se n t w here im m unoglobulins a re  found 
(224, 228, 229) and deposition of C lq , fac to r B and p roperd in  
(224, 227, 230) has been reco rd ed  although som e w orkers have 
failed  to find C lq  (228, 229)« ■ ïn  som e b iopsies th e re  is  no 
evidence of imm unoglobulin deposition.
Speculation has a r is e n  a s  to  the meclxanism of th is  d isease  
end se v e ra l explanations have been suggested!-
(1) IgA m ay be p a r t  of an im m une complex within the 
kidney. I t Iiao been suggested that IgA in  an  a lte re d  form  
m ay bo the antigenic component of the com plex. Ho anti-IgA  
activ ity  can be detected  in  the c ircu la tion  (231) and IgA is  
the so le  imm unoglobulin detected  in a  n llno rity  of biopsies*
This explanation is  tlie re fo re  unlikely. The possib ility
of an IgA anti «IgA complez; cannot be excluded,
(2) R ocurrenco  of the d isease  often follows an uppor 
re sp ira to ry  t ra c t  infection. I t  is  th e re fo re  possib le  that 
se c re to ry  IgA m ay fo rm  a  complosE with the antigens of
153*
re sp ira to ry  t r a c t  v iru se s . Although se c re to ry  p iece  
ha# been  detected  la  the g lom eru li in  one otudy (232), 
o ther eW dies have fa iled  to confirm  fid# observation  
(229# 231) GUggeotiag tha t tlie azo^ibody i@ not o ecre to ry  
IgA.
(3) IgA dieted from  the  kidney of à  single, pa tien t with 
IgA nephritis-w as shown to bind weaMy to  m e sanglai cells ' 
of norm al kidney using- an  in d irec t Im m unoflw reàcence te s t  
(231). I t  i s  th e re fo re  possib le  that FGN. with m esangial
IgA deposition, is  an atdoanfibody-disease, This hypothesis 
r e s ts  on the evidence froni.only  one kidney*. The m echanism  
o f  th is  d ise a se  th e re fo re  rem a in s  fo  be elucidated.
MATERIALS
■ Im m nnofinorescence stud ies w ere-perfo rm ed  on rén a l 
b iopsies obtained from  2S FGH patien ts none of whom Imd f in ic a l  
evidence of sy s tem ic  d ise ase . P ro te ln n ria  w as p re se n t in  14 of 
th ese  patien ts ranging fro m  O. Og to  9# %  p e r  24 hoiire (m ean « 3 ,5 g / 
24 hours) and th ree /pa tien ts  -had. eerm n c rea tin ine  leve ls  above the 
no rm al range . ■ ■ ' _  _ .
Between one and-16 g lom eruli (m ean # S, 2) w ere  esaaidiaed by
and se ru m  sam ples taken on thé day of biopsy , 
w ere  availab le  fro m  14 p a tien ts .
. ' ^  154.
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R enal B iopsies
G lom eru lar déposition of ârnmmmglobulino,' com plem ent and ■ 
control p ro te in s
The m im ber ofM opslo# positive and th e 'm ean  m tonsiiy  qî 
stain ing  fo r each p ro te in  studied is  ohov/n in  Table 5 ,1 .
Table 5.1 G lp ineru lar deposition o l hnm unoglobulm e. 
com plem ent and control p ro te ins
(See over fo r Table) -
D eposition of Im rmmoglobuilns ■. ' - • -
■ , ÎgA was the  predom inant immunoglobulin, being foimd in 
19 of E? M opcloe (70%), I t  w as p rec ea t ac the  cole im m unoglobulin 
in  ten  b iopsiec. Of the  eight b iopsies w here  IgA was not deposited, 
IgM w as found alone in-one, IgG in- one and, in  s ix  b iopsies , no - 
imm im oglobulins w erè  p re se n t. The m ean in tensity  q£ deposition 
of ÎgA in  FGN was h igher than In the- o ther d isease  groups otitdled 
(appendix 1 ), -
D eposition of c la ss ic a l pathway components
C lq  and C ln  w ore p re se n t only in  seven of ZB (29%) and six  of
24 (25%) b iopsies resp ec tiv e ly  and the intenoity of stain ing  was 
weak, G4 was found In 19 of 28 b iopsies (70%), A t le a s t  one 
c la ss ic a l patiïway component was p re sen t In 23 of 28 b iopsies 
(82%),
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F a c to r  B w as not deposited  in any of- the biopeios in  thia 
group and propordiU;Wao foimd in 12 of 24 (50%).
lyeposition of G3 and GS
■ 03 wao found in all-but th roe  b iopsies . ■ Two -of these  had 
no deposition of im m unoglobulins and in  the th ird  tra c e  am ounts 
of IgM w ore p ré se n t. " C5 was p re sen t in  13 of ZZ b iopsies (59%), 
a ll  of which showed C3 deposition.
D eposition of control protoins
CÎ*rNH was found in  tlie sam e num ber of biopsies# 6 of 
24 (30%) a s  d i e  alfixough they w ere  not alw ays p re se n t together. 
G3bïNA was deposited  in  only one and p iH  was found in  18 of
34 (75%) tissues examined* -
C o rre la tio n s in  in tensity  of staining be tween p r oteins studied 
. Using the Spearman- ranl< co rre la tio n  te s t, the In tensity  of 
staining of each  p ro te in  studied was com pared w ith the in ten sitie s  
of a ll o th e r s . . The ree id ts  .are shown iix tab le  5 .3 . R re p re se n ts  
the co rre la tio n  coefficient and p the p robabîlib / of significance. 
B ecause of the absence of fac to r B and the sm all num ber of 
b iopsies positive  fo r  C3bINA no analyses w ere  perfo rm ed  on 
the re su lts  of th ese . Significant co rre la tio n s a r e  shown in red .
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Table 5. 2
o A M G lq '■■/eie -C4' p C3 CS CÏ-ÎN H
A ;
”~ o 7 Ï6
NS.:
m J 0 .07Wfa -
T5., ig
- ' / m ■
C lq iTE
0 .2 0
MS
0 .0 8 " ? r i5
m
P
a .iQ
NS
% 34
0.p5
0 » 3%.
NS
.-8 . 0 9
' NS
(34 ■®" 
P
'  0 .27  
NS
0.75
0.001 N8
0 .09
NS
0.20
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^  ?
0 .00
NS
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Ha
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■ m
0&05 0 .27
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V
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0,01
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9 m
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NS
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0,01
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NS
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0 ,10
- m
0.35
0.05
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0.02
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p .01
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NS
0 ,32
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0.05;
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The, .co *^%*eïaUoïifi ox .c ïa s c lc a l  p a th w a y  -qom ppm enta
; XÎ.1Q intoaoiUp© of-dopooWoA of both C I 0 and C4 co rre la ted  
with thooe of IgA and C5 am! t-hss la teno ities of C4 alao co rre la ted  
•mth thooe of C3« '
Tho c o rre la tio n s  of the a lte rn a tiv e  pathway components
The inteneW eo of deposition of p roperd in  co rro la tod  only
with thope of G3*
The co r r elatione of GB and C5
The m tonsitiep  of C3 deposition co rre la ted  witlx those of 
IgO» %&,, C4 and x^ropei'din v/h|le tho mtexielticp of C 5 de%)oeltion 
c o rre la ted  w #x those of IgA# G l  a ,and G4.
The; co r re la tione  of the  con trol p ro teins
The ih tensltieo  of G Î^lN Id  deposition c o rre la ted  with those 
o flgA , G lq, C l a, C4And p lH  and the m tenaU ies of p IH  dcpoGltion 
C orrelated  a lso  w ith Üxose of IgG, IgA, G4, p roperd in  and G3.
The conc05?das.‘»co betw een deposition of control p ro te ins of 
coaiialoment aacl compotteata \vhooe activ ity  thoy repiflàte  
GÏ-mï-ï
The concordance between b iopsies poaitivo fo r  C1**INH and 
C lo  a n d  G 4 f.p sh o w n  In  ta b le  5 .3  '
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Table ,Sf S., The cohcordance between biopsies'positive'for 
m e ,  C4 and C l-IN H
s m M æ m
Cls+CI-INH+ 
Cle+Cl-ÏNH- 
C is- cr-OT-3+ 
C lS “ G l-M H '
Total
TW«j6>l>a5^ T4JS «*.
HOé of
0 4 /
3
3"
1Î)
C4+ Cl-I'NHr 
e 4 -  C l “ÎNH-!- 
C4- Cl-ÏKX-I-
'<W B.II
T o t a l .
No. of
blooeléo
' '■ 5,
IZ 
: 1 
6 •
C ls /  C4 
Ols4" 04+
O lS f C4- 
C ls^  C4i
C1 s * ' 04"
No* of
b io p s ie s .
5 
I
13
6
24 - .Total, 34 I
Of the nine Mopeleo positive for Gl#INH and/ or Cls> ùtûy  
three w ere  positive  fo r  both* ■ C4 was frequently deposited 
and ol. the six Wopeies positive for Cl-MH# live'had deposition 
of 04 and five of the sia: Ole positive blopsleo were'positive ■’
also for 04# , - ■ . . -. -
oahlNA -: '
In  the  sing le  biopsy positive  fo r 03MNA, 03» C4$ CS» 
p roperd in  and p lH  w ere  aloo present#
p m .  ■ .. . "  .
The m ttù 0 tM m e  between b iopsies positive  fo r JBIH and 
03# C4, 0 $  and p roperd in  Is shown In tab le 4.
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BlH wao pi'ooent i n  18 of ZZ (8E%) biopcico poulUvo for Q3 
and was not found i n  Üxe aboonco of G3. ïn two biopoiocs 
%>ooWve fo r  G6# B lH  wao aW ont but waa poGltlve in  th reo
tîseuoo where C.4 was xiot found. C3 weo found in each of the 
throe biopsies whore Ch was present in the absence of plK  and 
BIB v/as present In all but one foiopny whero propordin was
A  comparison of immanofiuoreecenco natterais
Only three biopsies w ore positive for boili C lo  and CÏ--4NH 
and. In all three* the pattern of staining was described as mainly 
.meeangial with some capillary loop ntainlng for both C ls and 
Ci-IMBh S eria l sections otoined for C îs  and 
showed the close olmilsritloa in the distribution of Cl© and 
CÏ'’IM‘I (figure 5»l)o C3HHA wa© found wdthhi the mooangin.m 
of only QtiQ biopsy In this group, although of more csrtemolve 
distribution, G3 ©talning was ale© meeaxxglal.
The pattern© of diotrlbutlon of botli G3 and p V H  were 
doocHbod no m ainly  mooaxxglal with ©ome cap illa ry  loop ©talning 
In 16 of 18 biopsie© whore both were positive. Of the remaining 
two blopeioG* G3 wa© preoont only round capillary loops while 
p  i n  was prooont in  the m enanglum  and round cap illa ry  loops. 
S e ria l ooctlon© oW nod fo r C3 and p iH  confirm ed th a t those 
proteins woro prosont In tho came areas within the glomeruli 
(figure S*-3).
« s #
' - ü i -
- _ A *  # '  A ' ' *  j
X bso
Figure 5-1 The top photograph shows the glomerulus 
stained for C ls and the photograph below shows the same 
glomerulus on an adjacent section stained for Cl-INH.
#X(oSO
Figure 5-2 The top photograph shows the glomerulus 
stained for C3 and the photograph below shows the same 
glomerulus on an adjacent section stained for ^IH.
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Sarttm  Sam ple» ,
The terum  concentration» o l each component In each of 
the 14 eerum iam ple» i t  ehown in figure 5"3#
Thp concentration» of claeelcal pathway component»
There w ere no euhnormal level» of any c lassica l patliway 
Component» and the lev e ls  as a group did not vary signlAcantly 
from  normal* Several raised  lev e ls  were found for each 
component*
The concentra^on» of alternative pathway components
One serum  sample had a m arginally reduced concentration 
of factor B* A ll properdin lev e ls  w ere normal or raised and 
the median lev e ls  o f both components did not differ significantly  
from  normal.
Tlie concentrations of C3 and CS ^
One patient had subnormal level* of C3 and C5. A ll other 
values w ere normal or raised  and 03  lev e ls , as a group, were  
signlficantily higher than normal*
The concentrations of the control prpteins
Ol-INH lev e ls  w ere significantly raised* C3bINA lev e ls  
were a ll within the normal range and p IB  lev e ls ,a s  a group, 
w ere significantly above normal.
The correlations between serum  concentrations of complement 
components and control proteins
C3bINA 
% of STD
C3 Mg/ml C5Mg/ml CÎ-INHMg/mlC4 M g /  mlC ls  M g/m l Mg/ml
-600
-300 -600-3000
-80
-50
-400
-150- 6(1 300 -200
2001-40
-30
» *
-50-20 - 100,
-200 - 1 0
0.001 t NSNSNS NSNS NSNS
Figure 5-3 The concentration of each protein studied in
each of the 14 serum samples in FGN is shown. 
The shaded areas represent the normal ranges 
and the horizontal lines represent the mean 
concentrations of each protein. The results of 
the median test are shown at the bottom of each 
column with arrows indicating whether the values 
are significantly higher or lower than normal.
NS * not significant.
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The eetreleilôiii'tietweiwt Ihe co»ce»tm Ueae of
5* 5# E #epre«#n$A the ootifeleUo» coefficient m â  p  
yepyeeent# th# pwoW blllty 0f #lgnlflc##ce. ' S lg^jR cant 
co tre le tlo iie  a t e  th o r n  In ted#
,T»W# $# 5 . GottelaUon# In eetnm  oottcenfctatione o l the 
ntotfiln» ftud led
..............:" C lij ; c i i ' m P B ■ C3 C5 C1*ÏNH C3MNA
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The covfelatton . o f si cal pathway compcment.
Only |W0  elgaîU cant c e tte la tlo n e  w e te  feund In thi« gronp. 
The## w et#  betv/##n 01q  and C l#  concentration# and betw een 
Ç4 end 03  leve l# .
' The co rre la tion#  o l e ltem a tlv e  patliwnv component»
The concentration# of p roperd in  did not c o rre la te  with 
thoee of any o th e r component while fac to r B level#  co rre la ted  
w ith thorn# of C3*
The co rre la tion#  of C3 and €5
A part from  the co rrelation#  wltîi the  concentrations of 
C4 and fac to r B noted above» 03  levels a lso  co rre la ted  with 
tinose of 0 5 .
The co rre la tion#  of the control protein#
O Î-ÏN H  level#  co rre la ted  with level# of C l# , 04» 03  and 
p iH .  p iH  concentration# a lso  co rre la ted  w ith those of Glq,
Cl#» 0 4  and fac to r  B. C3blNA concentrations did not c o rre la te  
w ith those  of any o th er component.
Til# relatlonsM p betw een se ru m  concentration# and the in ten sitie s  
of g lo m era la r deposition of com plem ent com ponents and control 
protein#
Using tlie Spearm an rank  co rre la tio n  test» the  in ten sitie s  
of deposition w ere  com pared with the se ru m  concentration  of 
each  component except fo r fac to r B and C3blNA which w ere
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oithoy absen t o r  p raoent i%% too  few b iopsies to allow  aaalysifî. 
The results are shown in tabla 5,6. Il represents the 
co rre la tion  coofficient oad p  the probability  of significance.
Table 5,6 The correlations botwemz sorwn levels and the 
Intensities of deposition of each complement 
comncmeat
<wewfl^\wwtA<S'T«t#eroiw-ayii«veM»*
Clq Cle C4 P C3
TP#.a^mi»,nWA'mwa
c s p m
R 0,39 -0.2? *0.22 *0.04 0, tz 0.0? *0.21 o.ss
p N8 NS
m.^iVi TC%^.T% ^ JS hrt .M.T. «
m N8
*4*
NS m m N3
H0 » not oigniileant 
No significant corrélations were found.
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Xntraiïlomeriïlaa? evidence of comploment activation 
The invoWemmit o f iim^nmqnlobulhio
ïntaroot ovor rocent yoaro In the doposllicsn of XgA in the 
gW m erull hao re su lte d  In a  num ber of cWdlee repo rting  and  
discoDsIng meoaBglal iloposUlon of îgA (2S5s 220, 231, 232, 233)$ 
F ew er re p o rts  of im m im ofiuoresotaieo ottidWs of FGN Xiiavo 
been piibE^kcd (224, ZZ'h 230), The asiaet 45S.ïêeiit of the 
m esangW  IgA p a tte rn  W FGN lo h a rd  to  gauge slaco  W m any 
fititdioo me Ganglial IgA deposition was tho main aolecüon 
erltorloa* Slooono found m esamglal IgA In leoe  than 50 p e r  cent 
of focal OH Wop0580 (228)* Other otadieo have found more?- %ii 
one Btudy, II of 24 were pooltlvo (225), W emo^er five of six 
(230) ami, in a third small otady, iomf of fom* bicpoleo vmtQ fouud 
to  Dhow m eonnglal deposition of IgA (22?) $ WWo varia tion  
therefore ezdsts, I ti this study mooaragial dopDoltlon of IgA 
was p re se n t in  19 of Z7 bic^psieo (table 5 , 1), V aria tion  a lso  
eïdsto iu tho type amd extent of accompanying immmioglobidine, 
IgG was most often foimd in association with IgA (225, 220, 230, 
232), In one oWdy, IgG was soMom foimd altlî.oiïgh %M was 
frequently present (224)$ Tho presence of IgA, as tho solo 
liimwnoglobuîîB, in ten of 19 biopsies positive ù>r IgA In 
this study is  higher than was found elsewhere, with the exception 
of one small series (227). Numerically, therefore. In this 
study, IgA was tho predcmilnant Immtmoglobulln detected.
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Thé la rg e  v a ria iib n  In FGN re iw îti from  varloun studle# 
m ay re p re se n t re a l  â îl lé r^ c e # »  perhaps enviromnexital o r  
genetic» In d ifferen t geographical a rea»  o r  m ay rep re se n t 
a  d isc repancy  In d iagnostic  c r i te r ia  from  one cen tre  to  ano ther.
C lq  has been found deposited in the glom eruli by som e 
w orkers  (224) but not by o tlte rs (22B, 229). In the  b iopsies 
exam ined h e re  (table 5 . 1), €1  subcom ponents w ere  seldom  
found but tl%e p resen c e  of C4 in  19 of ZQ b iopsies suggests 
tha t c la ss ic a l pathway activa tion  was taMng p lace  In a  m ajo rity  
of these  b iopsies# W here th e re  w as deposition o f IgO o r  IgH  
activa tion  of tlie <dasslcal pathway Is likely  to be  In itiated  
by im m une com plexes Involving IgO o r  IgM although n e ith e r 
In tensifies o f deposition of IgO n o r IgM c o rre la ted  w ith those of 
c la ss ic a l pathway com ponents. The deposition of tdasslca l 
pathway components' w here IgA was the  only Im mtmoidoballn 
p re se n t and the  sign ifican t co rre la tio n  betw een In tensities of 
deposition of IgA and C ls  and C4 (table S. 2) suggest* a  re la ^ o m  
ship  betw een IgA And the c la ss ic a l pathway. IgA .Immune 
com plexes a r e  n o t thought .to acttva te  the c la ss ic a l pathway 
(S3). One of the  following éxplanatlona m ay.be responsib le  
fo r th is  a sso c ia tio n  betw een'IgA  and C le  and C4;-«
(1) .amoimts o f IgG o r  IgM p roportiona l'to , but on 
occasions» too ,..small to  be  detected .by im m unofluorescence, 
w ere  p re s e n t and. caused, activation  of the c la ss lc é l pathway*
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(2) tgA m ay î>ç the  an tigen  involved in  an  IgG /IgA  im m m # 
complex* %i tide com plex w ere  in anttgen  exce»# m asking 
of IgG m ight occur* The absence of anÜ-IgA ac tiv ity  in  the 
c ircu la tion  (231) m ake# th is  unlikely*
($) A ctivation of the  c la ss ic a l pathway m ay be  taking p lace 
in  tîie clrcU la^on and product# of the  ac#va tlon  deposited  In 
the kidney* This could account fo r the  p resen c e  of C l 
subcomponent# and C4 but not fo r the co rre la tio n  # i th  
in ten sitie s  of IgA deposition.
T he'involvem ent of the  a lte rn a tiv e  pathway
E vidence a lso  W s te  in 'the  g lom eruli fo r  activation  of 
the  a lte rn a tiv e  pathway with 13 o f-24 b iopsies positive  fo r 
properdin* Tho re levance  of p roperd in  deposition  a s  an 
Ind ica to r of a lte rn a tiv e  pathway n e rv a tio n  w ill b e  d iscussed  
in  cliapter 9* ' In  o tiier studios, four of eight b iopsies (330) 
and four of four b iopsies (33?) w ere  found to have g lo m eru la r 
deposition  of p ro p erd in . A ctivation o f thé  a lte rn a tiv e  pathway 
m ay be  secondary  to  «dassleal pathway activation» m ay be 
in itia ted  d irec tly  by Im m une com plexes containing IgA o r  
som e o th e r Unknown fa c to r  m ay be  involved# -'There w ere  
no c o rre la tio n s  betw een the In tensities of deposition  of p roperd in  
and e ith e r c la ss ic a l pathway components o r  IgA to  support e ith e r 
possibility*
Tho terminal sequence " ■
T here  is  th e re fo re  evidence'lm FGN of ac tiva tion  of bom
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the  c la ss ic a l and the a lte rn a tiv e  pathway#. The significant 
co rre la tion#  he tw etn  Inteneitie# o f C3 a$%d those  of 0 4  and
p roperd in  suggest tW t both pathway# contribute to  0 3  
catahoU em . In two FGN hlopsios* deposition of 0 3  wa# 
found in  tl%e absence  of e ith e r c la ss ica l o r  a lte rn a tiv e  
pathway components* In  both ease# C$ wa# deposited  In 
only t ra c e  am dnntç. The m o#t like ly  explanation fo r  th is  
th e re fo re  ie  tha t c la ss ic a l and/ o r  a lte rn a tiv e  pathw ay 
component# w ere  p re se n t but in  insufÉ cien t q u an tltle i fo r 
detection  by im m unofluorescence. ' Explanation#, p rev iously  
c u sse d  fo r  o ther'type#  of ON m ust a lso  be  considered .
In trag lo m e ru la r  evidence of regu lâtinn  of com plem ent activation  
A# befo re , the four c r i te r ia  outlined in  chap ter 3 w ere  
used  to a s s e s s  the  ro le  of control pro tein#  In FGN.
The ro le  of CT-INH
Evidence fo r the ro le  of c t-IN H  la  FGN wa# inconclusive. 
The p re sen c e  of C t-IN H  In so m e 'biopsie# (table 5 . 1), the 
sign ifican t co rre la tio n  betw een in tensltle#  of deposition  of 
Ç1# and g T-INH  (tab le 3 .2) and the  d o s e  s im ila r it ie s  in 
d istribu tion  p a tte rn s  of G I# and C l ’^ INN» Where both w ere  
found (É gure  5*1), a rg u e  in  favour of a  reg u la to ry  ro le  fo r  
gT-INH. The poor concordance between b iopsies positive  
fo r C ls  and Gl-INH (table  5.3} and the p re sen c e  of C l-IN H  
in  tiio absence  of G ls  suggest# timt tlie deposition of G l-IN H
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need  not m ean-that regu la tion  o f.C la  b y C l^ lH H ts  taking 
p lace , - Some reasons" fo r a .poor ooneordance have been 
^dlseussed previons'lir in chapter 3.
G3bïHâ: w a s 'p ré se n t in one of 23 b iopsies (table S, I).and  . 
th e  d is tribu tion -patterns of G3 and CSblHA w ere  com patible. 
T here  is  no o ther evidence from  th is study to  support the 
ro le  of CSbîNA In the regulation  of G3b in  'FOK,
The ro le  of B IH
The frequent p re se n c e  of p  IB  In FGN b iopsies (table 5 , 1) 
the  good concordance between biopsies positive fo r  G3 and 
p lH , (table 5 ,3 ), the  significant co rre la tion  betw een in te n s itie s  
of deposition o f C3 anct-plH (table 5.2) and the close  s im ila r itie s  
in  d istribu tion  pattern (figure 5-2) all'auggoot that p iH  is  
involved in  the regulation  o f com plem ent activa tion  within 
the 'kidney, "
Evidence of com plem ent activation  In the c ircu la tion
M arginally  reduced leve ls  b f ' com plem ent com ponents w ere 
found in  only two pa tien ts; one had low lev e ls  of ^ c t b r  B 
and ano ther, low 03  and CS, The absence of gen era lised  
reductions of com plem ent components In FGN is  in  ag reem ent 
with o th e rs  (227* 228) w here no rm al levels of € 3  and B w ere  
found. In  th e  pa tien ts  reco rd ed  h ere , how ever, som e ra ise d
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value# w ere  foutsd fo r each coraponent except GSblNA, In 
the  p a p e rs  d iscu ssed  (22?» 2E8) norm al range# w ere  not 
included and th e re fo re  d ire c t com parison cannot be  m ade,
R aised  leve ls  of com plem ent components have been  die cue nod 
prev iously  in  chap ter 3,
% e r e  Is  tiie re fo re  no evidence from  se ru m  concentration# 
of •ttbetantial u tilisa tion  of com plem ent components in  FGN.
The ç o rre là lio n  analysis , however, suggests tha t tlie re la tionsh ip s 
noted in  deposition betw een 03  and the c la ss ica l and a lte rn a tiv e  
pathw ays a lso  e x is ts  In the se ru m  v/itH sign ifican t co rre la tio n  
betw een level»  of 03  and botin 0 4  and fac to r B (table  5 .5 ), The 
significant co rre la tio n s bet^veen G lq and C ls  and betweezi 03  
and C5 m ight have been anticipated, considering th e ir  c lose  
re la tionsh ip  in  the  complement, sequence. Itû ta o  m u st be 
considered  that synthetic fac to rs m ay be responsib le  fo r 
co rre la tio n s  in  concen tra tions'o f components.
Evidence of regu la tion  of com plem ent actiya tion  In iha. c ircu la tion  
The ro le  o l ÇÎ-1NH
C Î-IN ÎÏ leve ls  w ere  not reduced in  any FGN p a tien ts .
I t  is  tîie refo ro  unlikely tha t a  deficiency of CT«INH re su lte d  in  
c la ss ic a l pathway activation* Tîie significant co rre la tio n  
betw een concentrations of C Î-IN H  and C ls  suggests tha t C l-IN H  
w as regulating  c la ss ica l pathway com plem ent activa tion  in  the 
c ircu la tion .
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The ro le  of C 3 b im  ' ■ . -
- ,  . 4 : '  ' ' '  . t o  .
Thé' fa ilu re 'o f  CSbiNA concentrations ^ co rre la te  w ith 
those of èhy o th e r component m ay euggoal that 03MNA is  not 
controlling G # ,  .ilgnlR cant corroM tio## betw een se ru m  
■ concentrations o f G3bIHA and both 03  and fac to r B have been 
found 'e lsew here  i n  norm al se ru m  and in  o th er types of d isease  
{%$% 196* 197, I # )  and th is  lm& been dem onstra ted  In th is  study 
fo r  o th er types of ON (tab les 3 .5  and 4. 6). The fa ilu re  to 
c o rre la te  m ay be due to the  sm all sam ple eixe, -The fac t tha t 
the  concentrations o f .çompléméht components a r e  not reduced 
suggests th a t regu lation  of com plem ent activation  was taking 
place normally in FGN.
JÎJS  ,
The c o rre la tio n s  o f p l H  le v e ls  those of C lq , G la , G4#
GÎ-ÎNH and fa c to r  B; suggests- a  re la tionsh ip  .betw em  p lH  and 
the  c la ss ic a i and a lte rn a tiv e  pathways a s  was noted In the 
deposition  "S#dies Of FGN. It-was suggested th a t th is  m ay 
haye resu lted -from  the d o s e  relàtlonsM p of p  IB  with G3 
found in  the  k id n e y ., In  tho se ru m , -.however, p l ï l  did n o t • 
c o rre la te  with G3. I t  i s  possib le  th a t the sign ifican t co rre la tio n s 
betw een p W  cohcentrà tlona and 'those of o ther components 
a r e  due -to çommoh, synthetic ntimxài,^ A lterna tive ly  they 
m ay  be due to  an  Interdependence of a ll  the com ponents on 
#%e ex ten t o f CS icatàboliém and the -absence Of a- c o rre la tio n
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between-lévei# ofCS ond.BlH'may b# the result of sqme.ptlier 
fac to r èuch a s  in c to a sM  nyn thesis 'o f €3*-
The re la tio n ship .hfetwoen deposition and se ru m  eon.centrations 
of com plem ent:, composionta • ■■ ' ;
A i with Oil-other groups considored, oxoopt MPON# no 
sigslfloant corrolatloni were found (tabio 5.6)* \Poiiible 
rea so n s fo r  th is  ha%re been x>revloualy d iscu ssed  in  chap ter 3*
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- SUMMARY
là Thtrelor# evidence from  thi# itudy #ugge#tii that activation  
of both the c la sa lca l and the a lte rna tive  pathw ays takes place 
In FGN and the  m echanism s of activation  of each  have been 
. discussed* .
2, The co rre la tio n s  betw een the  in tensitie s  of deposition  of 
■both G4 and p roperd in  and thoae ol 03  suggest that' both 
patliways a re  involved in activa tion  of G3, This Is  substan tia ted  
in  the c ircu la tion  by the  significant co rre la tio n s found betw een 
se ru m  lev e ls  o f both G4 and fac to r B and those  of C3.
3* Evidence fo r  tiie regu la to ry  ro le  of CT-INH v/as based ,on  
i ts  p resen c e  In the g lom eruli, On tho significant c o rré la tio n s  
betw een Q Ib and CT^INH botli in  te rm s  of in tensity  of staining 
and a lso  se ru m  concentrations and the s im ila r it ie s  in  the 
p a tte rn s  .of dex>asi^on of C i-IN H  and Cls*
4* T here  is  l i t t le  evidence from  th is  study fo r the  ro le  of GSblNA 
since  i t  w as found In only one biopsy and  se ru h i concentrations 
of €3bïNA did not c o rre la te  w ith those of C3 o r  fac to r B.
5, As has been found in  o th er groux>s, good evidence w as found 
fo r the ro lo  of p iH .in  regulation! there was good concordance 
between biopsies positiva for both'C3 and p lH , strong  c o rre la t­
ions between intensities of depo»itioa of C3 an d .p lH  and d o s e  
s im ila r it ie s  in  th e ir  d istribu tion  patte m e  although no c o rre la t­
ion was foiutd between eerum concentrations of 03 and p lH . 
Eeasonu for th is  w ere  discussed*
CHAPTER 6 
Henoch-Schoideln Mephritia
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Henoch-Schonleha N ephritis
Introduction
Héîioçh-Schonleia n ep h ritis  (HSN) is  a  sy stem ic  d isease  
ch a rac te rise d  by a rth ra lg ia , pu rpu ric  ra s h  and abdom inal 
pain (1). H aem aturia  is  a lso  a common finding and w here 
the kidneys a re  involved, which is  in  between 12-64% of patien ts 
in  v arious stud ies (1), the prognosis is  p o o re r .
W here th e re  is  ren a l involvem ent, the h isto log ical p a tte rn  
is  m ost often a  focal g lom erulonephritis although se v e rity  m ay 
range from  a  m inim al lesion  to a  diffuse c re scen tic  GN and 
has been subdivided into five m orphological types fo r diagnosis 
(1). By e lec tron  microscoi>y, e lec tron  dense deposits a re  
apparen t in  the m esanglum  and a lso  a t the subendothellal a sp ec t 
of the basem ent m em brane (1), IgA, IgG and C3 deposition has 
been found, by im m unofluorescence, m ainly vdthln the m esanglum  
and a lso  to  vary ing  ex tents round cap illa ry  loops (I* 234, 235),
As in  FGN, the p a tte rn  of im m unofluorescence staining is  diffuse 
in  co n trast to the  focal h isto logical p ic tu re  m ost commonly found. 
IgA has been found to be the predom inant im m unoglobulin in two 
stud ies (227, 235).
Im m une com plexes have been detected  in  the c ircu la tion  (236) 
and som e of these  w ere  shown to contain IgA an tibodies. O ther 
w orkers failed  to find circu lating  im m une com plexes (180),
Serum  concentrations of C3 have been rep o rted  a s  being norm al
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(23?).
The pathogenesis of HSN is  unc lear. The d o s e  s im ila r itie s  
often found betw een HSH and FGN suggest tha t s im ila r  pathof 
genetic  m echanism s may be operative. Various m echanism s 
wore suggested for tho pathogenesis of FGN in chapter S. The 
presence in tho glom eruli of Iramunoglobulins and complement 
components# subendothellal and m osanglal electron- dense deposits 
and the presence of c ircu lating  Immune com plexes would suggest 
timt immune complexes are involved.
MATEmALS
Im m unofluorescence stud ies w ere pe rfo rm ed  on J 4 renal 
biopsies obtained from  13 patien ts with HSN# 12 o l whom w ere 
under 15 y e a rs  of age. P ro te in u ria  was p re se n t In five patients 
ranging from I to  13.6 g / 24 hours (m ean » 4 .0  g / 24 hours).
Seruiia c rea tin ine  lev e ls  ranged from  48 to  430 p m o le s /l  with 
th ree  values above the no rm al range.
Betw een one and 16 g lom eruli (m ean « 5. 8) w ere  exam ined 
by Im m unofluorescence and se ru m  sam ples taken on tîie day of 
biopsy w ere  availab le  from  four patients*
RESULTS
The num ber of b iopsies positive and the m ean  in tensity  of 
staining fo r each p ro te in  studied Is shown in tab le  6 . 1.
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Ab in  FGN, IgA wa» àgaW tho immmoglobulln,
bfeistg i n  I Z  W-14 (86%) biopsies with a  Mgh moan
intensity of staining (appenâfe 1)# IgG was îù\mû In 9 of 14 
(64%) m â  IgM la font ol 14 (Z8%) ' bWpslo». Nolthov IgG 
not IgM was foi#4 In the  absence Of IgA, ImmiinoglcibiAlns 
wete not detected in Wo biopsies*
D eposition of d a e s lc a r components
1^ 1 >,üi*j  .liHji' * Hill m,»
Ç lq  m û  G is  weye foond In two o l 14 (14%) and fomr of 14 
(88%) b iopsies respectively although c la ss ic a l pathway activation, 
a s  evidenced by 0 4  deposition was fotmd in nine of 13 (69%) 
biop sies, NoitheV G lq  nor G Is  was fonnd In the absence ol 0 4 .
Properdin was preaont in 11 of 14 (Î9%) , BSN biopsies 
but factor B was never found.
'■ 0 3  was foimd In a ll but one HSH biopsy although the  intensity  
of stain ing  was -relatively low compared with o th er disease  
groups studied (appendW I), OS was deposltdtl In nine o l IZ 
(75%) biopsies.
D éposition of control proteins
Cfi'-IHH was p re se n t in  eight of 14 (57%) b iopsies which is  
tw ice as m any as w ere  posiW.ve fo r C ls ,  Of the  regulator©  of
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C3b, CSblNA was found in four of 13 (31%) which rep re se n ts  
the h ighest percen tage  of b iopsies positive in any group 
studied (appendix I) and ^ I H  was found in 13 of 14 (93%) 
b iopsies .
C orre la tions in in ten sitie s  of staining betw een p ro te ins studied 
Using the Spearm an r*ank co rre la tion  te s t, the in tensities  
of staining of each p ro te in  studied was com pared with the 
in ten sitie s  of a ll o th e rs . The re su lts  a re  shown in  tab le  6 .2 .
R re p re se n ts  the co rre la tio n  coefficient and p rep re se n ts  the 
probability  of significance. B ecause of the absence of fac to r 
B and the sm all num ber of b iopsies positive fo r IgM, C lq , G Is  
and GSblNA, no analyses w ere  perfo rm ed  on the re su lts  of these. 
S ignificant co rre la tions a re  shown in red .
Table 6. 2; C orre la tions in in tensitie s of staining between the
p ro te in s studied
-. G ' A; C4 P C3 C5 CÎ-INH
A
' 0.76  
< 0.001
0 4  : ^
P.
0 .38
NS,,
0 .45  
NS :
P  ^
. P
0.49
<0 . 0 5 ■
0.33
NS
,0.91
<0.001
G3 P^
0 .18
NS
0. 21
NS
0.12
NS
““6737”
NSC5 : ^  :vp. - - - - <0.02
0.47
NS
0.40
NS
0,49
0.05
C l -iNH ^  
p
-0 . 20
NS
6.05
NS
0.41
NS
0.30
NS
Q. 14
NS
-6 .03
NS
BIH
. p . ;
^ 0 .3 2
NS
0 . 26 
NS
0.38
NS.
0.37
NS
0.20
NS
-0.01
NS
t •
0.39
NS
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. Tho of components-
O f the  pathw ay compme^W# .only C4 wao p re se n t
ii.i OROiîgà blopclon to allow moru).ltigftil cmotyolo and tho Kn'Wnolties 
o f 0 4  d<#ooKt%on o o rro W ô d  w ell w ith thO0<% o f propordtxi only.
As wall ao'thè oorrolatto  with 04* # e  WtwioWoo of properdin 
âapooiUon qù rro la ted  wW% tW ü# qî ïgQ  and CÜ,
Tim correlatlfônp ol G S and 05 . . .
■ înténeitloB of 03 deposition did not correlate with those of 
any other component t'/Mle ttie intonsltieo of CB deposition 
oorrelâtod viMx IgCI mid pyopordin,
■' ' NelthOt the Wênoltlos of deposition of Cl-^ SNH.ttor piH
correlated with th# intensities of any other component. Analysis 
on 03MNA was not carried  ont. 
The oongotdonco. boty/oen dcpopHlon of ccntrol pratelno of 
complement mid tine eomnonenta whoBo a otivlty■ they, rernilato
Ü m o.#
. The em W or#m w  -between b lopeies positive  for 
Gle and 04  lo shovm in table 6,3,
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Table 6* 3 ' The wm wrdamce WWmea b iopsies 
G io , G4 %W
C la /  CÎ-ÎNB No. OfM #8W .
N o. o l
.MS22SËE.
C U f  G4 No. ofbionaiee
Giet CÎ-JNH+ 4 C4+ 6 1 - m m 7 ClB+ G # 4
Cle-J- ÜÎ-ÏMH» 0 G44 CÎ-ÎM'Î- 8 :ClS+ C 4r 0
Cle- c t ~ m B 4 - 4 C4- cl-m B 4 I C Î .B -  C44 s
Cle-,OÏ-ïïttI- 6 - C4- eï-ÏKH" 3 Gls-^  G4"^ 4
Total 14 Total 13- Total 13
c!"INH was p r e so it  W all G la  posltlVo MopoWe gmd alae  
la  fo a r  WopéWa w here C Is  w as %tot found. In  th re e  of the  G le  
mogativè Mopêloe# G4 wàs depoalWd along with Gl^'INH and in 
W e W opsiea G4 w as p re s e n t w ithout CÎ«INH. G4 was alw ays 
fowad where G lo was present and a lee in d ve  hiopeiee with no 
evidoâoe of Gle^depODition,
G3hmA
Mpumn n#
The concordance betw een biopeiee posW ve fo r CSblHA 
and G3# G4, GS, p roperd in  and B l l i  ie  shown W tab le  6 ,4 , 
(overleaf)#
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• C3* .OS, p roperd in  an d .p lH  w ere  la  each  of the 
four blopOioc positive fo r CSbfNA, ami C4 was p re se n t b\ 
# r o o . . ' '
B IH  'érqMt-jHkr|é»i-a
T he . concordance betw een W opelee positive  fo r  p iH  and 
C3,. C4| OB and p roperd in  I© shown in  tab le  . 6. B,
■Table  6# B ' The concordance betw een b iopsies positive fo r
C 3/B ÎH
>  AHpte ».r* »
G4/B1H C5/BÎH
w a r  a- ■yt *
P / p m
C34-piH-!- IB c m  p i fph 9 C6-:- pîîrH' 9 p i - p m f  JO
a 3 + p îH - 0 C 4 + p iH “ 0 c m p m - 0 p + p m -  0
G3- jBlî-ï-î- 0 c4*  p m + 3 G5- p m -’r Z ■p- p m $  2
G 3 - fn H - 1 c 4 -  p m - ; 1 G5- p m - I p -  p m -  1
Total n ■Total 13 Total Î2 Tofc'*,l J3
a»*>: < t lyj» jHie Mürw. H #0 lUJi»m t#» M£rr‘
Thbre wa© very good coîicordanee between deposition of 
d 3 and pïH  with IB o£ 13 biopsies being pooitlvo for both and 
the x*einaîning one négative for both# € 4  was negative in three 
MopsieS'pPSitLv0 lor p lB  and ÇB and properdin were negative in 
two poallive for,|3lH. AB otlner components wore negatlvo in 
■the biopsy where plH  v/os not loimd.
Comparison of' Bnmimofluoreecence pattern©
Of the  lo u r b iopsies positive.fo?? both C lo  and CÎ-ÏNX-Ï, 
three had Idontical pattern© of staining and in tite fourtîi botlx '
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Gî© mié CÏ“1NH were preâomlîiaBily eaplllary loop whilo 
Cl^INH was a lso  p re se n t wltliln the m esanglum ., S e ria l 
eectlone eW nod fo r  G Is  and Gl«"INH showed v e ry  close 
elm llarl#@ s in  d istribu tion  pa ttern  (3Mgure 6^1).
When CSblNA etalniag was coneidered, C3bINA wae 
found to  be deposited  la  a  oegm ental cap illa ry  loop p a tte rn  
while C3, in  each caoo* was foimd round cap illa ry  loops and 
alco  wltldn the  meaangium#
G3 and BlH  wore found to have the sam e pattern of 
staining in  nine of the 12 biopsies where both were positive. 
In the remaining three* C3 wao found mainly round capillary 
loops while p lH  was present round capillary loopa and a lso  
in the moeangium. Serial eoctiona sW nod with antieera  
to G3 and B lB  showed d ooe  slm ilariiiea in distribution 
p a tte rn  (M guro
se ru m  aan
The serum  concentration of each component within each 
sample is  shown in figure 6-3.
The concentrations of c la ss ica l pathway components.
No subnormal values w ere found for any c lassica l 
pathway component. In one patient, Ciq and Clo leve ls  were 
raised#
V  4
"W:
f -  L  <
X(o50
Figure 6-1 The photograph on top shows the deposition 
pattern of C ls and the photograph below shows the same 
glomerulus on an adjacent section stained for Cl-INH.
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Figure 6-2 The photograph on the top shows the staining 
pattern of C3 and the photograph below shows the same glomerulus 
on an adjacent section stained for p l H .
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Figure 6-3 The serum concentration of each component
in each HSN sample is shown here. The shaded 
areas represent the normal ranges of each 
component and the horizontal lines represent 
the mean of the sample concentrations for each 
component.
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The o l a lte rn a tiv e  com poneate
A ll pyoperdW  v&lueo w ere  vAW a the novm al range.
.One oovmn had a ra ise d  factor B con contrat io-a while other 
aamploe- had ao rm ol valuee.
The concentration^ of and CÎS
Ko ûuhnormal. G3 and G0 soi’iioi concositratlons w ere 
found. One patien t had m iéod  leve ls of .tooth 03  and C5 
while another W o patiente had a  rained  con cen tra tion  of 
c ith e r C$ o r  C£h O ther 03  and C5 coneantrationa w ere  
normal#
The concentratienc of control p ro teins
Subnormal eornm  concentrations of the th ree  control 
p ro te in s of com plem ent âctivaJion w ere not foimd. One 
pa tien t had ra is e d  lev^ds of tooth Ci*»ïMH and B IB and another 
had. a  raised- concentration of oïdly CÎ-ÏNH. AE GSbïNA levolc 
w ore within the  norm al range#
C orre la tions betw een the ooriim concentrations of com plem ent 
and control, pro tcine could not toe exmnined because  of the sm all 
nunitoer of cam ples available fo r study. S im ila rly  co rre la tions 
betw een se ru m  eoneesitrat!.on and tli« in tensity  of g lom eru lar 
deposition of eompoiionto could not too studied#
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DISCUSSION
ïntraglomoiniiar evidence of complement activation 
The involvement of immmoglobuliras ■
In agvecmont with Bergerhj ctely (235), ïgA was the 
.prccloniineut immunoglobuUn hi HSN and tho intensity of 
staining was alao rolativoly high (appcndhg I), Immuno- 
globidhis rmvQ abccnt from  tw o. biopolo a# Urizar.' (330) foimd 
, that fibrinogca was often deposited in the abcerico of irmntmo» 
globnlino in  very  early stages of the cliceace and suggested - 
that coagulation may therefore be a pathogenic mechanism 
in HSN. Tho two immunoglobulin negative biopeios in tins 
study however ahowcd a diffuse proHferativo GH and fibrinogen 
, was present in trace amounts in on© and was absent from the 
other* The lack of immunoglobulin qtalnlng is therefore not 
associatod with early ntageo of the diecaee and some other 
factors must bo Involved,
The in%f'Olvomout of the classical pathvnw
There was evidence of classical pathway activation in 
71% of HSN Mopales* In eight of the ten biopsies whore 
ciasolcal pathway components were present, XgG and/ or 
IgM were also found. It is likely that the pathogenesis of 
HSH. involves deposition, of immune eomplozos and that 
activation of the classical pathway la duo to  the presence of 
immune complexées containing antibody of the îgG or IgM classes,
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I n  two biopsies, G4 was present w here XgA was the only 
ImmimoglobiiHu apparent. Since %A im m une complex:©o a re  
not known to activate the classical pathway (83), It Is pooolble 
that îgG o r  IgM w as-presen t m  tlnese tis su e s  in  sufficient 
am ounts to cause com plem ent activation but in in sufficien t 
am ounts to be viçttallced. Alternatively» activation of the 
clao si cat pathway hiay have Occurred by immime comploxieo 
o r  by some other means in the clveulstlon and the products 
deposited  in  the kidneys*
The involvement of the altommtivo pathway
Although factor B was not present In any biopsy, activation 
o£ the alt©rnati.vo pathway was suggested by the frequent 
propenca of p roperd in  (table 6#, 1), The good correlation 
between Intensities of deposition of IgG and prop or din may 
imply that activation  of the alternative pathway is secondary 
to classical pathway activation initiated by immune complexes 
containing IgCb The good correlation between the intensities 
of deposition of C4 and propordm supports this view* Adternatlvely 
the alternative pathway may bo activated directly- a s  the result 
of IgA containing im m une com plexes o r  by some immunoglobulin 
Independent mechanism. The possibility that p roperd in  may 
deposit in  the absence of alternative pathway -activation hds been 
suggeotect previously and will bo discus sod m o re  fully in 
chapter 9.
188.
Th© term iaiaî oocîuenqo
Activation of both the. eiacsical and tho alternative pathways 
io fotmd In HSH# Howover the in tencltlos o£ dopOBllion of G3 
clid not correlate with those oî any o thar eomppmqiit and conseqi^ently 
the contribution of oach p a t h ^ t a j  to  03 activation couM not be 
aofîosséd. i l  the  In to iisltiea o l 00  m ay bo token as  an  Index: of 
the oiftomt ol activation, thoa the pigniflcant coryelotlon between 
lateiifiitleo ol otoinlng o i €B and psropardhi onggoots that the 
alto rnaiivo  pathway Id m aW y rooponsible lo r  the activation  of 
the tormlnal eequonco,
Xntraglomcivuiar o v i é e n c e  o i  rogttlaiion of complement activation
Tho four criteria ouUlnod In dmptor 3 were ttacd to aooooe 
tho role o i  tho control protolno i n  regulation o£ complement 
activation im HSN.
The ro le  of CÎ-^mH# : j p # w » m s A ' M k * K t t t f  4h^=4f.t#* .1 <<W
Tho role of gT*-IHH In controlling olaoolcal pathway 
com plem ent activa tion  in  HBH io thoroforcvbaoed o n  Its p resen ce  
in 8 of 14 Mo;pslor> (table 6.1), tl%e limited concordance between 
cT«INI| and Cls and particularly.C4 (table 6.3) and tho 
élm iîaïitios in diatsibiitlon pattomc (Figure 6»I). Gîé was 
present in too few blopeieç to allow corrolatian amdyele to 
bo carried out#
Tho ^ 0  of C3W
G3bîHA w as found in  a  h igher percen tage  of HSH blopciea
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than in any o'tlior group (taMo 6 .1) although it was only
present in trace amounts in each of 4 blopsioB. The
concordance beWeen biopsies positive for G3bIHA and 
plH  being present hi all €3bXNA ])0aitlve Mopeles (table 6,4).
plH  being present in all C3bXNA ])Oaitive biopsies (table 6,4).
It may be euggeoted that the relatively fréquent presence oi 
CSbXNA accoraita for the la cl: &i intense complement activation 
in HSN* baaed on weak glomerular deposition. oi 'G3 (tablé 6,1)
. and normal serum 03. concentrations (Figure 6r3) * However, 
the two other groupa in which C3blHA wae found,.. MPGH- 
and SL'Eb are as.eoelated with eKcesalve complement activation 
(tables 4 .1 and 7,1 and figures 4«3 and 7*;3). ■
■’■ Alternatively, • it is  .poeoiblo that CSblNA in only found 
where considerable complement, activation is occurring,
■ since only in  th is  situation would one esspect slgnlE eant am ounts 
of C31> to be present* One facto3/ common to iViPOH and 81,E
lo the préoence of electron dohoo deposits in a subendothelial ' 
position. Jm the four H8N biopsies with clopOoltlon of G3bXNA, 
the staining pattern of G3 and IgA was predominantly cax^illary 
loop with two. biopoiooj-aloo showing meeangial staining for
■ G3 and IgA. Although electron micros copy was not performed 
on these biopsies electron dense deposits in IdSN are generally 
foimd within tixe mosangiiim and in a subendotlicliai position { 1) *
Thorefore the siibemlothellal position of tho complexes in these.
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thrno  dWoaoaa m ay allow  oaolor acceoo of com plém ent 
eompoaontü and C3WNA to tho complescoo and tlio transKto?;y 
CSblNA m ay tlio reforo  bo vlauaMood,
DoGpitc tho c?.oo© slaElarltWo boWoen FON and H8N aoon. 
In thlo study mal docarlbed toy others (?, 227)# CStoXNA wao 
fomwl in o%dy one of 23=FON toiopoioo. Tho dü'foronce co#d  
ho duo to dio fact tlxat thoro Is ralatlvoly more eapEIary loop 
deposition of hnmunoglotouEno ami complément componoïito In 
H8N oomparod v4th. FGN*
Ao with other groups ntuÆod# was frequently prosont 
(tatolo 6,1)* Tho ooncordaaoo 3)otwcen tolo%)Olco pooitWo for 
C3 and B IB  wao etrong and tho pattor^io of s ta W a g  %voro v e ry  
o im ilar. Ho slgaiiflcant corro latW a wao found, howovor# tootweon 
the  Intenoltlos of deposition of ^ 5IH and any o th er component# Tho 
ovldonoo for the role of BIH in controlling complomant aoEvatlcn 
In H8H W thoroforo  tonood on tho fac t tlia t th ree  of tho four 
erltorla employed wore oatlcfled,
I I :4 â 9 a sa .a iiæ » a 4 a i« a .â £ tE a â ïïa ^ ^ ^
Too few Dorum eamples wero avaüablo from the HSN group 
for cleîo.îioA study. No reduced valuoi,.. ol any component was found 
which agraas with the work of others (238)- There is thoreforo no 
evklence, from the low rooults available# of a doficloney of any ol 
tho regulatory proteins which would result In uncontrolled comple­
ment activation.
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SUMMARY
I. Thèr# ÎQ ©victonco of activation of both tho cXacoical and 
the alternative j5a.thwa.yfi ol complemont in-HSN and th© 
posûlMe mochahioms of activation were dlocuaood.
2* . Tho î-’olativo cositvibntlon of èaoh pathv/ay could not bo 
.a/isoasod oiîice the intonaitiog of ctàining of comnonente 
of neither pathway correlated with the Intencitles of 
■ dopûoltiôn of Câ and no analysis of the .30x12m con cent rations 
wao clone. ' The correlation found between tho Intohoitloo 
of staining of Cb and'x. r^op©vdin however may s.uggeat a 
greater involvem ent of tho alternative pathway.
3* .Evidence for the role of Cl-'IHH hi regulating clasolcal 
pathway activation wao baoèd on its preoenco in the kidney,
. tho reasonable concordance between biopsie0 positive for 
C Ï-ÏH H  and C ls  and the s im ila r itie s  in  d istribu tion  p a ttom c.
4, Although# by no moans conducive, there wa-o more evidence 
; for the regulation of C3b by GSblHA in PÏSN than in  any other
■ group studied.and reasons for tMfô woxo dlocussed. Tho 
regulatory vole ol GSblNA was based on itc presence in  four 
biopoieo' which also contained propovdin and C3 and the 
.compatibility of Eio distribution patterns of C3 and GSblNA.
5. There was good evidence for the role of ptB  based on Its
' pxcocnco, good concordance botwcea'biopiEles poBitivo for 
C3 and plH  and the oimllurlîloo In distribution pattoxnc Of 
th ese  tv/0 p ro te in s . ■
6. Since tho s'erimx concentrations of the three control 
p?:oteiîï.c wore either normal or raiced, activation of 
the complément,eystem in HSN was not duo to a oormn 
deficiency of tlnoGO p ro té in e .
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CHAPTER 7
System ic Lupus E rv them atosus
193.
System ic Hupus Eyythem atogus 
Intyoductiog
I# a  laxge nûmîîex of published s e r ie s  of 6IÆ  pa tien ts , the 
frequency of rena l Involvem ent was found to  range from  3? to  
07 p e rcen t of c a se s  (1) and w as a  frequent cause of death.
T here  is  a  v a rie ty  of possib le  h isto logical p a tte rn s  in  th is 
d isease  w ith evidence of p ro g ress io n  from  m ild  to  m o re  sev ere  
fo rm s in  som e pa tien ts  (239)* The single d iagnostic  c h a ra c te r is tic  
is  the appearance  in  som e glom eruli of imematoxyphil bodies.
Some b iopsies show a  focal p ro life ra tiv e  p a tte rn  while in  o thers , 
the  p ro life ra tio n  m ay be diffuse and accom panied by thickening of 
cap illa ry  w alls . C rescen ts  m ay a lso  bo p re se n t. In  the absence 
of p ro life ra tio n , cap illa ry  w alls m ay be focslly  o r  diffusely 
thickened, giving thé  appearance of MON.
V aria tions a r e  s im ila rly  found a t an  u ltra s tru c tu ra l level w ith 
e le # ro n  dense  deposits in  one o r  m ore  of the subendothelial 
in tram em branous o r  subeplthelial positions. T hese deposits 
m ay have a  c h a ra c te r is tic  **finger-prlnt“ appearance.
Im m unofluorescence, w here l it t le  o r  no u r in a ry  abnorm alities 
ex is t and  no h isto log ical le s io n  is  found la  repprW d a s  showing 
l in e a r  cap illa ry  loop deposition of IgG (53, 246). W here the  
h isto log ical p a tte rn  Is tha t of a  focal GK, IgG and G3 and often 
a lso  IgA and IgM a re  found m ainly In the m esangium  (246), In 
the  diffuse p ro life ra tiv e  fo rm s, the stain ing is  m o st often in both
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the m esahgiitm  and cap illa ry  loops and, l a  the  type reeem blW g 
MON# e taW ng  Is  In a  fine g ran u la r cap illa ry  loop p a tte rn ,
A l l  t h r e e  main I m m t m o g l o W W  d a o B e a  a r e  o f t e n  found t o g e t h e r  
partW olarly  W dleeaoee Involving aneeanglai dopoolüoa (240-241), 
DNA antigens m ay be dem onstra ted  with Immtmoglo^wlln and G3 
In the glom eruli (242) and antlbodlea wlMt opeOlHelty for native 
DNA may be eW ed from the Wdneye of 8I*E patients (41),
■ C i r c u l a t i n g  I m m u n e  c o m p l e x e s  l i a v e  f r e q u e n t l y  b e e n  f o u n d  
using a  num ber of d ifferen t agsays (179# 180, 242a& 242b) ami 
altliough antlbodlea to native DMA are generally considered  
dlagnoel&c for (243), antlbodleo to denatured DNA, RHA, 
r i b o s o m e s ,  p o l y n u c l e o t W e a  a n d  n u é l e a r  p r o t e i n s  a r e  a l s o  f o u n d  
b i t l % e © o r n m ( S 3 ) »  ' _
D eposition of bo#% ciaoolcal and a lte rn a tiv e  pathway com plem ent 
com ponents Imve been reco rd ed  (241) and reduced  eerum  
concentrations of C3, C4, fac to r B a re  cotnmon (245),
Inereaeed  catabo lic  ra te s  o f C3 l&ave a lso  been  noted, T h ere  la  
th e re fo re  evidence Of both c laee lca l and a lte rn a tiv e  p a# w ay  
activa tion  In 8DB.
Evidence baeed  on the p resen ce  of e lec tro n  dehee depoelte end 
anUgene w ith êpeclA c antibody In  the glom eruli and lmm%me 
com plexes In the  c lrcu la iion  strongly  suggests th a t the  pathogenesis 
of Involves deposition of Immune com plexes. The significance 
of type D hypersensitiv ity  w as d iscussed  In ch ap te r 1 and $nay 
contribu te  to  pathogenesis p a rticu la rly  In b lopslee  w here  
deposits a r e  In a  subeplthelia l position.
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M A T E IU A L B  : 
ïm m unôfîupresçencé stud ies w ere pe rfo rm ed  on renal 
b iopsies obtained from  ten  pa tien ts . P ro te in u ria  was found 
in  five pa tien ts  ranging from  2* 1 to 10.6 g / 24 hours (m ean 
a 4* 4 g / 24 hours) and the se ru m  creatin ine  lev e l was ra ise d  
in  one pa tien t. A ll pa tien ts, a t  som e tim e p r io r  to biopsy, 
had had c ircu la ting  antibody to DNA a s  m easu red  by the 
F a r r  technique (243), A t the tim e of biopsy, n ine patien ts 
had positive  DMA binding capacities ranging from  42 to  99 
p e rc en t (m ean * 81%),
Betw eeh I and 10 g lom eruli (m ean «« 0.6) w ere  availab le  
fo r  im m unofluorescence exam ination and aerum  sam ples 
taken on the  day of biopsy^ w ere  availab le  from  a ll  ten  patien ts.
\  , R m m ,w  -
Momit B iopsies ■
G lom eru lar deposition of im m unoglobulins, com plem ent and 
control proteino
The m unbér of b iopsies positive and the m ean in tensity  of 
■ staining fo r caoh p ro te in  studied is  shown in  tab lé  7 ,1 .
(see  overleaf).
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Depoollloa. o l
IgG waa deposited irn-ali MopBioa with %A and IgM 
present in eight out of tea (00%) and nine of ten biopsioa (9 0 %)
■ AE three claseléal pathway componento were present 
In each of the biopsies examined.
D eposition of a lte rna tive  pathway components
Properdin was prseent in seven of siine blopoles (78%). 
otadied while factor B was never dotoetod.
Deposition of G3 ami G5
C3 and C3 were each present in oil blopolos studied.
Deposition of control protainc;
CÏ-INH wap deposited in seven of nine SHE biopsies (78%) 
While C3blHA wao only found in  two, (22%). |3lH was pro sent 
in each of nine Mopoies o:isamlned.
Correiatione In intensity of staining between the proteins studied 
Using the Spearman rardx correlation tost, tho intensities 
of staining of each protein studied wag compared wltîx tho 
intensities of all otliore. R roprosentc tho correlation 
coefficient and p the probability  of significance, 3;he results 
of this aro shown on table 7, 2, Because factor B wao not 
present and C3b|NA was only found in two biopsies, no analyses
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w ere  perfo rm ed  on the  résu lté  of these. Significant 
co rre la tions a re  shown in red .
Table 7 .2  : C orre la tions In h 
p ro te ins studied
G A M C lq C ls G4 P C3 05 C l-IN N
-  : 0,850,001
«  J
0,78
0,01
0,82
0,001
0 1 ,  J 0,57
0,05
0.34
NS"
0,50
NS
TÎ
C ls
P
0,62
0,05
6. 46 
NS
0,53
NS
0,10
NS
C4 ^  
P
0 .44
m
0.26
NS
0,13
NS
0,29
NS
0,41
NS
P  ^
P
0 .46
NS
0,65
0,05
0,71
0.02'
0 ,36
NS
0,28
NS
0.08
NS
C3 ^  
P
0 ,43
NS
0 .2 4
NS
0,35
NS
0,80
0,01
0,38
NS
0.15
NS.
0,41
NS
C5 ^  
P
Orl9
NS
0.28
NS
0.32
NS
0,09
NS
0,42
NS
0.09
NS
0,55
NS
0,43
NS
CÎ-ÏNH ^  P
5745
NS
0.51
NS
0,41
NS
0, 24 
NS
0.28
NS
0,27
NS
0.90
0,001
0,51
NS
0.55
NS
BIH 
1 P
0 .5 Î
NS
0,61
0,05
0,73
0,02
. 0 ,29 
NS
0,41
NS
0.25
NS
0,83
0,001
0.50
NS:
0,76
0,01
0.85 .
0.001
NS « not oignificant
The co rre la tio n s of c la ss ica l pathway componente
The in tensitie s of staining of C lq  and C ls  co rre la ted  weakly 
with those of IgG and C lq  in tensities a lso  co rre la ted  w itlvthose of C3.
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Ho o ther ulgnlEcaBt co rre la tio n s w ore p resen t.
The cQyrelaiipas of the a lte rn a tiv e  patlw ay
F a c to r  B w as not p re sen t in  SLE asid tho W e n s iü e s  of 
p roperd in  deposition -co rre la ted  only with those of ïgA and 
%M.
Tho correlaUoQO of CS and G5
Tho întonsitîoD o l G3 deposition co rre la ted  only with those 
of G Iq -w h ile  the  In to n s lt io o  of C 5 -déposition failed, to c o rre la te
v/it?.^  th-doe o i  a.ny o th e r componoat* '
The correlations of tho control proteins
The IntensltloFJ'of deposition ol cl-IHH correlated well with 
tWoo of tooth propcrdW and pIB . .. The intensities of plB  
dopotrltion àlpo correlated with those 'of IgA, IgM, properdin 
and G5,
The concordance hotwee%% deposition of the contro l p ro te in s of 
com plem ent.and the components v/hoco activ ity  they regu la te  
CÎ-ÎW.H
The concordance betw een biopsies poaltlvo for GÏ-IHH 
and those p o s i t iv e  f o r  C l s  and C 4 I s  sh o w n  in  ta M o  7 , 3 ,
(séo over). -. ■
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Table 7 .3 ; Tito emoot'claace botwoeti ‘blopîîloa poeitlvo fo rp f f . f c *  *-!"*«?* I ',Will,,1,^,1 W ill ;»i i I -»'»  l*m l^ll^ JUl]> iki # ,!"#»%*%llW
■ • C ia. C,4 ami CÛ-INH , '■
Clfs/ GÎ-ÎNH
, No. of
Mopoloo
•11 *#riiJro.*! vV ^ * >*^ =* ■*»
c 4 i c i ~ m M  .
'  VV-raç-re-tï i V^ Wît 4-i WI» A-iTKTT-^ îïï-fcW <# 5t
pis-{- c i ~ i m n 7 C4^ cl»rm î!-
Cici'}’ CÏ-ÎKH" Z . C4-S- C l'4M -î"
CÎO» c i ~ i m K [ ’ . 0 G4~ GÏ-INH-Î-
ciB" cT -n^a- 6
r ~ i«mn ifniTin*M~i rwiwr a i a i 'nwiM#
C<1- cI-îiSKi'"
Total 1 9 1 Total
No. of
biqpdios 1 G 4 /'C ls
C #  C la f
C4‘l' Clo*" 
Ç4- CÏ8+ 
C/4- C l$
No. of
9 
0
ro to i
CSb artd 04 w ers proeent in all nine blèpoleo escomtnod and 
olnce Cl-IHH was procoi&t in sovon 61 thmo the çonoordanco 
was goad.
C3bn&&
The two biopslod positive for CSblNA also showed deposition 
of C3, C4j CB| iKcopordIn a tî4p i3rl.
p m
The conoor '^lance between blopslco podltive for. p lH  
a n d  CS# G4 , G 5 a m i p r o p e r d in  io  ehow n In  t a b le  7 . 4 .
Table 7 .4s The concordance b e tw e e n  b io p o ie o  positive for ' 
B IH  and C3, 04 , CB àhd p roperd in
G 3 ^ m
-^KL» ,ti*ez*I»M»WW.3eWii'Ra «<l» it^ lr
No. of
biopBses
: ;v w s .»
* Bu«>'=c r^B!a>»rsc.'»«WPEW;a«.^Ktj*-jwp
C4/J3JH
No. of
b iopsies
■f» W.^ïtfc
c B j f p m
# «  w-n*» "
No. of- 
H epsiee P /B IH
No. of 
blopsiei
CS+jBlJ-K- 9 C'fA-pim - 9 GS-!-pSH*!- a p f ^ i m 7
C 3 + ;« H - 0 G4-:-plH«- 0 G 5-!-pm . 0 B + p m - 0
C3- p iH + 0 G4>-pia-i- 0 CS- p iH + 0 p -  p i m Z
C3~ p m - ’ 0 C 4 -J B la . 0 C G -BÎH "Tw.4sasti«-.#e*i* ]*# .#< «**#«  .*.4^ 0 P# B IN - Q
Total 9 T otal 9 Total 8 Total 9
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Slnca all Wopoloe ptndleet were positive for p lH , C3*
G4 and C5* dompleto concordance existed  betw een each of 
: these  and p  IB  %va$ p rocen t in  each of the seven blopcleo 
pocltB/e fo r p3zoperdln.
Comparison of brnmimofluorescenoo patterns
-'eight bioj.>iiiei3 in the SLB gronp, moot proteins 8to.died 
vàei-'c.. foimd both In the- mesanginm and round the capillary 
loops. In  one, the p a tte rn  was m ainly m esanglal and. In 
anotlxer, moot p ro te ins w ere  foimd alnioot exclusively rottnd 
the capillary loopo.
w hen the patto;mc of C lo  imâ C l-IN B  w ere  considered, 
i t  was fowid tha t C lo  and c i-IN H  woi'o both found round 
caplEaiy loops asxd within the mooanginm in four and,, in the 
rom aining three, was present again  round cap illa ry
loops and within tho niesanglum, while Glo was deposited 
mainly round capillary loops. Staining of adjacent sections 
with anti Cora to CSb and C Î dem onstra ted  a very close 
similarity In the dlotributlon patterns (figua*o 7"1),
In one of the two-biopeiee positive for C3bIHA, C3 
and G3blHA,wèro both found ;ln a me sanglai and capillary 
loop distribution although C3bIN.d. staining was patchy while 
C3 staining wa,0 'diffuse, In the other Mopny, 03 was again 
found In a mosanglal and capillary loop distribution but GSblHA 
was deposited focaily and sogmontally round cax^illary loops.
Vj
•)
XLSO
Figure 7-1 The top photograph shows the staining pattern 
for C ls while the photograph below shows the same glomerulus 
on an adjacent section stained for Cl-INH.
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The p a tte rn s  of depoaitlon fo r 0 3  and p iH  w ere  Identical 
in eight out of n ine biopsies# In the  ninth  03. w as found both 
in  the m esanglum  and round cap illa ry  loops while p lH  showed 
only a  cap illa ry  loop staining p a tte rn . The d istribu tion  on 
s e r ia l  sections was again very  s im ila r  (figure 7-Z),
■Serum Sam ples
The Sérum  concentration of each component in  each of 
tiie ten  Sérum  sam ples is  shown in  figure  7*^3.
The concentrations of c la ss ica l pathway components
Reduced leve ls  of com plem ent components w e re  found 
in  seven of the  ten  sam ples studied and the m edian values 
of Clq* C ls  and 0 4  w ere  significantly  low er than n o rm al.
The concentrations of a lte rn a tiv e  pathway com ponents
V alues of fac to r B and p roperd in  a s  a  group did no t vary  
slgniE cantly  from  norm al although one pa tien t had reduced 
lev e ls  of fac to r B and p roperd in  and fac to r B lev e ls  w ere  
subnorm al In a  fu rth e r  two pa tien ts .
The concentrations of C3 and G3
Bight o f ten  C3 concentrations w ere  reduced  and the 
group w as significantly  low er than n o rm al. T h is m arked  
reduction  in  C3 leve ls  was not noted fo r ÔB w here only one 
sam ple had a  subnorm al value and the lev e ls  in  two sam ples 
w ere ra ise d .
K .
■ v  i »
XU-SO
Figure 7-2 The photograph on top shows the staining 
pattern for C3 while the photograph below shows the same 
glomerulus on an adjacent section stained for p iH .
C3bINA 
% of STD
C3 CÎ-INHbg/mlCls C4
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-40
-200*MOO* •100 • 200'-20 -1000
-200 -50- 2 0
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0.05 ^0.02 I0.05 \ NS NS0 .0 5 i 0.05 + NSNS NS
F i g u r e  7 - 3  T h e  c o n c e n t r a t i o n  o f  e a c h  p r o t e i n  s t u d i e d  i n  
e a c h  o f  t h e  t e n  S L E  s e r u m  s a m p l e s  i s  s h o w n .
T h e  s h a d e d  a r e a s  r e p r e s e n t  t h e  n o r m a l  r a n g e s  
a n d  t h e  h o r i z o n t a l  l i n e s  r e p r e s e n t  t h e  m e a n  
c o n c e n t r a t i o n  f o r  e a c h  p r o t e i n .  T h e  r e s u l t s  o f  
t h e  m e d i a n  t e s t  a r e  s h o w n  a t  t h e  b o t t o m  o f  e a c h  c o l u m n  
w i t h  a r r o w s  i n d i c a t i n g  w h e t h e r  t h e  v a l u e s  a r e  
s i g n i f i c a n t l y  h i g h e r  o r  l o w e r  t h a n  n o r m a l ,
N S  =  n o t  s i g n i f i c a n t .
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concentyatlonK control pyûtelns .
CÎ**ïHH lev e ls  w ere  r^gnlfleantly îmcreased-wlfih only 
W o v?à%\m rem aW n g  w ithla the norm al range , Ho reduced
C3MHA o r  B IH  lev e ls  w ere  noted and the values fo r  the group
I
did not vary (9lgnW,eantly from  normal* Two raised  G3b|MA 
and fou r ra is e d  p lH  concentrations w ere  found,
, e m A e m L e m E e s e . s s â J & ^ ^
The cor re lay o n s  betw een se ru m  concentrations of each 
o f the  com ponents studied w ere  calculated  using the $pearmm% 
rank  co rre la tio n  te s t  and tlie re su lts  a re  shown In tab le  7* S#
E  re p re se n ts  th e  c o rre la tio n  coefEclent and p  the  probability  
of significance# Significant co rre la tion»  a re  shown in  red* 
C o rre la tio n s betureen serum  concen tra tions, of
C3bINAC lq
0 .50
MS
0.001
w :w rw :m
MS
0*41 I 0T72 
NS 0.02
NS
0.82 I a . 13
0.0011 m
m - -0* ICl-ÎHÎ:I
MAW#*
C3MNA t s 0*13 0 .37  NS I NS
111®
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The co rré la tio n s  of coni
The corrolatioufi of ctaselcat i^atWay compommts • ■ ■ ' ,
iW«*>#*ic-4**i»ÿTW:tiAâMewy'''1WA|-'hWv«iw.eef;6S'^VSéM^
The concentrations of C4.eorrelated v4th those of Ol<i ami 
fc.lb and loyolo of both,Cls and C4 eorrelatecT\7 lth/G3  comceBtratlonB. 
The €orrelations of alternative. patWay ■ comntmonis ■
• Factor B levelp correlate with levels of 03 and C#o*
The correlations^ of €3 and G5 \
Boveio of C3 correlated witli Cle* 04, 'faotbr B and G5 
concentrations. -C5 a lio  correlated %vlth Ole*
:ToWns;, ':
.;■ C4-dHHlovele correlated'only with properdin, 03bïNA 
: correlated vd$h CB and BIH with faotor D a W OS, . . . /
The relations Mo Imtymem serum eoh'centrathmo and Inteniiltleo ’ 
of nlomorular dopooWon of complement comnohentü and control ', ■ 
nroteino - "'
. tfcing tlie Snearnmn rank correlation tept,- the IntanoltleD 
of deposllkm were'compared with-thé,, eort&m concentrations of each 
component e:s:çopt' for- facto?; B and CSblNA which wore not .deposited 
or present in  too few blopeloe, '^The-'robuits are ohown im taMc 7 .6 , 
It' ropreeénto thé' correlation coblAcient and p the probability of • ■ 
clgnigiconco,'.'. . -' . ■ . .
TaM0  -7# 6 î v vTho correlation  ^Wt^voen oorum lovolc &àû Intenaitles 
' ' of.elenoeition of oad î‘complement com
V#rjr«ww*NrAh to»rrMhrWFMWEAK
\  clq,
4Fk6#:.-i-WrMK^*r rp.
,  Ç - 1 C : C 4 . p  - '  ' : G 3 . ■ G S C Ï - Ï N H p l H  I
R  - 0 . Ô 5 " P . 3 Ù - 0 *  3 3  ■ 0 , 2 7 - 0 . 2 8 0 . 0 Î 1 4 0 * 2 9
P  m . N S  ,  = œ , m K S • N S . ' j
N«S» not significant ' ' 
Ho significant; co rre la tio n s w ere  foimd*
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DISCUSSION
In trag lo m e ru la r evidence of com plem ent activa tiôn  '
The involvem ent of tom unoglobialins ,
In ag reem en t with o ther stud ies o l  im m unoglobulin deposition 
in  SLE, IgG was alw ays p re sen t (S3, 240, 241). IgA and IgM 
w ere a lso  frequently  found in  the b iopsies included h e re  (table 7 . 1), 
although in  o th er stud ies IgM and p a rtic u la rly  IgA deposition was 
seldom  seen  (240, 241). K offler (246) found IgM and IgA 
frequently  deposited  except w here tlie stain ing  had a  lin e a r  
p a tte rn .
The m volvem ent of c la ss ic al pathway
A ll tliree  c la ss ica l pathway components w ere  p re se n t in each 
of the  b iopsies (table 7 .1) with re la tiv e ly  high in tensity  of 
staining x>articularly fo r  C lq  and 01» (appendix 1) suggesting 
tha t m arked  activation  of the c la ss ica l pathway had taken p lace. 
Since sign ifican t co rre la tio n s  ex isted  betw een IgG and C lq  and 
C ls  (table 7 .2) i t  is  likely  tlxat im m une com plexes containing 
IgG w ere  no rm ally  responsib le  fo r the activa tion  of the c la ss ica l 
pathway.
The involvem ent of the  a lte rn a tiv e  pathway
The p resen ce  of p roperd in  in seven of n ine SDE b iopsies 
suggests, th a t the a lte rn a tiv e  pathway was a lso  activated . The 
a lte rn a tiv e  pathway m ay be activa ted  d irec tly , independent of the
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c lass ica l pathway. Evidence fo r th is is  the weakly significant 
co rre la tio n  betw een the in tensity  of deposition of IgA and 
p roperd in  and the lack  of co rre la tio n s between the in tensitie s  
of deposition of p roperd in  and c la ss ica l pathway com ponents.
As a  m eans of d irec tly  activating the a lte rn a tiv e  pathway in SEE, 
a  "neph ritlc^ fac to r lik e"  substance has been described . This 
was found, hov/ever, to be dependent on calcium  ions and th e re fo re  
activa ted  the c la ss ic a l ra th e r  than the a lte rn a tiv e  pathway. (247).
In  favour of a  rec ru itm en t o f the  a lte rn a tiv e  pathway, secondary 
to c la ss ic a l pathway activation , is  the co rre la tio n  betw een in tensities 
of deposition of IgM and properd in . D irec t and in d ire c t activation  
of the a lte rn a tiv e  pathway need not be  m utually exclusive.
The absence of fac to r B need hot n e c e ssa rily  a rgue  against 
a lte rn a tiv e  pathway activation  since  deposiüon of fac to r B has 
been found v e ry  ra re ly  even w here m arked  a lte rn a tiv e  pathway 
activation  is  known to occu r. In one study, fac to r B was found 
in BIX of eight rena l b iopsies from  paUento with SI,E (247a).
A d iscussion  of the general absence of fac to r B in  th is  study with 
re fe ren c e  to the above com m unication is  included in chap ter 9.
The te rm in a l sequence
The x^resence of C3 and G5 in  a ll b iopsies is  consisten t with 
the findings of o tlm rs (240, 241). C3 activation  is  like ly  to re su lt  
from  the activation  of both the c la ss ica l and the a lte rn a tiv e  
pathway but since  the in ten sitie s  of C3 deposition co rre la ted  only
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with ^ 0 se  of C lq ,i t  Is  pexhaiss m ost likely  that the c la ss ica l 
pathway is  tine m ain  pathway of coznplement activation.
■ B ecause of the d iv e rs ity  of types of rena l dam age in SEE, 
is  i® not p o ss ib le  to estim ate  the significance of com plem ent 
activation  in  a  general way. All the b iopsies in th is  study 
had evidence of an  in flam m atory  p ro c è ss m ost often rep resen ted  
by ce llu la r p ro life ra tio n  and i t  is  likely  that com plem ent 
■activation would b e  involved in tills# ■. The ro le  of com plem ent 
in  the type of BEE resem bling  MOH, with .no evidence of 
inflam m ation is  unc lear. Several possib le  m echanism s w ore 
suggested fo r idîoxjatîiîc MON and th ese  m ay apply here#
In trag lom eru la r  evidence of r egulation of com plem ent activation 
The ro le  of com plem ent p ro te ins in SEE b iopsies w as a sse sse d  
using the four c r i te r ia  outlined in chapter 3.
The ro le  of 01  ^ im-I .
The frequent p resen ce  of CÎ-IN H  in  Bio g lom eruli of SEE 
patien ts (table  7* 1) the  good concordance betw een b iopsies positive 
fo r C ls  and C l-IN H  (table 7 .3 ) and the s im ila r itie s  in d istribu tion  
p a tte rn s  (figure 7 ,1) suggest tha t CÎ-IN H  la  p re se n t in  the kidney 
in response  to the  p resen ce  of C ls . A gainst a reg u la to ry  ro le  fo r 
Is the absence of a signi:Rcant co rre la tio n  betw een the 
in ten sitie s  o f deposition of C l-IN H  and C ls . This m ay be due to 
the fac t that c la ss ica l pathway activation is  In tense in SEE. CÏ-INH 
m ay be p re se n t in  the  kidney in  response  to  a need fo r regulation
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but m ay be inadequate fo r the control of activation. Thé reduced 
m v m n  cohcontratlons o l d a s  Bleat pathway componente (Hguro 6.3} 
would oupport thie view. - .
The ro le  o l G3bmA -
C3bîHA w as p re se n t in two rena l biopeieu and was p re se n t 
in  a re a  G a lso  positive lo r  0 3 . No o ther evidence ex is ts  from  
the deposition o l CSbXNA in  BEE to suggest th a t CSblNA is  controlling 
C3b. ■ ■
p iH  was p re se n t in  a ll  b iopsies . % e  concordance betw een 
G3 and B IB  was tlie re lo ro , by n ecessity , p e rle c t. ■ The d istribu tion  
p a tte rn s  \ _ suggest t i i a tp lH  was binding, to C3b. ' The co rre la tion  
re su lts , how ever, p re se n t conlllcting evidonce-lor the ro le  o f p lH .  
The in ten sitie s  of deposition  o l p lH  did not c o rre la te  %vith those 
o l G3 although they did -relate to the In tensities;o f C5. Tho
slgniE cant co rre la tio n  betw een deposition of 03  and p U i  m ay re flec t 
a m utual dependence of p U f u m i  0 3  on C3b. This point has been 
d iscussed  p rev iously . ■ '
The fa ilu re  o l thé in tensifies of déposition of C Ï-îN H  and p lH  
to c o rre la te  w ith  G Is  and 03 respec tive ly  m ay have sev era l possible- 
explanations,
1) The sample alao may be too small*
E) Activation may, be too great lor effective regulation. This 
is supported by the observation that the serum concentration of
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,G4' ar0 often, reduced in tho proson.co 'oi Mgh lovcXs of-'OÎ^ I^NH.
3) The abocnce of corrolatlono m ay be céuBcd by the iuhorent
InoonCitivity of the immimoliuoreàociice technique at high 
lutcuoitloo. . The lutouuity of qtainWg for each protom was 
Gcorocl cm a scale from aero to lour* It Is imlikoly'.that thooe 
G cor 08 ropreGônt a  l in e a r  rolatlonohlp betw een the sc o re  and 
the quantity ol antigen in tho tlsoue*’ ■ Xt ip more probable 
■ that, with increasing  sc o re s , - tho;dlAqrenco In. quantity .of 
antigen represented between two e cores a lso  in c réas  eo due 
, to  Gtorio hindrance /and perhaps o ther fac to r 8* - The In tensities 
of.staining of Ç3 and BIH w ore particularly high in SEE* '
4) ItJ.8 olso 'pqpciWo that, in SEE, and B lH  in tensitie s do
not C orrelate  with those of C lo  ami C3 rcppectivolybecauB e 
they a re  deposited independently. Tiiie m ay be  tru e .o l C l-lN H  
widch m ay bind, to sev e ra l o ther Çnàymcü (240) , Ba®ed on the
- d istribu tion  p a tte rn s  and .the goad concordance between b iopsies 
positive  for'the control pi“Otein and the protein regulated  ihlB 
would oeom im probable.
Evidence of concernent activation  in tho circulation 
The Classical Pathway
Serum  concentrationo of„claoplcal pathway components have 
been m easu red  in  aeveral studios (245, 247) and low value® 
of these components have frequently been found. In tSiio otvidy 
70% ( 7  ol ten) patient® had evidence of intense ciatssical pathway .
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activation ae dermonatrated by aubsormal lovelo ©£ at least one 
classical pathway cèmponont/- Tho C3 concentration for each 
of tho patlento with' subnormal claosteal pathway componoats was 
ai BO low an il lovola of C3 côr related oigaif&cantly with C l n  rmd C4 
euggeetlhg that .elaeoEcal pathway activation Is rooponsiblo for a  
üignlfiean!; increase, in  G3 catabolism.
Tho altom ialive pathway
Concentrations of alternative pathway compononta wore reduced 
in tiireo ol tea samplee. These results are similar to those of 
others (245,. 247) and concentrations of‘factor-B correlated 
with thoBO of C3 and CS, This may either ropreeent a direct 
•activation of tho alternative- pathway or a  recruitment of the 
alternative pathway oocondary to classical pnthwBY activation. The 
concentrationo of alternative pathway compcments did not correlate 
with classical patlnvay levels. The. alternative pathway however 
is an amplillcatiozi system (249) which, once triggered, may be 
Independent of the generation  of C3b by tho classical pathway G3 
convertase. Serum factors capable of activating the alternative 
pathway aro not p re se n t in  SEE (247). Recruitment of tho 
a lte rna tive  pathway via the classical pathv/ay is therefore the 
most probable means of activation. Sonne direct activation by 
IgA immune complexes canhot be excluded since IgA was frequently 
found in renal biopsies (table 7..1), Thesfeforc as was found in 
the deposition studies, there la evidence In SEB-for-activation of 
both the, classical and the altornaEve pathways.
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Evidence of regulation o l com plem ent activation  in the c ircu la tion 
The ro le  of CÎ-ÎNH
Elevated levels of Cl-INH, lack of correlation between 
levels of Cl-IHH and Cls and reduced Cls serum concentrations 
may suggest that Ci-IHH plays no. role in the modulation ol the 
classical pathway in SEE. It is possible either that the small 
sample sIko in the group rep o rted  here may account for the lack 
of correlatiosi or a relationship between C ls and cl*INH may 
have been masked by an increase In Gl-INH synthesis.
The strong correlation between serum levels of properdin 
and Cl «INH, like the correlation between the Intensities' .of 
their depooltibn In the kidney la dIfEeuU to  explain, Gî^ïNH 
is not Imoxm to play any role In tho control of altoraatlvo pathway 
activation, _ It la possible that activation of the alternative 
pathway, secondary  to classical pathway activation, may have 
resulted in this rolationshii>., If this were true, however, a
correlation would also have been expected between the serum '
«=» . ' levels of Cl-XHH and classical x a^thway com|ioneuts. This was
not found (table 7. S), . B Id possib le  that som e other* as yet
unknown, interaction may exist between CÎ-îHH and the alternative
pathway.
Tho role of C3WNA
C3blHAil,avels all fell v/lthin tho normal'range. Only C5 
levels correlated with those of C3bIHA and since low lev e ls  of 
CSblNA cculd result in,increased C3 turnover and consequeSit
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05 cataboHsm, thÎB corrotatlon ouppoyta the regulatory yoW 
oi CSbîNA, Tho small sample also may again aocoimt for
lack of cosn^clatlon hetweea C3 ami CSbXHA,
The role of p m
p iH  lavolii w ore e ith e r ra ise d  o r  norm al and di4 not d iffer 
significantly  fro m  norm al. ■ C orre la tion  ex isted  betw een 
cOncentratlond of BIH  and fac to r B and çS  again  supporting the 
ro le  of p lH  aa-a- reg u la to r of com plem ent activation  in  tho 
cU 'cidatlon. '
Tho •i^elationsMp betw een denpoltion and serum  concentration 
of comolom ont conmonento .
Ho co rre la tio n s  ex isted  bciv/een .the Intcnsitloo. of déposition 
and 'the eo rw n  leve ls  of any of .the components (table 7 .6 ). 
Severa l rcaeons have a lready  been suggested fo r  th is . A nother 
reason- exclusive BEB- awl HSN is  the fac t tha t they a r e  systemic, 
d ise ases  with a  va riab le  am ount of renal Invo lvem ent,.. ' Since 
the com plem ent system  m ay be activated  In o th er tis su e s , the 
se ru m  lev e ls  m ay re flec t activation  s ite s  o th e r  than in  the 
kklaey.
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SUMMARY
L KvidoncG from thf,a study auggaot® that infsnae  activation  
of both tl%o claooical and tho alternative pathways occu rred  
m BEE and the m ochaniom c of activation were discussed . ■
2 , C orre la tion  analyses of tho intensities of dopooition of 
components auggeeta that the classical j^athway is  the
. main pathway éf activation in the glomeruli.
3, Concordance results and tho study of distribution patterns 
suggest k that ci«INH and BIH were present in response to 
deposition of Cls and C3 respectively and were therefore 
likely to foe" exerting a regulatory effect on tliose proteins.
The co rre la tio n s between the in tonsltios of depoeition of 
th ese  p ro te in s , hov/over, did not substan tia te  th is  and 
reasons fo r IMo w ore disousoed,
4. Some evidence existed in two biopsies for the ro le  of 
CBbXNA as a reg u la to r of C3b since the patterns of deposition 
of C3b and GSblHA w ere  com patible.
5. 3?here was no deficiency in the se rum  concentrations of 
ci^ïNîd? GSblKA o r piH  to account fo r the in te n se  com plem ent 
activation  seen in  SEE.
M inim al Change N ephrotic Syndrome
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Minimal Change Hephrotic Syiidrome 
Introduction
Originally called lipoid nophrosis, minimal change nephrotic 
fjyHclromo (MiCHB) is a dioeaso, p t^fhmrily of childhood, associated 
with ûQjâivéUG oyndx o^mo and minimal or no histological abnormal­
ities. By electron microscopy, tho moot noticeable change is the 
fusion of epithelial cell foot processes (I). Moot studies have 
fomcl that immimoglobuHns and G3 are not dox’soslted in the glomeruli 
of MCNB patients (18* 173) although oceasiomilly trace amounts have 
been noted (18). XgE was found in  four of five patients In one study 
(13) but this finding has not beam confirmed by others (12, 16, 17). 
There Ib therefore littlo evidence that MCHB involves the deposition 
of i^nmuno complo^:;es.
Some ovkîeheo oxiots, however, to suggest that MCNS 
Involves immunological mechanlsmo. Although serum complement 
levels are normal, Ngu (2 B1) found- raloed Immunoconglutinln levels 
In MCHS patients. Lymphocyte changes have also been noted. 
X,ymphocytoo from MCHS patients appear to have an enhanced 
ability to Mil renal target calls (76). Also the formation of both EA 
- (181) and BAC (252) rosettes has been shown to bo inhibited by 
prior Incubation of the colls with serum from MGNS patients 
ou-ggaatlng tbe presence of circulating immune complexes. The 
possibility that immune complexes» although apparently not 
deposited, may be involved f.u the pathogenepiD of MGNS has been •
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suggested (252). One proposed mechanlem in that, co%nplo%os 
cause the release of lymphoMuos from lymphocytes which results
in damage to the glomerular basement mombrano and loss of 
protein Into the urlno.
The association between MCNB and typo I hyperrjencttivity (13, 14, 15) 
may suggest that the Increased pormeabillty ol the capillary 
loop may in some eases be due to the release of vasoactive 
a%miixos from seneltloed mast coil G.
Bo cause of the failure to detect Immmioglobulins and 
complement proteins In tho glomeruli of MGNS patien ts, this 
group could, to some mstont, bo treated as a control group. for 
the study of clepoeUion of complement components and more 
particularly regulatory proteins.
MATEmAES
Immuao:€lii>oresconce studios %voro performed on renal 
biopsies obtained from eleven patients. Proteiimria was present 
in only live patients at the time of biopsy and ranged from 2 . I to 
20 g per 24 hours (mean '*» 11. 6 g/ ? A  houre). However, the 
remaining six patients had had at least one episode of proteinuria 
prior to the time of blopoy. The serum, creatinine level of one 
patient was raised with a value of 300 nmoles/ I, the levels in 
tho other patients rnaged from 25-132 nmolos/1 (moan » 70 ^imoles/1), 
Bix of the 11 patients In this group wore children under the age of 
15.
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RESULTS
G lom eru lar deposition of immrnidjglobuXIn»» com plém ent and
The num ber of b iopsies positive fo r each of the p ro te ins 
studied and the m ean in tensity  of staining fo r  each p ro te in  is  
shown in  table 8 . 1 (see  over).
■m
I
z i i .
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PepO Bitlgaof Im m m ogio M to a
of H  (Z*I%) b iopsies w ere  positive fo r ïgM . In 
one of tliege, tlio staining was in  a  fooaX and aegm ental oapiXlary 
loop p a tte rn . In  tîie o ther two, tlie staining wag a lso  patchy 
cap illa ry  loop h #  not r e s tr ic te d  to a  single a re a  of tîie g lo m eru la r 
tuft, : The la t te r  two b iopsie g a lso  hàd tra c e  amonntcs of staining 
fo r IgA and IgG. A photograph of tlxe patchy capills.ry loop 
stiiining p a tte rn  is  shown in  figure  B«l,
Deposition ol claaeicat pathway component a
. The two biô%)Gio^ with trace am ounts of all three immuno* 
globidlnc were positive.for C lq  and G4 andlwas also positive fo r 
G Is* C la ss ica l pathway components w ere  only p re se n t w here 
immunoglobulins were deposited.-
D eposition of a lte rn a tiv e  pathway components
P ro p erd in  was p re se n t in  tra c e  mnounts in  one of the
immunoglobuUii pordfiva Mopflioo. F a c to r  B w as not found.
D eposition of C3 and CS
G3 was p re se n t in  th re e  of the 11 b iopsies . Two of these  
w ere  the  b iopsies w here immusiogIol>ulinc w ere  found in  a  patchy 
c ap illa ry  loop p a tte rn . .. In  the th ird , tra c e  am ounts of C3 w ere 
p re se n t in  the absence  of immunoglobulins*
tepoaition of cohtr<
GÏ-INH w as p re se n t in  fou r of 11 b iopsies .
X (oSO
Figure 8-1 The pattern of deposition of IgM in a biopsy 
from a patient with MCNS.
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-. GSblNA wao not p rd sen t any of the M opalba àhd . 
B IB  wao found in  tho two'biopsKoa.poo&tlyo fo r aÙ 'thrôo.. •
• Tho corroWiono' in intonoWeo o l oWning boWaon tho ■ 
varWuo compone#o etWied wc^ ro not examined bècauéo #>0 .
fôw biopïsloo were ppîîitlmT'fer any of iho proteins. • '•
,$feâJEB£E$âEEB.SS!SESHLâS^iâELB£iEESHàLE£Ê$MBE»S$
■Cog > j,ga M fc :i# l« to .« w k !^ g s tg ^
Tho cowcoïdance betw een blopaUiw positive fo r C l-IN'H, 
d o  and G4 ia  ahow nin  tab le  0#%, '.' . . :
Tho.. comêordanoe , hotwogn Mppales
M M S i i d Ê Ê L ^
No. of 
;.Mppsie#._
H o .'o l
. 9 M M , . ,
Ho# of . 
bibasi*!»
CÎO + ci-im;» i 04f 01 "im# a d s 4 ’ 04$ I...
C ls  f  G Î< m B - 0 044- oï^imi^ ■•' O' cl@+ 04^ 0
C I b- 'C Ï “ÏNH4- . .-S' 04" GÎ-^INI^':' 2 ' C io" 04$ 1
C le -  .c i-IN H - ■,  y _ C4- Ô Ï-m H ^ 6 . 01.0-04'^ 8
■ T o ta l ' n.' \ .  ■ T o m 10 ' - ■ Total 10
, in' one o f’tUa pbBitlvo'biopoioa, dm  mû 0 4  w ere
prooont whUo in  anothor only '0 4  v>as found# In  .tho ' rem aining 
two blôpoloài ’ was? fotmd in  thm  aboenoe of-any o th er ■
com plem ent p ro te in . C îo  and C4 w ore no t found, in  the abosnce 
of CM NB#
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C3bIKIA
C3bî^TA was Siot p re sen t in  any MGNS biopdy*
pm.-
The concordance between b iopsies positive fo r p  IB 
and C3, C4, CS and p roperd in  is  shown in tab le  Ô. 3,
Table 8 ,3 ; The concordance betw een b iopsie s  positive for 
BÎH , €3, C4, C5, and properdbx
No. of No. of No. of No. of
C3ÿpiH biopsies C 4 /p lH biopsies G 5/p lH biopsies P / p i B biopsie
G3+B1H+ 2 G4+piH-!- Z C5+piî-î+ I B+piH 4 I
C 3+plII- I •■ C4+B1H- 0 0 P + p i B - 0
G 3-p iH + Ô C4- p m + 0 C5- p lH + 0 P - p iH f 1
C3- p lH - 8 C4" p iH - 8 C 5 - p lH - 9 P - jBlH- 9
Total n Total 10 TotaX 10 Total U
C3 and C4 w ere  both p re sen t in tlie two biopsieo w here p iH  
whs found., G5 was deposited in one and p roperd in  in  the o ther. 
03  was found w here p I B  staining was absen t in one biopsy. p i B  
was not found in  the absence of 03» C4 o r OS.
C om parison of imm unofluo rescence patterns
In the single biopsy positive fo r C ls  and OT-IHH both pro teins 
w ere found to be  deposited -rom%d capillary  loops and w ithin the 
m osangium . G3bINA was not found and in the two b iopsies w here 
both C3 and p  iB  w ere  present» the p a tte rn s  of stain ing w ere  again 
the sam e. B ecause of tim sm all num ber of b iopsies positive  and
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the low in tensity  of staining, i t  was not possib le  to obtain 
photographs of s e r ia l  sections stained  fo r G I s and Gl«ïHH 
and 03 and p lH .
Serum  oamplos
The seritm  concentration of each component w ithin each 
sam ple Is  shown in  figure  S**2. B ecause of the  sm all num ber 
of se ra  availab le  lo r  study no s ta tis tica l analyses w ere  c a rr ied  
out*
Serum  concentrations of classical, pathway components
No subnorm al values of any c la ss ica l pathway components 
w ere fotmd* Two patien ts had ra ised  leve ls  of a ll  th ree  
components and a  th ird  had a supranorm al 04  concentration*
Serum  concen tra tions of a lte rn ative pathway components
T hree MCNS patien ts had ra iaed  propor<lm concen tra tions.
One of these  a lso  had a ra ise d  fac to r B level w h l%  In a  second, 
the  fac to r B concentration was subnorm al. O ther values w ore 
within the no rm al range.
Serum  concontratlons of G3 and CS
F o u r MCNS patien ts had ra ise d  concentrations of both C3 
and 0 5  and in the fifth  the C3 level was ra ised .
The se ru m  concentraticnB of the control p ro te ins
A ll CT'^ÎÏ^Ï concentrations, one of the five C3MNA concentrations 
and four of five p lH  concentrations w ere above the norm al range 
in MCNS. One patien t had a  subnorm al G3blNA leve l.
CSbina 
% of STD
C4 
H E /m l
C l-IN H  
h e / m l
C3
H g / m l
C lq  
H g /  m l
-600
-800 -300' -60%
-3000
-80
-400
-50
-600*
•BOO# -150-60 300 -200
■2oo5-40
•600 -400 -30
-400 -20 -200-1000
- 100, -50-20
-200
F i g u r e  8 - 2  T h e  s e r u m  c o n c e n t r a t i o n  o f  e a c h  c o m p o n e n t  
i n  e a c h  M C N S  s a m p l e  i s  s h o w n  h e r e .  T h e  
s h a d e d  a r e a s  r e p r e s e n t  t h e  n o r m a l  r a n g e s  a n d  
t h e  h o r i z o n t a l  l i n e s  r e p r e s e n t  t h e  m e a n  o f  t h e  
s a m p l e  c o n c e n t r a t i o n s  f o r  e a c h  c o m p o n e n t .
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DISCUSSION
lutvaglomertiXar evidmcç of complement activation 
The involvement of immmioglpbnîine
Three biopélefô ehowecl déposition of Immimoglobullns in 
MCNSr One had .trace amounts of only IgM In a focal, segmental 
caj>illa.ry loop x?attern* This patterzi Is more often associated 
•with focal glomeruloccleroois (FGS) than MCNS (1). Differentiation 
between tiiese two diseases is complicated by thé focal nature of 
,FGS (253). Twenty glomeruli were available for histological 
analysis in this ïgM positive biopsy and all glomeruli were eiUier 
normal or showed minimal mesangial Increase with no segmental 
lesions. Since tlxe biopsies in this study v/ere categorised 
according to.their'histological appearance, this biopsy was 
therefore considered in the MCNS group. It is  possible that, 
had a different sample of glomeruli been available for light 
microscopic examination, the diagnosis would have been FGS. 
Whether MCNS and FGS are two distinct diseases oi whether 
one is a variant of the other is a subject of debate (254).
In the other two biopsies, IgG, -> IgA and IgM were all found 
in a trace or'weak patchy capillary looj? pattern. As can be 
seen from figure 8 ^1 , the stabling-pattern is unlike that seen 
lln other types of ON. It is possible, therefore, tlxat the
staining does not represent deposition of immune complexes.
One possible explanation is that the staining is caused by the
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passage of proteins tiirpugh the capiUary.loops. MCNS.- 
is associated with defective protelnmda with excretion mainly 
of albumin. In a dlti^ation where albumin passes through the 
loops into the urine, It may be possible that larger protein 
molécules are trajsped within the loops and demonstrated by 
imm\mo£î.uore s canoe *
|n  each of the biopsies with evidence of dsposition of 
|mmmoglo1>u.îîîïG, the intensities of stalnmg were either trace 
or, in the case of IgM in one biopsy, weak. The significance 
of staining of such low intensity must be considered dubious.
In the remaining eight MCNS biopsies, there was no glomerular 
imimmoglobulin deposition evident. Those findings are consistent 
with the results of others (18, 173),
The Involvement of theclassU al pathway
AWM11 s I,  L, J ilin 1,1 *w;i'' m#,
The f£ict that the two biopsies positive for all three Immuno­
globulins studied also showed deposition of classical pathway 
components and all other nine biopsies were-negative for classical 
pathway x>roteins, may suggest, either that the immunoglobulin 
staining does, ii% fact, represent depooition of imm^une complexes 
or at least that the immunoglobulins in the loops are capable of 
activating the classical patliway. It is also possible that these 
proteins were trapped in the capillary loops as was discussed 
for immunoglobulins,
In tlie remaining nine MCNS biopsies, there was-no evidence of 
deposition of classical pathv/ay components.
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Thé involvement of the aUomative m thvw
Only one biopsy showed trace depoaltlqm of propordm 
and none was poaltlye for factor B. The properdin positive 
biopsy wap also positive for the throe Immtinoglobxdino studied 
and the three-classical pathway components* ■ Staining of such 
weak Intensity however is of doubtful significance. If the 
staining does represent specific deposition rather than non specific 
trapping then it may mean direct activation of the alternative 
pathway, activation secondary to the classical pathway or 
trapping of properdin independently of comjdement activation.
In the other ten biopsies,alternative pathway proteins were not 
■ found.
The terminal socmenc©
G3 was foimd in the two biopsies with deposition of inimuno- 
globuHno and classical pathway components and in trace amoimts 
in one biopsy where no immiaioglob^dine were foiuid. The close 
concordance beWeen deposition of immimoglobxdins, classical 
pathway components and C3 in tliis group suggests that the 
staining represents specific dei^osltion and may be circumoW-ntial 
evidence fo r the intraglomerular activation of complement by - 
im m une com plexes.
If the staining of all those components merely represented 
trapping then it mày be expected that proteinuria would be 
greater In the two biopsies with déposition. In fact, at the time
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of biopsy, those tv/o patients had iooo than 0. Sg of protein 
in the mine par 24 home. Xn order, to asooso the %3ooolblXity 
of trapping, it may have been uoéW to examine the Mops lea 
for the preooncG of pvotelhs of 'similar olso but which are 
mot known to' be Involved in the imimme I'osponee.
în moot biopsies, there is neither depooitlon of imrmmo -^ 
globulin© or complement, component© 'and -MCNS in thevoforo 
a useful control group for studying the role of regulators of 
com plem ent activation  in-ON.
lutraglomeindar evidence of regulation of oompiement activation 
Mo correlation, atudlon could be donp because so' few. biopsies 
were positive iov .any of tlie proteino considered. Assessment, 
"therefore, ■ of the role of regulators was based on thelr'preeehce 
in the kidney, the concordance between biopsies positive for the 
control protein and the compoi-icnt regulated ;md a comparison of 
tho diBtribution'pattewns of the two proteins Involved , -,
The role of qî'4MB ' '
Cl"XNIi' was found more frequently In MOMS than any bther 
protein studied, i t  was present in two biopsies positive for 
classical pathway components# The distribution pattern of 
CT'^ IMM in these two biopsies-was the same as that of the classical 
pathway components. GÏ-XMH however, was.found in.two biopsies, 
without evidence of deposition of any other complément protein. 
Only six other biopsies In the rest of the disease-groups showed
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OT-'ÎNH in tlié absence of any classical patliway components 
and In each of these six, C3 was present. There are three 
possible explanations for G1 *-XNH being fomid in the absence 
of all other components; a) tlie insensitivity of the immmto- 
Buorescence test results in a failure to demonstrate other 
classical pathway components where they are present, 
b) Cl*ÏNB deposition may be in response to some otiter 
mechanism* While fibrinogen was present in the two biopsies 
where C4 and Ç3 were found it was absent where Cl«lNH was 
found alone. For UiIb reason It is perhaps improbable that 
Cf-'-XMH is present as a regulator of one of tlie components pf 
the coagulation or fibrinolytic systems, c) Ci-INH may bo 
trapped on passage tlàrough the capillary loop. Absence of other 
proteins would make tide unlil;ely. In those two biopsies, therefore, 
the role of CÎKCNH is unknown* This may place in doubt the 
significance of CÎ^ÏHH as a control protein of complement 
activation where only concordance .results support the regul.atory 
role of GÎ-INH.
The role of CSblNA
C3bMA was not deposited in MCNS and there Is- therefore 
no evidence for a regulatory role for C3MNA in this, disease.
The ro le o fB IH
plH  was preoent In the two biçpBios whoro 03 staining was 
weak but wan not found in the biopsy with only trace G3 deposition.
227.
til the two biopsies positive for both €3 and plH, the staining 
patterns were compatible with each other, Hq p IH deposition 
wap found in the aight biopsies whore C3 wap absent. Evidence 
for a regulatory arole fo r plH. is therefore baoed on tho-prescnce 
of p  IB in two biopfîieo, . the  good concordance'between 
biopBierj poaitlvo for C3 and pIH and the similarities In distribution 
patt'oms of G3 and plH,
Evidence for ■ complément activation, and regxda.t|on in the circulation
MCKS is a  dip ease associated witl^  marked proteinuria and 
hypoalbuminaemla, Tlie loss of protein in tho urine, however, 
has not resulted in a generalised reduction In serum complomont. 
concentrations, In fact# as m othow GN groups, the lovels 
are often raised above normal (ligures 3-%, 4*^ 3, S"3, 6-3, 7**3 
and 0 *^2 ) , Two subnormal values were found m two separate. 
samples and those were factor B and €3bïHA levele. It Is 
[possible that these proteins were lost ,in tho urine of these .patients 
both of whom had high levels of proteinuria (6g and 20g per 24 hours). 
With molecular weights of around 90,000 for factor B ând C3bïNA 
rodpoctlvoly (E53, 256), these are relatively small molcculoo 
and may be excreted in preference to other complement components. 
Other reaoons for low levels would be either reduced synthoeis or 
increased catabolism. The low CSbïNA concentration does not appear 
to hiiVQ resulted In an uncontrolled activation since G3 and factor B 
concentrations were normal.
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SUMMARY
L  T herefo re  In m oot MCNS paUooto theyowe no evidenco of 
acÜvÂtloa of olthor tho d ooelca l or tho .altovnot&yo pathway©
o r  ©ohééqoént oatâboUpm of C3,
2. F o u r blopslo© ©howod deposition of Im munoglobulins and/ o r  
complément oompoaoâts and the atgolflcanoe of tWs was 
dW oussW .
$# The ahaonoo of deposition of tho control proteins of C3b 
where C3 was a lso  absent helps to substantiate the 
relevance of the ' concordance between blopeloo positive fOr 
G3 and b o th p lH  and G3b%NA foimd In ether dleeaee groupe. 
Thle Is Important because of the high percentage o f biopoles 
pooWve for'C3 In the other types of ON studied.
4* The presence of Gl'-INH In the absence of any other . 
complement proteins suggests' that care Is needed In 
Interpreting the significance of concordance between biopsies, 
"positive for Gib and In tho other d isease groups.
CHAPTER 9 
DISCUSSION
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. F1NA3Ü DISCUSSION
Complqmeiit actlyàtion  m ay occur by one of two lîathwaysî 
the cla s si cal ■ aud th é  a lterna tive  pathw ays. The purpo se of , 
th is th es is  was to study the pathways of activatioh  in human GN. 
Since activation  of com plém ent is  controlled by sev era l p lasm a 
p ro teins, the ro le  of these  p ro teins in thé  m odulation of com plem ent 
activation was a lso  examinedV Six m ajo r types of GN w ere 
considered and renal b iopsies and serum  sam ples from  patien ts 
with these  d iseases  w ere studied.
Of the d isease  groups studied, MGN and SLE a re  generally  
considered to involve c la ss ica l pathway activation  (173, 176).
The activation  in  MGN is  slight with generally  no evidence of 
reduced levels of com plem ent components (183-184) and weak 
in tensities of deposition of com plem ent p ro te in s m  tîie g lom eruli.
In som e biopsies C3 is  absen t (172^ 176, 177) while^ in SLE, 
serum  concentrations of C3 and c la ss ica l pathway components 
a re  frequently  reduced (213, 245) and 03 and c la ss ica l pathway 
components a re  a lm ost always p resen t in tlie glom eruli (187, 240, 
344). Both c la ss ica l and a lte rna tive  pathway activation, a re  
thought to be involved in MPGN (205-216) although p a rticu la rly  
w here NF is  p resen t, thé  activation of the a lte rn a tiv e  pathway m ay 
be predom inant (205). The in ten se  activation of com plem ent In a 
d isease  w here th e re  is  often litt le  evidence of an im m une complex 
pathogenesis m akes MPGN p a rticu la rly  in te res tin g  for study.
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L ittle  w ork has been done on com plem ent activation  in 
FGN and HSN. The fac t tha t IgA is  the predom inant 
immunoglobulin in  both (224-227, 235) suggests that the 
a lte rna tive  pathway m ay be involved in com plem ent activation 
since IgA im m une com plexes do not activate  the c la ss ica l 
pathway (83). The p resen ce  of o ther immunoglobulin c la sses  
m ay re su lt in  c la ss ica l pathway activation. MCNS was chosen 
to re p re se n t a control group because th e re  is  generally  no 
deposition of im m unoglobulins o r com plem ent components 
and se rum  lev e ls  of these  a re  not reduced (18, 173). T here 
a re  however sev e ra l disadvantages; the m echanism  of MCNS 
is  not Imown but the p resen ce  of ra ised  immimoconglutinin 
leve ls (251) and som e abnorm alities of lymphocyte function 
(76, 181, 252) suggest that Immunological p ro c e sse s  a re  
involved, a lso  high leve ls  of p ro te inu ria  m ay re su lt  in non specific 
trapping of p ro te ins within the cap illary  loop. In the  absence of 
norm al rena l biopsy m a te ria l, MCNS was accepted as  a control 
group.
A ctivation of com plem ent is  known to occur in  the  c irculation  
of patien ts with certa in  types of GN, fo r exam ple MPGN and 
SLE. This Is dem onstra ted  by reduced se rum  com plem ent 
concentrations (figure 4-3 and 7-3 and re fe ren ces  (205, 208, 209, 
212-214, 245-248) and by fac to rs  in the serum  capable of causing 
activation  of e ith e r the c la ss ica l o r the a lte rn a tiv e  pathway of
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com plem ent in  norm al m v v tm  (20B, 247)* - In o th er d isease  
groups mch no MONt FGN and ÏÏBN* the-ro Is little évidence 
that activation occur© within the circu la tion  (eoo figu res 3-2,
5-3, 6-3)*
It Is more difficult to oetablloh -whether activation occur© 
within the glomerulus o r -whether component o lo ca lise  by one 
of ti%e following a lte rn a tiv e  m ethods î-  I) trapping  of components 
which a r e  In the  native state* This m ay he expected to  occur 
w here cap illa ry  perm eaW llty  le  in creased . In  MCNS* however, 
w here  higii lev e ls  of p ro te in u ria  suggest that cap illa ry  permeability 
is Increased^ complement component©, nre generally not present 
in  the kidneys {18, 173 and tab le  8* I)* Z) trapp ing  of complement 
components %vMch have been activated In the circulation* It 
is îîôssifola that C3b fo rm ed in  tho circulation may bind to G3b 
receptors in the glomeruli In tide way (70), or 3) com plem ent 
components m ay a ttach  to  W%e im m une com plexes in  the circulation^ 
and be deposited  a s  p a r t  of the  complex*
The Spearm an rank  co rre la tio n  analysis  fa iled  to  show 
significant co rre la tio n s betw een in tensitie s of g lo m eru la r 
deposition of com plem ent components and the  se ru m  levels of 
these  components w ithin each d isease  group except fo r an 
Inverse  co rre la tio n  fo r  C3 and a  posiMve correlaU on for C le  
in MPGN* R easons fo r  the absence of co rre la tio n s have a lready  
been d iscu ssed  and som e suggestions w ere  m ade to  explain the
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somewhat anom alous co rre la tion  of C ls  in  chapter 4. D espite 
the general absence of useful inform ation from  the co rre la tion  
analyses, I t has been shown th a t d iseases  which have in tense 
com plem ent activation  in the circulation, a s  dem onstra ted  by 
low m edian C3 leve ls , fo r exam ple, 8LE and MPGN a lso  show 
high in tensity  of deposition of C3 while le s s  deposition of com plem ent 
components is  found v/here serum  levels a re  no rm al, fo r exam ple 
in  MGN, HSN and FGN. This m ay suggest that deposition in 
the  g lom eruli is  secondary to activation  in the c ircu la tion . It 
is  a lso  tru e  however that the sam e fac to rs  which cause activation 
in the c ircu lation  in SLE, that is , imm une com plexes, a re  
p re sen t in  the g lom eru li. In MPGN, the m eans of activation 
is  le s s  well defined. W here complexes a re  Involved, the 
m echanism  m ay be sam e as fo r SLE. Since NF m ay bind to the 
a lte rna tive  patliway C$ convertaee, i t  is  possib le  that NF may 
a lso  deposit in the kidney with resu lting  activation . I t  is  a lso  
possib le , though le s s  likely, tha t lov/ se rum  lev e ls  re su lt from  
in trng lom eru lar activation of com plem ent. The p e rs is ten tly  
reduced se ru m  com plem ent levels a fte r nephrectom y in  MPGN 
argues against th is (217). No d ire c t evidence ex is ts  to verify  
tha t activation takes p lace within the kidney in hum an GN but 
sev era l studies suggest that i t  m ay occur; Î) activation  of the 
a lte rna tive  pathway m ay take place, in  v itro , on kidney sections
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fro m  ra b b its  w ith  acute serm n s idm eso (257). 2) Surfaces
w ith  a lo w  s ia lic  acid  content a re  known to  a llo w  a m p lific a tio n  
o f a lte rn a tiv e  pathway a c tiva tio n , and basem ent m em brane 
m a te ria l fro m  pa tien ts  w ith  GN has been shown to  be low  in  
s ia lic  a c id  (214)* The potential fo r  a c tiv a tio n  m ay th e re fo re  
re s id e  in the ba,sement m em brane its e lf, and 3) if ,  as has 
been suggested fo r  MGN, im m une com plexes m ay fo rm  a t the 
e u b e p ltlie lia l aspect o f the basem ent m em brane ra th e r than 
being deposited in  a p re fo rm e d  sta te , then a c tiv a tio n  m ust 
occu r w ith in  the g lo m e ru lu s .
The ro le  o f com plem ent in  the c irc u la tio n  m ay be d iffe re n t 
fro m  th a t in  the  k idney. In  the p lasm a, com plem ent m ay b ind  
to im m une com plexes v ia  C lq  and the a c tiva tio n  w il l  re s u lt 
in  the opson isa tioh  o f the com plex, a id ing  the in g e s tio n  o f 
the com plex by phagocytic  c e lls , bea ring  G4b o r  G3b re ce p to rs . 
S im ila r ly , the a lte rn a tiv e  pathway m ay be ac tiva te d  d ire c tly  by 
gram  -negative b a c te ria  and the b ind ing  of C3b to these w ill again 
a id  Ingestion . L y s is  of these m ic ro -o rg a n is m s  m ay a lso  re s u lt 
by the actions o f the C 5b-9 ly t ic  com plex. In  the k idney, the 
a c tiva tio n  o f com plem ent m ay re s u lt in  extensive  damage. 
H ow ever, the com plem ent system  is  e s se n tia lly  a p ro te c tiv e  
m echanism  and an im p o rta n t fu n c tio n  m ay be to  cause the 
solubiliRation o f in tra g lo m e rid a r im m une com plexes.
I t  has been shown th a t antigen is  rem oved m o re  slowly
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ivQin the Ickhieyo of rabb its with dopoolted irmm m o oom plçiés ' 
if  the animalD a re  depleted of com plem ent (257). . If the  rem oval 
of antigen hwoXvod the com plem ent dependent solubiH‘.nation of ' 
Immune complexe© tîîjosi th is would req iilre  that activation, 
p a rti Gidarly of the  a ltem a tlv o  pathway, o ccu rred  %viihln the 
glomeindup (145). .
The a c tiv a tio n  o f the c la s s ic a l im th w ^  '
A c tiv a tio n  o f the c la s s ic a l pathway was a fe a tu re  o f a ll the 
dloease groups stud ied w ith  the exception o f MCNS. I t  was 
dem onstra ted by deposition  o f c la s s ic a l pathway com ponents 
w itlm i the k idney in  a ll groupa although reduction©  i i t  a e rm ii 
concen tra tions o f these componenta w ere on ly  found In  8LE  
;md MPGN. N orm al aerum  concentrations of com plem ent 
eomponent© in  MGN (182-184), FG N (227, 228) and HSN (238) 
have been 'fom ct by o th e r g and reduced o laae lca l pathw ay 
compononto. a re  a gene ra l fe a tu re  o f SLE (248), and p a rtic u la r ly  
tho oubendotholia l type Of M'PQN (205). The c o rre la tio n s  w hich 
e x is ted  between In to n c ltlo c  o f deposition  o f clao© ica l pathway 
components and IgG  and ÏgM- in  MPGN and SLE o ffe re d  evidence 
th a t im m im © complesioo w ere  invo lved  in  a c tiv a tio n  in  these tw o 
d isease group© and m ay ouggeot th a t a c tiv a tio n  is  o ccu r r in g  
w ith in  the g lo m e ru li. Tho presence o f co r re la tio n s  between 
the în tene itieB  o f depoolticm  o f c la s s ic a l patliway com ponents and 
€3  in  FG N and SLE m ay suggest that c la ss ica l pathway a c tiv a tio n
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contributes to G3 catabolism in thooe disoaDO groups.
Absence o f a ro la tio n sM p  between h ite h e itie s  o f e ta ln ing  o f 
c la ss ic a l pa tliw ay component© and G3 need n o t exclude the 
c la n o ica l pathw ay ao an im p o rta n t fa c to r in  com plem ent 
a c tiv a tio n . W here no c o rre la tio n s  w ere  p resen t be W e en 
in te n s itie s  o f deposition  o f C3 and e ith e r c la s s ic a l o r  a î to m n U v e  
pathway com ponents as was the ease In MPGN, i t  is  poss ib le  
iSiat b q tii pathways con tribu te d  to  va ry in g  extmkto in  d iffe re n t 
p a tie n ts . Absence o f c o rre la tio n s  m ay a lso  be due to  d iffe re n t 
ra te s  o f rem ova l o f va rio u s  com plem ent p ro te in s  fro m  the k idney 
in  hum an GN a lthough no In fo rm a tio n  Is  a va ila b le  to  asseeo th is  
p o s s ib ility . Gar© was necessa ry when ana lys ing  the c o rre la tio n  
re s u lts  to  cons ide r th a t w ith  correXaticm  values vA thm vobabU ltiee 
o f 0 .05 , B% o f the covro la flon a  w ould be duo to  chance* & h im  
la rg e  num bers o f c o rre la tio n  analyses w ere  p e rfo rm e d  I t  is  
lik e ly  th a t som o o f the s ig n ific a n t c o rré la tio n s  o ccu rre d  duo to  
chance.
The activation  o f the a lte rn a tiv e  pathway
Components of the aXtornativo pathway wore â o m m w tw a t& â  
i n  # 1 0  glomeruli of at least 50% of the biopsies from each disease 
group except MCNS and MGN. In agreement with one large 
study (187a) however, factor B was rarely present. There 
are  several possiMe explanationo for this; 1) the C3b, factor B 
complex* GSbBb iû  unetaMe, with B b decaying rapidly from tïiç 
complex (109). Also factor B may be displaced from  the converts se
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by plH  (J.2Ï) wMcli %mo deposited h% a high porcontage of 
hiopoioa* Tho nhmmto bî factor B h% tho prosonco of tntoaee 
dopooitW:^ of B IB# 03  aW  a leo  p ropord ia  m ay oiiggeot
that piH to extremely ©ffoativ© In displacing lactw B ît&m 
C3b m  # e  For ihoso yoasons abfemrKrq of factor B
&a not inoompatIM© with a lto raa tivo  pathway aoUvatioa, 2) tho ■ 
antioorum  m ay liavo boon too weal: to dotoot fac to r B . Tho 
antleovimx uood fo r  immunoEuorcciccmco rmu a lso  usod fo r tho 
rad ia l im m unodiffusion stucUco a t  a  dilution com payablo wltli 
other ontieora and in i!i© immimoBimrescoace tost a higher 
oonoentration of antioorum was employed tium was used for 
the  o ther non^H w arescelnatel an tieo ra , 3) I t  is  pooelblo that 
tho method o l fixation used In tklB atudy may have destroyed 
the B antlgomloity or laotas? B may be soluble In tho fhmtivo* .
In  aupport of th la  i s  the la e t tha t W yatt (24?a) found fac to r B 
doposltloïi in six  of eight hiopolCiS from 81/0 %m#entf3 using ■ 
unfixed £ror.e:o tinsnie aceilons aWmugh fELctor B was only 
p re se n t in  one o l 18 b iopsies from  MPGH patients* O ther 
worker0  (187a) however Mvo failed to find factor B in tho ■ 
glom eruli of BLE patien ts using un&bced tie  cue aecllon©#
Also #%o motliod of fixation need in tide v/as able to 
domonetrate factor B In the cytoplasm of cultured peripheral 
blood monocytes (288).
The in trag lo m o ru ia r evWonoc of activation  of tho a ltom ^ttvo
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pathway wâo tlieroforo  a lm oot e n # ro ly  baoed on the  prooonco
of propo3'dW wiWn # 0  glomorulL 3?ropordLi may Wad to C3b 
la  the abnenco of factor B (189) and oonooquon#y la  the abooàce 
oi activatloa of th e  alternative pathway, %t io tlioresore permlWo 
that dopoolüon, of propoWh). I© i%ot a good IWoz: of aXtpraatWo 
pa#\way àôtlva#o%%._ . Tho prooonco of both propqydln oitd pIH 
la  #10 glo&noruH of patloat^ wWi GN otiggooto that C3b lo prooont 
a#d It iG proMMo that factor 3  would bhtd to G3b to form 
o%tor%a#Lve pathwy G3 cozÿvortaéo mid oubooquoutly decoy o%? 
be dWplaWA by p lH , That aotWatloa of #%o.altoraa#ve pathway' 
occurs Im OH io further oi?ggostod by tho oceaclonul low eoBcoutrat- 
tone. of-oompùnente in the m m  oi patient» wW% MPGN# FOH#
8LIC and MCMB qmd by the fact that factor B lovelc in- tho aemm 
of MPGN pattonto w ore stgn iB caaay  low er normW,. Tho 
correlations In ihe intonçltioé oi otainiug between proper din and 
&  h% FGH mid bôtwcoR eerum coucèntmtîono ol 03 and at leant 
one alternative pathway component hi MPGN# FGN and BhB 
m g g m t  tW t tlie a lte rn a tiv e  pathway contributes {-signtflcantly to 
€3 cataWii^m#
The ?olo ol the altornatlvo pathway |u colubiHris'^n kamime , 
complcc^e© la uaclcnr. H i t  wore a miivoriial %)rotoc#vo meohaulem 
then a ll  M opsioa would be  expected to  show evidence of activation . , 
A lso  If the activation  ©Ï tho a lte rn a tiv e  pathway was beneficial# 
one would <%üpoôt that damage would bo t e a  oevore whovo
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activation  o ccu rred . This is  not Uio caa&,-' étîncù thorn  %vas 
evWonco of pariioulavAy In M FC# and OLE, both
aocociatcufi v/ith oevoro pathological dam age-, ' I t  Is  im possible 
to  judge» ItQWiwqr, t;Iieth©s thosio kldnoyi) would bo m o re  badly  
damaged In the 'absence of alternative pathway activation. In 
sonic b lopslee, a t  least» • therefore» dam age m ay be caused 
and re p a ir  m ay he  m ade by the  aetl.valkm of the altorriaHve 
pathway.
On the- bastcj of the remAW from  th is  study» MON Involves 
eeoen tW ly  c la ss ic a l patkv/ay acUvalion although th e re  xma 
dexaooition of %)roperdln In four Wopaloe. The significance 
of properdin deposition'has been dleousecd ami tMo deposition 
may inéimt& that alternative pathway activation may play a • 
lim ited  ro lo  In  MON# In  MPGN b # h  paüw aye  of
com plem ent .ectlvation a r e  involvocVaïthough activa tion  la m ore  
intonoo In MPON, and apprmdmaWy êqival numbers of biopoleo 
positive fo r  qlaoelecd and alternative pathway components. 
Reduced oerw n  concentrallonsf o l component© of both pathways 
w ere  found In MPGN although only the m edian leve l of £&çMv B  
vyae reduced» Since th e re  wao no co rre la tio n  betw een (he 
In toaeiiiee of deposition of C3 and e ith e r claseloal- o r  .a lternative 
pathway components I t  In not pooeible. to oay  which' pathway Is 
p r im a r ily  roeponeible fo r  .03 cataboHom in  MPGN and HBH. 
laFCIH both pathways are again Involved and tho,significant
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corrélation between Intcncltle© oi deponitîom of G3 and both 'G4 
and proporçlkx f3iigg©f3t that both contvibuto to a ©IgxiiRcaat 
é?£tént in  G3 'a.ctlvation. Although thero W.ovWenco of activation 
of both pathv/ayo in SLS, more Mopalo.o wore pcmitivo for 
dab si cal pathway components and there was moré_ evidence of 
classical pathway actlvatioxiin the circulation. . Also there was 
■a eigmfl cant cor relation between Intcnsitioa of deposition of G 3 
and Clq but not àl.tèrnàtlvo pathv/ey components,- For these 
reasons, this study shows that the classical pathway is predominant 
in SIiE, .
■ The m odtdation of com plem ent activation  '
_  ■■; .- ■, /
G W m  : , , \  .
■ '■ Cl 4'NH^n0nlroln, the-activation of the classical phtlw/ay 
by fjtblchiamçtrlcaîly Inhibiting Cls; thus prey anting it from 
cleaving C4 Wd C2 to form the classical-pathway C3 conveytasc, '
C42 ’(1 1 0 ). > This ' regulation is  known to bo relatively inolf|.cioiit
•; . _  ■ /  ' - ; ■ '  ■ .
'aWa%AOU&t$ o f m a r k e d l y - i n \ 0 %ceo8  of.phydiqlogicol - ,
levels arc necessary to InMbIt activation of complément in the. ,
prepence of immune complexes (2 S9 ). The role of Cl-INH may
therefor0  be to prevent spontaneous acavatlon of the classical ■
pathway, , Thie rniggestioii la substantiated by the fact that
diseaOGR may res# t frOxn a deficiency ol Ol'^IKH, The moot
common of tliese '1 6  hereditary angioôodomà-(Is 1) but SLE with
CvM has also been 'reported (2 6 0 ), : The data reported in W.o •
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Study suggest that C.I-ï,Mîï in Involved In régulation.ol;the ■ 
.'dasolcalt' pathway- i This'Is based 03i the•■prcfseace’-of’GI-INB 
in the kuhioyB of patients with each tyjic of GN, tlie .oorreJ-atiou 
between the intensities of 4oppc4t!.on of Cls and CL’IMH in MPGN 
and FGN and #ie 'similarities i#-distribution-patterns isi all- 
biopsies where both proteius were deposited. There was no 
evidence t.hat clàsolcal patliway "'activation was the result of 
a deficiency of Gl-dNH since oorum eohceutratione. were' either 
normal or" raised-fu all sample© oludied. There are however"
Géveral'factor© which do n o t  ôupport a regîdàtory role £or-cI«lNH 
iu GH. Firstly, Cl -INH is  not effective in halting complomeut 
■ àctivatiori. This i s  c teaouo trated  by the p resen ce  of G4 ami € 3  
with Cvio .asad'Gl'“ÏNH ia the  Iddaeye.. • ThoinofEclonoy ol CÎ-ÏNH 
was flioeusaçd à t tho Wgmmlng of tMo' section and the''pros enco 
of Çl-ÏNài may ropreoent. Only limited regulation. ' Secondly,
' the côncordencé betw een biôpoieo poslilvo for C lo  and CI^INH 
w as genera lly  poor with preqont in  the  àboénco o l C lo .
Possible reason© for this have boon outlined in Chapter 3.
The presence of Clp ànd"'Gl-XNB-ln the kidney m ay appear 
oomewhat anomalouo since the binding ol CLdMH to G la  and 
. G lr  on aggregated  IgG in  known to cause-the diaooclatlem ol a  
Glr Cla (GI-ZNH^ complex from tho GI complex (E6 I), It ir> 
th e re fo re  possib le  th a t w here Clo and O l-IN H .are  found together 
in tho kidney, they are not attached to Im mune com plexes via
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C lq  but a r e  lying f re e  and W e  m ay account fo r the  fac t tîiat 
G Is W often absen t from  îddnoya positive  fo r  XgG, C4 and OS,
Control pro tein#  o l C3b
CZhW A  aM  p iH  a re  both control protein» of C3b hv^ a c t 
in  d ifferen t way». C3blNA i» an ennyme which causes the 
degradation  of C3h to  fo rm  an  inactive m olecule which is  fu rth e r  
catabollsed  by try p sin  o r  like  enr-yme» to  fo rm  C3c and C3d 
(121), CSbïNA cannot bind to  C3h which i s  hound to  fac to r B , 
p iH  ac ts  to  p reven t the ampllBcablon of the  a lte rn a tiv e  pathvmy 
hy d isp lacing  fac to r B from  C3h (127) and thus aiding tlie 
ensym atic  degradaU on hy CSbJNA and hy binding to G3b to  
p reven t the  C3 convertase  from  refo rm ing . Thus p  IB  inhibits 
s to ich iom etrica lly .
GSbmA
T h ere  is  l i t t le  evidence from  tM s study to  suggest that 
regu lation  of C3b by 03blNA w as occurring* since only seven 
b iopsies showed deposition of CSblNA. A bsence of CSbXNA Is 
not how ever, incom patible with regulaUon since  the  m echanism  
of acUon is  enzym atic  and GSbJNA would no t be expected to  
rem a in  In  position  a fte r  inactivaMng G3b, Two o th er studies 
have failed  to  dem onstra te  deposition of GSbXNA in  va rious 
types of GN (24 ta, z62)). In the c ircu la tion , regulation  by 
CSblNA would no t re s u lt  In reduced se ru m  concentrations of 
C3bINA since th is  enzym e is  not consum ed during i ts  Inactivation
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of C3b (î9.5)i Low CBfoïHA Icvolo  m ay how ever reo tilt in  
am plification  of tixe a lte rn a tiv e  pathway. ■ Tho exioteneo of 
a pooWvO correlation between oevum concentration© of CSblNA
and G3 lii B/JPGH may arglio that, in MPGN, C3MHA. is involved 
■ In the regiiiatlcm ol activation. ,
BIEJ..v*#rr-r^.üsr«»A.«
That |3ll-I wao involved in regulation of G3b in GH v/ao well 
fmbotanllated by it© frequent prooeace m ihe Mclaey, good 
, ooacordanco between biopoieo positive-for*-03 and jBIH in a ll 
gvcsupà,, good correlation between.intonsMos of deposition of 03 
and plH  in MGH, MPGN and FGN and closo eWilamties in 
tho-distribution pattorao of thene two proteins in all blopsloo 
where.both xveré-fotmd together. There was-also no evidence 
of à generalised defi ciency- of jBlH la Mio cerum. ■ There Ib 
Jhovefove close a^sociiitlon between C3 and BIH in tho kidney 
in each of the clleeaoe group© otudied aad gince pi'B  acts by 
binding to G3b to farm the relatively otablo complex C3bpiH, 
the clone relationship ©uggeoto that B IB in fimctioniag to control 
G3b In GN« T his appears to  be the case  even w here  ren a l 
Mopoieo wpre oi^Wned fro m  patlcato  with c ircu la ting  n ep h ritic  
factor and réasbnç for tMo were dis cits oed in Chapiter 4. p i ’B 
VKiD oimllarly found to he frequently present in kidneys from 
ON parents hy .otherp (247, 2 6 2 ),
D espite tho d o s e  relationoMp botwoeh 0 3  and BIH in the
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Mdmey# i t  is  a tlE  tW t the  preaeAee o i p i t i  â o m  mot
3%preae%t effective aregeîatle» q£ fee ac tiv itie s  of C3Î> by piH*. .
Two OKplmiations £03? fee presence of pSH In fee absence of ' 
i’egiiîatiçB may bo onggeeted. It Is hx%om% that sialic ackl 
deficient anrfacea offer a 'ÿ^otected". site i o ^  C$h» ■ preventing 
effective regulation by plH  aacl baoemont m m u h v m - m .I n ù lo H à  
from  glosB oralonephrltlc bidneya have been  shcnm to  cental# 
only half fee sialic,acid content of normal basement membranes .
(SI4)* The m ecltanlsm  fo r  th is  lo s s  of s ia lic  oMûn is  n o t  h n o v m  
bnt I t in  por^sfMe tliat o lfeor m lcro -'o rgan lsm s o r  cells# sm& ae 
nentropbllo  o r  m acrophages wMch accxmudat'e In th e  kidney . 
becaim e of the  b # .am m ato ry  p ro ce ss  m ay contain nenra in ln ldaso  
wMd.% rem oves fee  s ia lic-add*  T hese m em branes' m ay therefore# •
■ '‘protect** €3b  allowing em ipllflcatioa of fee  a lte rn a tiv e  pathway* 
Studies using neutam lxddaae tre a te d  ehee%3 erythrocytes*  have' 
ehovm that in  th ie  “p ro tec ted "  sltm tlom  about 10 p e r  c m t of C$b 
m ay bind B i l l  (90) end therclbre#  in fee Mdney# fee  p resen c e  of 
p iH  m ay ind ica te  Unit i t  lo- controlling only a  om all pereemfege 
o f fee  C3b molecule©I fee rem a in d e r re ta in ing  th e ir  activity# 
Although tM c po ssib ility  could xtot be positive ly  esscludèd* fee
■ s im ila r  In ten sities  o f 0 3  m iûpA U  In a ll  groups stud ied  m ay-suggest 
.that, a t  most* only a  sm a ll p roportion  of 03b  m olecu les a re  
“p ro tec ted "  .in th is  way#
The eecond po ssib ility  lo fea t fee  e n tl-p lH  an tlse ru m  m ay
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Imvç hùmi eontumlnatod antibodies to 04~W%dlng protein 
(C4#bp), -Ftgita et al# ( l i t)  showed 044)%) binds ta C4b 
and caW ysoi^ tîie degradation  pf C4b h f  C3WNA# T hese 
antham aWe showed that anti IB antisam olten-contained 
nntl"C4''bp spcclÈcEy* Thu# some or ali ol thep iB  staining 
coidd îiavo been due W fee presence of C4«bi> in tlxo Mdncy.
Although again  vm  cannot o xdW o tbio poasibllity» Uïop l fT  
antigen used  In tlie .p réparation  gave-a single lin e  on sodium  
dodeoyl ©ulphafe polyàorylam ide gol e loc tropho reels  and did not 
bind olgnllieantly  to  EAC4# po ten tia te  the inactivation  of CAh hy  
OSbïKA o r  cîectaM lîeo C4B# The an tin erw n  ob ta ined  by Immunteat* 
ion of rab b its  v;ith fee antigen was ohown to  be p u re  by double 
diffusion and im m unodestrophovools and fee  sW ning  obtained 
w m  com pletely blocked by p r io r  absorp tion  of fee  anfecerum  
w ife.fee p u re  antigen preparutioxt# -Further evidence to  support 
th is  com es fro m  fee fac t fea t fee only biopsy in  which € 4  was 
deposited In the absence of G 3# did not a tain for pVB*
Therefore# in th is  ctudy# fee m ethods and extent of 
com plem ent activa tion  in  husnan GH have been  aaeeosed  and the  
ro le  of the  contro l p ro fetns examined# While the  fa c t th a t 
complement -activation In ON Hu 0 %tenalve* ham been ostabliohed# 
mo a ttem p t hMs been m ade  to  define fee  effccta  of felo ac tlva tlo iii 
I t  ÎB preWiMe #m t the  com plem ent oysfem  developed to  r id  
fee body of infection  # d '  fee im portance of fee ëyètem  ia
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dem onstra ted  by the fac t that pa tien ts with defic iencies of 
c la ss ica l pathway components have a  h igher incidence of im m une 
com plex d ise ase  than norm al (263, 264) and a lso  tha t patien ts 
w ith p rim a ry  deficiency of C3 (265, 266) o r deficiency of C3 
resu ltin g  from  a genetic  deficiency of GSblNA (93) su ffer from  
p e rs is te n t b a c te ria l infections. The com plem ent system  is 
e ssen tia lly  a beneficial p ro ce ss  and i t  is  probable  that com plem ent 
is  involved in  the prevention  of the  developm ent of GN by its  
ro le  in aiding the  rem oval of an tigens. W hether in trag lo m eru la r 
com plem ent activation  is  beneficial to the kidney is  le s s  likely  
since i t  causes cell ly s is , a ttrac tio n  of Inflam m atory  cells and 
in c reased  cap illa ry  perm eab ility , a ll of which w ill re s u lt  in 
dam age to the kidney. I t  has recen tly  beenrshown that activation  
causes the so lub ilisa tion  and rem oval of im m une com plexes from  
the cap illa ry  loops of rabb its  with acute se ru m  si cimes s . W hether, 
on balance, in trag lo m eru la r activation  does good o r  h a rm  th e re fo re  
rem ains a m a tte r  fo r conjecture.
I t is  possib le  tha t a r tif ic ia l a lte rna tion  of the  com plem ent 
system , perhaps by in c reas in g  the concentrations of control 
p ro te in s m ay becom e a  therajDeutic tool in the m anagem ent of GN. 
This m ay be m ost useful in  d iseases  not involving the p resen ce  
of an ongoing infection since the dangers of reducing the effects 
of com plem ent during an infection would be like ly  to outweigh 
the advantages to the kidney. Such d iseases  m ay be those involving 
endogenous antigens, p a rticu la rly  a n ti-g lo m eru la r basem ent 
m em brane d isease , bu t a lso  imm une com plex d ise a se s  involving 
se lf an tigens.
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